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The author of this thesis – Hans-Jörg Lang – completed his medical studies in Freiburg/Breisgau, 
Germany. During a student elective in a remote district hospital in the République du Benin 
(Kouande/Atakora, supported by the German development service/DED) he first was exposed to 
challenges health services face in resource-limited settings. After graduation he conducted most of 
his post-graduate training in the UK (Bangor/North Wales, Cardiff, Leicester, Birmingham, London), 
with a short period as interne in France. Before starting his training in paediatric and paediatric 
intensive care he profited from internships in internal medicine, general surgery, traumatology and 
anaesthesiology. As medical officer in a district hospital in Northern Namibia he gained further 
experience (2001-2003; via the German development service/DED). From 2007-2009 he was 
substantially involved in the preparation of a large RCT (FEAST-study), which was conducted in 6 
paediatric units in East Africa. Hans-Jörg Lang was particularly involved in pragmatic training 
programs in essential paediatric emergency and critical care in four paediatric departments in Uganda, 
where most of the patients were recruited for this RCT (Mulago Hospital/Kampala, Soroti, Mbale and 
Lacor-Hospital near Gulu). In cooperation with colleagues from participating paediatric units, training 
programs included extensive “on the job-training”, improvement of patient circuits as well as 
activities facilitating the integration of study procedures in routine clinical processes. Additionally, 
during the preparation of the FEAST-trial a small study assessing cardiac function and fluid 
responsiveness in 30 children with severe malaria was conducted in Kilifi/Kenya. Point of care 
echocardiography studies and supra-sternal doppler assessments were done by Sophie Yacoub and 
Hans-Jörg Lang. Paper 2, was conducted in Lacor-Hospital, Gulu in Northern Uganda (one of the 
sites of the FEAST-study) and arose from persisting contacts to colleagues in this remarkable hospital. 
From 2011 to 2014 Hans-Jörg Lang worked at Kamuzu Central Hospital (KCH) in Lilongwe/Malawi 
on a paediatric unit with around 20,000 paediatric admissions per year (employment by the Malawian 
College of Medicine and the German international cooperation/GIZ). Despite extreme resource-
limitations the clinical team managed to substantially reduce paediatric hospital mortality within 
several months by strengthening different elements of a patient circuit. Particular support was 
provided by the late Prof. Peter Kazembe (previous head of department of the paediatric unit a KCH 
and head of the Baylor, HIV-services at this stage). In 2011 the Malawian College of Medicine 
(Malawian-COM, based in Blantyre) opened a second campus at KCH. In cooperation with Dr. Ajib 




contributed substantially to the start of a 3rd year medical student paediatric course in Lilongwe. In 
2014 in cooperation with Dr. Bernadette O’Hare and Dr. Ajib Phiri he contributed considerably to the 
start of a clinical officer bachelor training program. During his time in Lilongwe two basic 
observational studies assessing the use of bCPAP in the treatment of children with acute respiratory 
dysfunction were conducted, including Paper 1.  
Since 2015 Hans-Jörg Lang worked for two humanitarian organisations. Via Médecins Sans 
Frontières (MSF) he supported projects in different countries in Sub-Sahara Africa and Afghanistan. 
As paediatric advisor for the NGO “The Alliance for International Medical Action (ALIMA), 
https://alima.ngo/en/news/) the author worked since 2019 in Ebola treatment centres in the eastern 
part of DR Congo, a large COVID-treatment centre in Guinea and other projects. At the same time 
he remains involved in training programs, research projects and guideline development. He also 
holds a lecturer post in the Global Child Health Department of the University Witten/Herdecke in 
Germany. In the last years he was involved in some activities supported by WHO (Ebola training 










Great thanks and respect for all my colleagues and students I worked with over several years in 
paediatric departments in different countries. So many colleagues work with amazing dedication in 
challenging and sometimes overwhelming conditions. My thoughts are with all the critically ill 
children treated during these periods as well as their parents and families.  
Particularly I remember the late Dr. Peter Kazembe, who supported many colleagues, including 
myself with advice and always positive spirit. Dr. Kazembe was one of the first paediatricians in 
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In 2019 approximately 5.2 million children died before the age of 5 years. More than 40% of deaths 
in this age group were due to deaths during the neonatal period. Around 2.2 million children and 
young people died between the age of 5-24 years.1 Children living in “fragile states”, exposed to 
socio-economic challenges, political instability and humanitarian crisis with limited access to 
essential, good quality health services are at increased risk.1-3 Most deaths in children and newborns 
are either preventable and/or treatable. Social, economic and political determinants have a major 
impact on child health as highlighted in the United Nations Sustainable Development Goals.4,5 
However, public health interventions and essential emergency and critical care (EECC) in health 
facilities and streamlined referral pathways have the potential to substantially reduce preventable 
mortality of children, adolescents and adults in resource-limited contexts.6,7 Pragmatic research 
projects addressing important clinical challenges can contribute to improved quality of care and guide 
policy makers towards the set-up of efficient health care systems. Publications presented in this thesis 
address aspects related to respiratory support and treatment of haemodynamic instability in critically 
ill children treated in resource-limited countries in sub-Saharan Africa (SSA).  
GlobalBurdenofdiseasesandregionaldifferences
Since 1990 there has been a substantial reduction in child mortality globally.1 In 1990,12.5 million 
children under the age of five years died, while in 2019 this had reduced to 5.2 million.1 A number of 
low- and middle-income countries (LMICs), for example in South East Asia achieved the United 
Nations Millennium Development Goal number 4 which was to reduce the under-five mortality rate 
(U5MR) from 1990 to 2015 by 2/3. However, a number of countries in SSA were less successful in 
reducing child mortality.1 In 2019 approximately 50% of all child deaths occurred in SSA.1 Child 
mortality is higher in fragile states and among populations exposed to humanitarian crisis (e.g. conflict 
or post-conflict situations, displaced populations).1,2 Economic factors play an important role and 
wealthier countries can spend more on public services and have much lower levels of child mortality, 
however countries in SSA often have as little as $100 per capita to spend on all sectors including 
healthcare.4 Additionally, there are considerable geographical and social inequalities within countries 
in terms of child mortality.8  
A large number of deaths in children are attributable to severe infections (e.g., respiratory 
infections, severe malaria, diarrheal diseases; figure 1).1 Most severe infections are either preventable 




dysfunction and death. This process can be defined as sepsis,9 a syndrome caused by severe infections 
associated with a disease progression potentially leading to multiple organ dysfunctions. Sepsis is not 
defined as a separate entity in the standard Global Burden of Disease estimates,1,9,10 but is a major 
cause of morbidity and mortality worldwide and in many low-resource settings is the terminal event 
of poor and/or delayed management of severe infections. Incidence of sepsis peaks in early childhood 






Malnutrition increases the risk to develop severe infections and worldwide around 50% of deaths 
in children under age of 5 years are associated with undernutrition.1 Additionally, the prevalence of 
human immunodeficiency virus (HIV) infections and tuberculosis (TB) substantially contribute to 
morbidity and mortality among children and adolescents.1 In most low-income countries, neonatal 
mortality did not decline to the same extend as overall U5MR and world-wide, neonatal deaths 
account for more than 40% of deaths in children under the age of five years.1 
Maternal health is critical for disability-free neonatal survival,1 yet maternal morbidity and 
mortality remains high in resource-limited settings.11,12 Most causes of maternal deaths are 
preventable and or treatable e.g.: severe sepsis, post-partum hemorrhage (PPH), eclampsia, 
complications associated with unsafe abortions.12 A considerable number of maternal deaths, 
stillbirths and neonatal complications can be prevented by improving access to essential obstetric 
emergency care services.1,12 Complication rates in pregnancy are particularly high in young mothers.12 
Therefore, management of obstetric emergencies in adolescents and young adults is an important 
aspect of emergency and critical care. 
In the age group between 5 and 24 years approximately 2,2 million children and young people died 
in 2019 of mostly preventable and treatable conditions.1 Injuries (including road traffic accidents, 
drowning, burns, and falls) are important causes of morbidity and mortality in children and young 
people above 5 years.1 In fact, road traffic injuries are among major causes of morbidity and mortality 
in older children, adolescents, and young adults,13 while exposure to violence is particularly relevant 
in conflict zones.2,3 Non-communicable diseases (e.g., diabetes, sickle cell disease, epilepsy, 
malignancies) contribute considerably to disease burden in older children and adolescents.1,10 
Adolescent health takes a central role within the “LIFE COURSE (figure 2)” as outlined in the United 
Nations Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030).14  
A considerable number of children who survive critical conditions (e.g., cerebral malaria) suffer 
subsequently from preventable life-long disabilities.15 Access to essential emergency and critical 
care (EECC) has the potential not only to contribute to reduction of mortality, but also to the 
reduction of preventable disability.7,15,16  
The SARS-CoV2 pandemic is having direct effects on health systems. However, indirect effects 




of essential health services as well as effects on allocation of health resources can potentially have a 
severe impact on maternal and child health, especially in low-income countries.1,17 
In this thesis, aspects of essential paediatric emergency and critical care will be discussed, with a 










The international community recognizes the need to urgently reduce preventable child deaths. This 
objective is outlined in the United Nations Global Strategy for Women’s, Children’s and Adolescents’ 
Health (2016–2030)14 and the United Nations Sustainable Development Goals (SDGs).5 In this 
context, EECC is an important element of Target 3.8: To achieve universal health coverage, including 
financial risk protection, access to quality essential health-care services and access to safe, effective, 
quality and affordable essential medicines and vaccines for all.5,6,18 EECC has the potential to 
contribute to reduction of preventable morbidity and mortality in children, adolescents and adults in 
resource-limited settings.6,7,19,20 Examples for critical clinical conditions, which can be treated within 
a referral system, able to provide EECC: 
x Children with severe pneumonia and hypoxaemia need access to health facilities who can 
provide supplemental O2 and non-invasive respiratory support. 
x Children with severe anemia associated with severe malaria need stabilisation of vital organ 
function, including the possibility to receive a safe blood-transfusion if indicated.  
x Patients with prolonged seizures need stabilisation of vital organ functions, seizure control and 
treatment of underlying causes. 
x Sick newborns have higher chances of survival with access to essential newborn care.  
x A pregnant adolescent with postpartum haemorrhage needs access to EECC and specifically 
to emergency obstetric services. 
In order to improve access to EECC, a robust referral pathway from communities and peripheral 
health facilities to district or regional hospitals is crucial.21-24 The majority of critically ill patients 
enter and move along this referral pathway. However, access to adequate hospital based emergency 
and critical care is challenging for a large part of populations in SSA.23 Additionally, improvement 
of quality of paediatric care in peripheral facilities and hospitals needs a multi-disciplinary approach, 
including sustained training programs for health workers.21,22,25,26 
Strengthening access to EECC on different levels of referral pathways, is also a vital element in 
outbreak response strategies (e.g., Ebola Viral Disease, SARS-CoV2), in association with infection 






Community health workers (CHWs) can be trained in the recognition of signs of serious illness 
and can therefore perform “triage” on community level. Early recognition and referral of sick patients, 
associated with a clear referral mechanism, has the potential to reduce morbidity and mortality. 
Comprehensive training programs need to be adapted to different contexts and skill levels of CHWs.32 
Participation of civil societies and community leaders is vital in all aspects of community based care.33 
PreͲhospitalcare:Peripheralhealthfacilities&“referralhealthcenters”
Services provided in peripheral health facilities are crucial in improving access to essential health 
services for local populations. By decentralising certain health services, workload in district and 
regional hospitals can be reduced. Peripheral health facilities play an important role in the initial 
management of critically ill patients and act as primary referral facility for communities.  
The WHO algorithm, integrated management of childhood illnesses (IMCI), guides treatment of 
common childhood illnesses at the level of peripheral health facilities. Curative care elements are 
integrated with advice on nutritional care, immunization schedules etc.34-37 Essential newborn care is 
part of IMCI algorithms.  
In some settings, certain peripheral health facilities can provide basic level of in-patient care and 
can act as “referral health centers”. In this context WHO guidelines outlined in the pocketbook: 
Hospital Care for Children can complement IMCI-algorithms.38 These guidelines include emergency 
triage assessment and treatment (ETAT), pragmatic algorithms designed for initial identification and 
emergency treatment of critically ill children as well as for children at risk of clinical deterioration. 
ETAT-algorithms follow international principles of paediatric emergency care.38-40  
Severely ill children need immediate emergency treatment, prior to transfer to district or regional 
hospitals. In this context, provision of O2 can have a major impact on survival chances of children 
with respiratory dysfunction and needs to be available at this level of a referral pathway.41 Sustainable 
energy solutions in combination with O2-concentrators can facilitate reliable provision of O2 even in 
remote settings.42,43 Portable O2-concentrators can provide O2 during transfer of critically ill patients.  
PreͲhospitalcare:Transfer
In many low-resource settings, ambulance services are under-funded or might not even exist. 
Communities need to find opportunities to move sick patients to a health facility or organize transfer 
between health facilities. Referral systems are important elements of EECC, which need to be 
strengthened in many countries.24,44. The set-up of “referral health centers” at geographically strategic 




facilities where initiation of emergency treatment as well as clinical surveillance is feasible for a 
period of time. Limited “ambulance service capacities” can then target transfers from these “referral 
health centers” to district/regional hospitals where more advanced emergency and critical care can be 
provided. Efforts to strengthen referral systems need to be adapted to available resources and contexts. 
This requires a sustained multi-disciplinary approach (Appendix 1, Table 11). 
Hospitalbasedcare:Patientcircuits–emergencyandcriticalcare
District or regional hospitals play a crucial role within referral pathways and are the primary 
“referral hub” for peripheral health facilities and need to be considered as vital elements of universal 
health coverage as defined in SDG 3.5,21,22 In many low-resource settings referral to tertiary hospitals 
may only be feasible for specialized services of a minority of patients and only if stable enough for 
transfer. Additionally, tertiary hospitals in many low-resource contexts also cover the function of a 
district hospital for populations living in closer proximity. Within health facilities set-up of efficient 
patient circuits is important in order to provide good quality emergency and critical care, including 
optimized, context-adapted respiratory support as well as treatment of haemodynamic instability.19,20  
Triageandemergencydepartment
Primary entry point to a hospital is the emergency department (ED). WHO in cooperation with 
other agencies suggests a pragmatic “triage tool” categorizing patients according to severity of illness 
and/or risk for rapid clinical deterioration.45 Other triage tools exist (e.g. South African Triage System 
(SATS; Manchester Triage Group).46,47 However, the “WHO inter-agency triage tool” is pragmatic 
and adapted to needs in low-resource settings (figure 3). An efficient triage process ensures rapid 
evaluation of severity of illness, followed by immediate emergency care in case of life-threatening 
conditions. In the context of disease outbreaks, evaluation of the risk of presence of a highly 















Red:Immediateemergencycareisneeded:Patients require urgent resuscitation and support of 
vital organ functions in the emergency unit. Simultaneously treatment of underlying conditions is 
initiated (e.g., sepsis, severe malaria). Pregnant women and newborns need specific attention. Other 
aspects like limb-saving surgical procedures or the potential of rapid clinical deterioration need to be 
considered (e.g., poisoning, neuro-toxic snake-bite envenomation).
Yellow/priority care:The “priority category” commonly presents the largest group of patients 
presenting for triage. Patients in this category have significant illness and the majority require hospital 
admission. Efficient treatment needs to be initiated as soon as possible. Particularly vulnerable groups 
of patients are inherently classified as “priority” e.g.,: young infants, malnourished children, patients 
referred from other facilities.
Green/nonͲurgentcategory:These patients can often be managed in outpatient departments. 
However, treatment should not be delayed. A number of children classified as “non-urgent” may 
benefit from observation in a short stay unit. These patients need to be reviewed regularly. In case of 
clinical deterioration, abnormal vital signs (e.g., SpO2) or point-of care (POC) tests, patients are re-





The set-up and space provided for EDs needs to be considered carefully during construction or 
rehabilitation of hospital facilities. Anticipation and planning for a variety of situations contributes to 
resilience of health facilities and the ability of hospital teams to cope with challenging situations e.g.: 
x Seasonal variation of clinical activities (e.g., rise of activities during malaria seasons). 
x Surges of activities (e.g., mass casualties) and outbreak management (e.g., Ebola, SARI). 
Triage zone, ED and critical care units need to be in close proximity in order to optimize 
communication and support between clinical teams as well as rapid and safe patient transfer. This set-
up improves possibilities to cover 24-hour periods with experienced clinical teams.  
In many low-resource settings a large percentage of patients admitted to hospitals are children. A 
designated part of the ED therefore needs to be prepared for paediatric and newborn care. In smaller 
or medium-sized facilities it is useful to maintain one ED for adults and children in order to facilitate 
rational use of logistic set-up as well as 24-h coverage of the unit with experienced health workers. 
Larger hospitals might consider to separate adult and paediatric sections of EDs. Additionally, EDs 
need to be equipped for the care of specific patient populations e.g.: pregnant women as well as 
surgical emergencies. Rapid access to operating theatres and obstetric emergency care is needed.  
Multi-disciplinary teams are needed to maintain the quality of care in EDs and critical care units 
including e.g.:19 biomedical and logistic support, pharmacy, supply chains, laboratory/blood bank, 
access to imaging/radiology facilities (e.g., point-of-care ultrasound (POCUS), mobile X-ray 
machines). Health workers need support and adequate working environments. Pragmatic training and 
management guidelines are important in this context (Table 1, levels of critical care).  
Shortstayunit
Short stay units are vital elements of efficient patient circuits and should be associated with the 
ED.19 As clinical conditions of children can change rapidly, clinical observation periods can 
contribute to improved safety and quality of care, especially in settings where access to health 
facilities is challenging. An observation period of several hours allows the evaluation of clinical 
conditions of patients and their response to treatment (e.g., in children with non-severe pneumonia, 
non-severe malaria, diarrhea). While reducing risks to miss early signs of clinical deterioration of 
patients classified as “non-urgent cases”, short stay units can help to reduce the number of hospital 





After initiation of emergency treatment, critically ill patients require further care and monitoring. 
Without critical care units, hospitals will struggle to establish efficient patient flow and adequate 
quality of care. Dedicated critical care units for children and adults are needed. Realistic levels of 
paediatric emergency and critical care can be defined (Table 1), taking into account that basic levels 
of critical care have the potential to serve a large number of severely ill children.6,20,49 Higher levels 
of care can be considered if essential elements of services are established in all parts of a patient 
circuit and if adequate resources and skill levels can be maintained.  
Patientcircuitsandnewborncare;Neonatalunits
Neonatal care needs to be considered at all levels of a referral pathway.50 In view of their particular 
vulnerability, newborns in the first week of life are classified as “emergency/red cases” in the new 
WHO Inter-agency triage tool.45 All young infants under the age of 6 months (or practically all breast-
feeding children) are classified as “priority/yellow” cases.45 Patient circuits need to be set-up for the 
treatment of newborns and young infants. Dedicated context-adapted neonatal units in district and 
regional hospitals contribute to improved quality of care.50  
Stepdowncare
Patients recovering from critical illness often benefit from a gradual reduction in levels of 
monitoring and treatment before they are ready for general ward care. Step down care is best provided 
in close proximity to the critical care ward. The set-up of a step-down unit is crucial in order to 
guarantee adequate patient flow, while allowing identification of potential clinical deterioration, 
which may be missed on standard wards.  
Unitsforyounginfants
Experience in large paediatric departments in low-resource settings, shows the importance to 
establish specific clinical zones for young infants (e.g., 1-6/9 months). After stabilisation of vital 
organ functions, these clinical zones can function as “step-down units” for young infants, while 
providing better adapted care and protection for this vulnerable group.  
Otherclinicalareas&paediatricearlywarningsystems
Hospitalized children who deteriorate in standard ward areas (e.g., nutritional units, general 
paediatric or surgical wards) should be transferred back to critical care units after the immediate 




use of paediatric early warning systems (PEWS) among hospitalized children have the potential to 
facilitate recognition of early signs of clinical deterioration.51,52 However, PEWS need to be integrated 
in clinical processes of paediatric units, including pragmatic training of clinical teams and well 
defined patient circuits.52 Care-takers can be integrated in these processes.53 Health workers need to 
be trained to rapidly perform clinical assessments of patients, prior to the formal evaluation of vital 
signs.54,55 This approach is particularly important in case of high work-loads on paediatric units in 
resource-limited contexts. Concern of health workers and care takers, regarding the clinical condition 
of a child should trigger rapid evaluation by an experienced nurse or clinician. Following rapid clinical 
assessment vital signs are then reviewed, including basic point of care tests (e.g., blood sugar, Hb) as 
indicated. Further research regarding integration of PEW-systems in different clinical contexts is 
needed.51-53 
Outbreakpreparednessand“isolationpathways”
Health systems need to be prepared on different levels of referral pathways for identification and 
treatment of patients with suspected or confirmed highly contagious diseases (e.g., Ebola, 
Lassa,SARS-CoV2, measles, cholera). Experience from the Ebola epidemic in eastern DR-Congo 
(2016-2018) shows that good quality EECC can be provided for patients with highly contagious 
diseases, while respecting principles of patient centered care.28,29,56b In this context, efficient set-up of 
treatment centers is crucial in order to provide EECC, while ensuring visibility and transparency of 
patient care for relatives and communities.27-29,57  
ContextͲadaptedlevelsofessentialpaediatricemergencyandcriticalcare
Essential paediatric emergency and critical care has the potential to reduce hospital mortality 
considerably.19,20,49 Training modules and management guidelines recommended by WHO (e.g., 
ETAT)38,39 are adapted to resource-limited settings and follow principles of international emergency 
care algorithms (e.g., advanced paediatric life support/APLS).40 While ETAT-guidelines are 
extremely valuable, they are not designed to cover the whole spectrum of knowledge and skills needed 
to treat critically ill children in district, regional or tertiary hospitals. Table 1 describes suggestions 
for levels of critical care, which can be adapted to available resources, work-load and skill levels of 
clinical teams.
 
b Personal experience in Ebola treatment units supported by the NGO ALIMA in DR-Congo in 2019 and 2020 as well as in 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Respiratory support and treatment of haemodynamic instability are essential elements of context 
adapted critical care in low-resource settings.  
Respiratoryfailure:singleorganfailure(SOF)
Severe respiratory infections are common causes of mortality in newborns and older children.1,62 




The 2014 WHO pneumonia-guideline recommends to treat children classified as “non-severe 
pneumonia” as out-patients, if no additional dangers signs are present.65 To decide at one time-point 
if a child with non-severe pneumonia can be discharged or needs hospital admission is challenging, 
especially in contexts where care-takers have difficulties to return to health facilities in case of clinical 
deterioration of their children.66,67 Observation periods of several hours in short stay units can help 




(SpO2) has the potential to improve quality of clinical assessment and improve identification of 
children with hypoxaemia, who carry an increased risk of mortality.66,68 Biomarkers can potentially 
contribute to clinical risk-assessment and rational use of antibiotics in certain settings.69-71 
Additionally, it is important to include care of children above the age of 5 years in efforts to reduce 
mortality associated with severe respiratory infections.72  
Health workers in district and regional hospitals need to be aware of different factors associated 
with signs of respiratory dysfunction and hypoxaemia e.g.:  
Ͳ Signs of upper-respiratory tract obstruction need to be recognised.40 
Ͳ Foreign body aspiration is among differential diagnosis in children with sudden onset of 
respiratory symptoms. 40,73  
Ͳ Further clinical aspects need to be evaluated: presence of bronchospasm (e.g., asthma), pleural 
space pathologies (e.g., pleural effusions/empyema, pneumothorax). 
Ͳ Cardiac causes need to be considered as a differential diagnosis. 
Further factors influence risk-assessment and treatment of patients with respiratory problems e.g.: 
Ͳ Newborns, infants as well as malnourished children need particular attention.67,74 
Ͳ HIV-infection and associated opportunistic infections (e.g., pneumocystis jirovecii 
pneumonia/PJP, tuberculosis) as well as tuberculosis in children without HIV-infection need 
to be considered.75,76 
Ͳ Children with sickle cell disease (SCD) carry a high risk to develop severe infections, while 
non-infectious patho-mechanisms can co-exist (sickle cell chest crisis).77,78 
Ͳ Presence of other signs of organ-dysfunctions increase mortality risk among children with 
respiratory dyfunction.79-81 
Access to essential elements of critical care on different levels of referral pathways has the potential 
to improve outcomes of a considerable number of children with respiratory dysfunction. Reliable 
provision of supplemental O2 plays an important role in this context.41,43,63 Reliable provision of O2 
is challenging in many contexts in SSA.82 At this stage further non-invasive or invasive respiratory 
support is rarely in hospital settings in SSA. 
MultiͲorgandysfunction:Respiratoryfailureinthecontextofcriticalillness
Severe infections can lead to a complex systemic inflammatory response syndrome (SIRS), while 
different infections such as bacteraemia and malaria can coexist.9,83,84 This disease process can 




Respiratory support is therefore an essential element in the management of critically ill children with 
single or multi-organ dysfunction.85 Pragmatic criteria for the definition of paediatric ARDS were 
defined, considering that in children arterial blood gases are not always available. This is particularly 













Provision of supplemental O2 and non-invasive respiratory support plays an important role in the 
care of children with respiratory dysfunction. A study conducted in Malawi showed that use of pulse 
oximetry in peripheral health facilities and village clinics can help clinicians and CHW to identify 
children with severe pneumonia and hypoxaemia.66,68 A study in Papua New Guinea demonstrated 




On the other hand, reliable provision of O2 remains a challenge in many health facilities in sub-
Saharan Africa (SSA).82 However, O2-concentrators in conjunction with reliable electricity systems 
are cost-effective and provide a reliable method of O2-supply in low-resource settings.93-96 The 
combination of solar-powered energy systems and the use of O2-concentrators can be an option to 
improve O2-supply in health facilities even in remote settings.42,43 
Non-invasive respiratory support has the potential to improve outcome of critically ill children 
managed in low-resource settings. Different forms of non-invasive respiratory support exist: 
continuous positive airway pressure (CPAP), heated humidified high-flow nasal cannula 
(HHFNC/HFNC)c as well as different modes of non-invasive bilevel positive airway pressure 
(BIPAP) support.97-100 CPAP has been used efficiently for the treatment of children with respiratory 
dysfunction in high-resource settings (e.g. viral bronchiolitis).101-103 The role of non-invasive 
respiratory support in the management of septic children with “less severe” paediatric ARDS is also 
under evaluation in high-resource settings.98,104  
CPAP is part of standard care on neonatal units in high resource settings, including the use of non-
invasive respiratory support in combination with surfactant-therapy in the care of preterm infants.105-
107 It has been shown that bubble CPAP (bCPAP) offers a relatively low-cost alternative to ventilator-
delivered CPAP in newborn care.108 There is growing evidence that the use of bCPAP on neonatal 
units in middle-income and low-income countries is feasible and safe.109  
In a previous study conducted in a busy paediatric unit in Lilongwe/Malawi, an improvised bCPAP 
set-up was used in the treatment of severely ill children with acute respiratory dysfunction.110d  
Advancedrespiratorysupport–mechanicalventilation
Interventions described as part of level 2 critical care (Table 1) are quality improvement measures, 
which can realistically be established in certain resource constraint settings (e.g., non-invasive 
respiratory support). A well-functioning level-2 unit is an essential step in the process to develop a 
level-3 intensive care unit (ICU). Advanced airway management and mechanical ventilation can be 
considered in settings where adequately trained clinical teams can treat and monitor patients 24 hours 
per day. Additionally, interventions associated with a level 3 ICU require considerable investment in 
logistics (e.g., biomedical equipment, pharmacy supplies).  
 
c Heated humidified high flow nasal cannula (HHFNC) and high flow nasal cannula (HFNC) are expressions for the same mode of 
non-invasive respiratory support. In this thesis the term HFNC is used. 





Up to 5.4 million people are annually bitten by snakes with one third to one half experiencing signs 
of envenomation. It is estimated that world-wide this results in up to 138,000 deaths per year.111 
However, accuracy of epidemiological data is limited due to under-reporting and poor access of 
snake-bite victims of to healthcare services.111-113 The burden of snakebites is unevenly distributed 
over the globe with 95% of cases encountered in low- and middle-income countries (LMIC) in Africa 
and Asia.114,115 In those countries, snakebites disproportionally affect rural and economically 
disadvantaged populations, who often have limited access to essential health services.116,117 In 2017, 
WHO recognized snakebite envenoming as a neglected tropical disease.117-119 Accordingly, snakebite 
antivenoms are included in WHO’s list of essential medicines.120 
Depending on the snake species, common acute clinical conditions arising from snakebites include 
neurotoxicity, which can rapidly lead to acute respiratory failure (ARF), abnormal coagulation, shock 
and further organ dysfunction, as well as local tissue destruction.121 Multiple factors, such as delayed 
presentation to healthcare facilities, adversely affect outcome of snakebite victims.112 Restricted 
access and high costs are factors limiting the use of antivenoms, particularly in sub-Saharan Africa.122 
123 However, even in the presence of efficient antivenoms EECC measures are vital in the 
management of critically ill snakebite victims. In the case of severe neurotoxic snake bite 
envenomation airway management and respiratory support is particularly important. 
TreatmentofshockinlowͲresourcesettings
Haemodynamic instability is a common complication in critically ill children presenting with 
severe infections and is associated with a high risk of mortality.85  
Definitionofsepsisandsepticshock
Sepsis is a major cause of morbidity and mortality worldwide. Incidence of sepsis peaks in early 
childhood and among older adults. Health-related burden associated with sepsis is particularly high 
in African countries south of the Sahara.9 The International Pediatric Sepsis Consensus Conference 
(2005) published definitions and criteria for sepsis, severe sepsis, and septic shock in children:124  
Sepsis = proven or high suspicion of an invasive infection and the presence of a “systemic 
inflammatory response syndrome” (SIRS). 
Severe sepsis = Sepsis plus one of the following: cardiovascular organ dysfunction OR acute 




New adult definitions and criteria were published in 2016 with “sepsis” defined as life-threatening 
organ dysfunction caused by a dysregulated host response to infection (Sepsis-3).125 In this consensus 
the new adult definition “sepsis” equals the previous term of “severe sepsis”. “Septic shock” is 
therefore defined as one of the organ-dysfunctions associated with sepsis: a circulatory and 
cellular/metabolic dysfunction associated with a high mortality-risk.125 The “Surviving sepsis 
campaign international guidelines for the management of septic shock and sepsis-associated organ 
dysfunction in children-2020 (SSC paediatric guidelines, 2020)” still uses the 2005 nomenclature for 
definition of sepsis and severe sepsis.85,124 Adaptations of the international paediatric sepsis definition 
are currently debated.126  






WHO uses clinical parameters to define shock in children (Appendix Table 14): presence of the three
followingsigns:Coldextremities,CRT>3seconds,weak&fastpulses.38,39
Differentcausesofcirculatoryfailureneedtobeconsideredbycriticalcareteams.40,127
At this stage, the vast majority of paediatric units in in SSA lack resources to implement all steps of 
the management algorithm outlined in figure 5.128 Nevertheless, it is feasible to apply internationally 
accepted strategies of critical care and implement essential, initial steps of these algorithms. 
However, interventions need to be reviewed and adapted to resource-limited contexts. Additionally, 
regional epidemiology of burden of disease needs to be taken into account (e.g., nutritional status of 
children, prevalence of SCD, severe infections like malaria, dengue). The “European society of 
intensive care medicine (ESICM) global intensive care” working group describes similar challenges 












Aim and objectives 
The aim of this thesis is to evaluate essential elements of respiratory and circulatory support in the 
care of critically ill children treated in resource-limited contexts. 
Specificobjectives
In Paper 1 the specific objective was to: 
Ͳ Evaluate non-invasive respiratory support with bCPAP in the treatment of critically ill 
children with the following clinical presentations:  
o Children with respiratory dysfunction (as single organ dysfunction).  
o Children with respiratory dysfunction in the context of multi-organ dysfunction (e.g., 
severe malaria/sepsis). 
o Children with respiratory dysfunction and associated co-morbidities e.g.: severe acute 
malnutrition, HIV-infection. 
In Paper 2 the specific objectives were to:  
Ͳ Evaluate the clinical outcomes of critically patient snake-bite victims, including patients with 
acute respiratory failure due to muscle paralysis following neuro-toxic snake envenomation. 
Ͳ Describe the characteristics of an intensive care unit in a resource-limited settings using 
invasive respiratory support. 
In Paper 3 the specific objectives were to:  
Ͳ Review the impact of IV fluid resuscitation on respiratory, cardio-vascular and neurological 
function among critically ill children with haemodynamic instability.  
Ͳ Describe the effects of normal-saline and human albumin solution (HAS 5%) as resuscitation 
fluids on electrolyte and acid-base balance.  
Ͳ Evaluate the benefits and risks of fluid resuscitation among patients with haemodynamic 




































































The studies in this thesis were conducted in the following countries: Malawi, Uganda, Kenya and 
Tanzania, table 3. In addition, patient cohorts from Malawi, the United Kingdom and South Africa 
were included in Paper 3. Table 4 gives basic country information regarding the human development 
index (HDI) situation and child mortality in 1990 and in 2018.1,132,133 The data highlight the 
considerable reduction in child mortality in Malawi, Tanzania, Uganda, Kenya and South Africa. The 
data also show that neonatal mortality did not decline to the same extent as mortality rates in children 
above the age of 1 month. Health interventions for children above the age of 5 years and adolescents 
need the same attention as activities targeting the well-being of younger children.1  
The economical situation of a country has a major impact on child health.4 Regarding child 
mortality and access to essential health services considerable regional differences within LMICs 




systems are needed.5 Improving access to essential paediatric emergency and critical care on different 






















Malawi 1990 50 139 239 22% 40 172
2018 22 35 50 46% 14
Uganda 1990 39 109 185 23% 32 1592018 20 34 46 44% 15
Kenya
1990 28 68 107 26% 18 147
2018 10 31 41 48% 10
Tanzania 1990 40 100 166 25% 30 159
2018 21 38 53 41% 13
South
Africa
1990 20 46 59 34% 8.1 113
2018 11 28 348 32% 5.5
United
Kingdom
1990 4.5 7.9 9.3 48% 1.8 15







This was an observational study of all children 0–15 years treated with bCPAP between 26 
February and 15 April 2014 conducted in the paediatric department at Kamuzu Central Hospital 
(KCH) in Lilongwe, Malawi. KCH is one of the 4 central hospitals in the country with more than 700 
beds. The paediatric department has around 300 official beds, including paediatric surgery and the 
neonatal unit. In 2014, the department had approximately 20 000 admissions of children between the 
ages 2 months –15 years. It was conducted during the peak of the malaria season in March and April 
2014. During this period more than 2500 children with different levels of severity of illness (SOI) 
were admitted per month.49 A re-organisation of the patient circuit in this paediatric unit contributed 
to a reduction of paediatric hospital mortality (reported mortality in 2010: around 7%).134 Since 2011, 
further quality improvement measures were put in place and a further reduction of mortality was 
achieved. During the study period in 2014 hospital mortality in the paediatric unit in KCH was 





In this large hospital in Lilongwe the adult ED functioned separately from the paediatric triage and 
patient circuit. Paediatric patients were initially screened in a triage/admission zone, situated in close 
proximity to the paediatric department. Critically ill children were immediately managed in a “4-bed 
resuscitation zone”. This area was directly connected to a “critical care/emergency zone” 
(approximately 16–18 beds), where further essential critical care was provided. During extremely 
busy times several patients had to be placed in one “bed-space”. In an additional “treatment room“ 
less severe “priority cases”, who needed hospitalization received initial treatment before further care 
was continued in the different clinical areas of the paediatric department.  
In a 6-bed “high dependency unit (HDU)”, closer observation of selected critically ill children 
could be offered. The number of HDU beds was insufficient for the management of the large number 
of hospitalised critically ill children. This deficiency could be partially compensated by the 
introduction of the “critical care/emergency zone”. Close proximity of essential elements of the 
patient circuit (triage, resuscitation zone, critical care zone and HDU) allowed health workers to work 
as a team and adapt to different levels of work-load. Senior supervision by at least one consultant on 
site for 12 hours/day was assured. Consultants on-call arrangements were made to cover 24 hours/day.  
A step-down unit allowed observation of patients, who improved clinically during the treatment in 
the HDU or emergency/critical care zone, but who still needed closer surveillance. The introduction 
of a step-down unit for young infants (<6-9 months) contributed to improved quality of care for these 
particularly vulnerable children and reduced work-load in other clinical areas. All newborns born in 
KCH and almost all newborns admitted via triage and the emergency zone were treated in a dedicated 
neonatal unit.  
Despite resource-limitations, the paediatric department tried to strengthen crucial elements of an 
efficient patient circuit. Centralisation of basic critical care enabled a limited number of staff to 
provide best possible care to an extremely large number of critically ill children.  
Paper1:SupportofchildreninfectedwithHIV
The unit’s policy was to offer HIV testing and counselling to every hospitalised child. However, 
because of high workload and limited numbers of HIV counsellors not all hospitalized children were 
tested. Of note is the remarkable support by the late Dr. Peter Kazembe, head of Baylor College-HIV 
services and previous head of the paediatric department at KCH.136 His team contributed to good 




lymphoma). This included ambulatory care and in-patient support during day-time working hours and 
week-days (e.g., initiation and adaptation of anti-retroviral treatment/ARV).137 Support of Baylor-
College also included clinical advice from a paediatric cardiologist for a period of time.  
Paper1:BubbleCPAPdevice
The low-cost bCPAP devices used in this study are modified O2-concentrators with a maximum 
air/oxygen flow of 16 liters/min (LPM) (maximum O2-flow: 8 LPM, maximum air flow: 8 LPM). 
FiO2 can be determined by adjusting the ratio of O2/air flow. Blended flow is humidified and warmed 
using the heat produced by the compressor of the device. Pressure is determined by the distance of 
the distal part of the expiratory limb of the ventilation circuit below the water surface of a water bottle 
(“resistor”). These bCPAP devices were reviewed by an independent biomedical team in Sweden and 
performed similarly to bCPAP devices used in high resource settings.138 It is important that new 
bCPAP systems follow the conventional set-up for bCPAP in order to guarantee pressure stability 
and low flow resistance withing the system (figure 6).138-140 In case not enough “bCPAP set-ups” were 
available, O2-cylinders were used to provide O2-flow required for provision of bCPAP. With this set-
up, FiO2 could not be adapted but O2-flow could still be humidified. Patients were switched to 













Paper 1 describes an observational study evaluating clinical outcomes among children treated with 
bCPAP between 26. February and 15. April 2014 in the paediatric department at Kamuzu Central 
Hospital (KCH) in Lilongwe, Malawi. Most newborns were treated on a dedicated neonatal unit. A 
small number of newborns born outside KCH, received respiratory support with bCPAP on the 
paediatric unit. Only these newborns were included in the study. 
Critically ill children (0-15 years) were initiated on bCPAP if, after initial resuscitation, they were 
found to have severe respiratory distress and/or hypoxaemia with or without further organ 
dysfunctions (e.g.; shock, severe anaemia, altered level of consciousness). BCPAP was initiated in 
the “emergency/ critical care zone” or HDU depending on bed availability. 
Very severe pneumonia was diagnosed by the presence of either SpO2 <90%, severe respiratory 
distress (severe chest indrawing), danger signs such as inability to drink or breast feed or reduced 
level of consciousness. The term “very severe pneumonia” used in this study corresponds to the 
classification “severe pneumonia” as defined by revised WHO pneumonia guidelines from 2014.65 
Multiorgan failure (MOF) was defined as respiratory dysfunction associated with further organ 
dysfunction at the time of bCPAP initiation: cardiovascular dysfunction (including severe anaemia) 
or neurological dysfunction. Severe anaemia was defined as an Hb <7 g/dL or clinically when POC-
testing of Hb was not available. Neurological dysfunction was defined as a Blantyre Coma Scale 3 
or status epilepticus.38  
HIV status was defined as “infected” if a child <2 years had a positive DNA PCR test or a child 
2 years had a positive rapid test. A child was considered to be HIV exposed if there was a positive 
rapid test for a child <2 years or a documented maternal positive test, but no DNA PCR had yet been 
performed. Malaria was diagnosed by a malaria rapid diagnostic test (MRDT). All children with 
malaria receiving bCPAP were considered to have severe malaria in view of their respiratory 
dysfunction. 
Nutritional status was described as either normal, moderate acute malnutrition (MAM) or severe 
acute malnutrition (SAM) according to WHO guidelines.38 The following conditions were classified 
as comorbidities: congenital heart defects diagnosed by point of care echocardiography, neurological 





This study was conducted on the ICU in St. Mary’s Hospital, Lacor (Lacor Hospital) in Gulu, 
Uganda between January 1, 2006 and November 30, 2017. Lacor Hospital is a private, non-profit 
(former mission) hospital located in the north of Uganda serving approximately 700,000 inhabitants 
in a poor, post-conflict region. During the time of the study, the hospital had 476 beds and six 
operation theatres. The hospital ran an 8-bedded ICU for critically ill adults and children with eight 
trained nurses and four assistant nurses (nurse: patient ratio per shift, 1:4-8). One anaesthetic officer 
and physician shared the medical responsibility for the ICU patient (Table 5). This team was assisted 
by a senior anaesthetist from 2002 until 2016. Data from this ICU were reported previously.141  
The paediatric unit of Lacor Hospital was one of the study sites of the FEAST-study (Paper 3).131 
During the preparation of the FEAST-study the author worked intermittently on the paediatric unit 
and the ICU of Lacor-hospital between 2007 – 2009.  
Paper2:Studydesignandparticipants
This observational study was designed as a retrospective analysis of a prospectively collected 
database which included all patients admitted to the ICU of Lacor-hospital between January 1, 2006 
and November 30, 2017. 174 (2.5%) out of 6,976 patients admitted to the ICU were treated for 
snakebite envenomation and were included in the study. 
 
Paper3:Studysetting
Patients recruited and treated in the following study sites were included in the analysis of this 
publications: Paper 3 is a review of the FEAST study published in 2011.131 In this study 3170 children 
with signs of respiratory distress and/or reduced level of consciousness and signs of circulatory 
impairment were recruited and treated in 6 paediatric departments in Uganda, Kenya and Tanzania 
(Table 6). Results of four further studies describing treatment of critically ill children with signs of 
haemodynamic instability and/or neurological complications were used to compare physiological 
derangements among study patients of the FEAST-study. These additional four studies were 







































































































































































In Paper 3 data from the FEAST-study were re-analyzed. Data from 4 additional studies were 
integrated in the analysis: Two published paediatric studies of critically ill children (meningococcal 
disease in the UK, and cerebral malaria in Malawi)145,146 together with data from two unpublished 
cohorts (one from South Africa, the other from St. Mary’s hospital in London, UK).  
In the original FEAST study 3170 patients with fever, respiratory distress and/or 
prostration/reduced level of consciousness and signs of impaired perfusion were enrolled between 13. 
January 2009 and 13. January 2011.131 In “Stratum A” 3141 were randomly assigned to either 
maintenance fluids only (4 mL/kg per hour; n=1044), or to receive IV fluid boluses of 20 mL/kg 
human albumin solution (HAS) 5% (n=1050) or normal saline (n=1047) in the first hour. A further 
20 mL/kg of resuscitation fluids were administered if signs of impaired perfusion persisted.131 
Children initially assigned to “Stratum A” developing severe hypotension during the course of the 
treatment received 40 ml/kg boluses of study fluid (normal saline in the control group).131 In “Stratum 
B” patients were classified who presented with hypotension (systolic blood pressure of <50 mm Hg 
in children younger than 12 months of age, <60 mm Hg in children 1 to 5 years of age, and <70 mm 
Hg in children older than 5 years of age). Children in “Stratum B” were randomly assigned to receive 
40 ml/kg of HAS bolus or normal saline. Only 29 patients were enrolled in this group (13 received 
HAS boluses; 16 received Saline boluses).131  
Of note, initial boluses were increased in “Stratum A” from 20 to 40 ml/kg (60 ml/kg in “Stratum 
B”) after a protocol amendment in June 2010.131 This is an important information, as 40ml/kg is a 
high volume of resuscitation fluid administered to critically ill children in settings without possibility 
to provide non-invasive or invasive respiratory support or infusions of vaso-active drugs. 
Children with SAM (weight/height – z-scores <-3)38 and patients with signs of severe dehydration 
were not included in the FEAST-study.131 WHO defines specific fluid management-regimens for 
these particular patient groups.38,39 
Vital signs were assessed in surviving children at 1 h, 4 h, 8 h, 24 h, and 48 h after starting IV fluid 
bolus in the HAS and normal saline groups, or after randomisation in the control group (Paper 3 
Annex 1 p 21). Hb levels and plasma lactate were measured at baseline, 8 h, and 24 h. Base excess, 




Further clinical details of the FEAST-study have been described in different publications.131,147,148 
FEAST-data were the main source of the secondary analysis of results presented in Paper 3.  
Paper3:ObjectivesandsetͲupofthereͲanalysisoftheFEASTͲtrialdata
In view of un-resolved questions raised by the FEAST-trial, authors of Paper 3 believed that a 
review of data from this RCT would be beneficial. This review reflects an important scientific process, 
which can contribute to improvements of a comprehensive approach to the care of critically ill 
children with haemodynamic instability treated in malaria-endemic, resource-limited contexts.  
Paper 3 postulated that increased mortality in patients receiving IV fluid boluses was associated 
with adverse effects of fluid resuscitation on respiratory function, cardiovascular function as well as 
O2 carrying capacity or neurological function. In this context biochemical and acid base haemostasis 
of IV fluid bolus recipients was affected as well.  
To test this hypothesis “organ function-scores (physiological scores)” were developed in order to 
measure essential parameters describing severity of respiratory, cardiovascular and neurological 
function. For this purpose, sequential vital sign data from the FEAST-study were evaluated. These 
“organ function scores”, evaluated at “baseline” for patients recruited in the FEAST-study were then 
compared with the severity of organ-dysfunction and clinical outcomes in four other cohorts of 
critically ill patients treated in Malawi, South Africa and the United Kingdom (paper 3). 
For FEAST-patients, further analysis were performed in order to detect sequential changes in organ 
function within the first 48 hours of admission. In addition, effects of the actual volume of 
administered IV resuscitation fluid was evaluated. Additional important clinical derangements were 
considered in the analysis process: Hb levels, electrolyte and acid-base derangement (paper 3). 
In order to better understand the impact of fluid resuscitation, subgroups of patients presenting 
with comparable “clusters of patho-physiological phenotypes” were defined (paper 3). 
Comparisonoforganfunctionscoreswithfurther4cohortsofcriticallyillpatients
In paper 3 “Organ-function scores” (respiratory, neurological and cardio-vascular scores) at 
baseline in the FEAST-study cohort were compared with cohorts of critically ill patients with di൵erent 
degrees of severity of illness (SOI) and causes of disease. Additionally, different levels of critical care 
could be provided for patient cohorts treated on a research ward in Blantyre Malawi (level 1 unit with 
relatively high health worker to patient ratio)146 as well as EDs and PICUs in South Africa and the 





In a Malawian cohort, between 4. June, 2010 and 5. June, 2011 448 children were admitted to 
Queen Elizabeth Central Hospital, Blantyre, Malawi, and reported in a study describing children with 
severe neurological insults associated with cerebral malaria (including the presence of malaria 
associated retinopathy).146 Results of serial magnetic resonance imaging (MRI) of the brain and 
clinical variables were related to outcome.  
CohortfromSouthAfrican(2013–unpublisheddata)
In a South African cohort, 61 children receiving fluid resuscitation for presumed sepsis and acute 
gastroenteritis at Red Cross Children’s Hospital, Cape Town, South Africa were recruited between 1. 
February, 2013 and 1. June, 2013. Vital signs and other clinical details were documented on admission 
to hospital and related to outcome (need for intensive care admission or death).  
CohortfromUK–meningococcaldiseasestudy(1997Ͳ1999)
In a UK meningococcal disease study 148 fatal cases and 354 survivors with meningococcal sepsis 
in England and Wales were enrolled between 1. December, 1997, and 28. February, 1999. The cohort 
has been described previously.145 
CohortfromanemergencydepartmentinLondon/UK(2014Ͳ2015–unpublisheddata)
In the St Mary’s (London/UK) cohort, vital sign data and outcome (need for hospital or ICU 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Patients admitted to the paediatric unit at KCH in Lilongwe benefited since the end of 2011 from 
different activities. The Malawian College of Medicine (COM; based in Blantyre/Malawi)149 opened 
a second campus at KCH, in Lilongwe in 2012: 
Ͳ In 2012 a part of the Malawian medical student training program was moved to KCH. This 
included a clinical paediatric rotation for 3rd year students.  
Ͳ In 2014 the clinical part of a clinical officer bachelor training program was started at KCH.26  
In the context of these training programs experienced paediatricians were integrated in clinical care 
on the unit.149-153 Additionally, clinical officers enrolled in the bachelor-training program contributed 
as “middle grade clinicians” to improved quality of care. The author worked as a paediatrician in 
KCH from end of 2011 to 2014 and contributed substantially to the start of the paediatric rotation of 
medical students as well as the initiation of the bachelor training program for clinical officer.26  
BCPAP was established as a routine form of non-invasive respiratory support on the paediatric 
unit. In this context bCPAP was integrated in continuous “on the job training” and tutorials for nurses, 
clinical officers, post-graduate trainees and students. In 2012 a first CPAP-study was conducted on 
the unit, using an improvised bCPAP-set-up.d 110 Quality of care improved between 2012 and 2014, 
while work-load remained extremely high. The conduction of the observational CPAP study 
described in Paper 1 contributed to improved surveillance of critically ill children.  
Paper2Mechanicalventilation:training&benefitforthestudypopulation
A senior anaesthetist contributed over several years to continuous on-the-job training on the ICU 
at Lacor-hospital. A formal training program in anaesthesia was initiated for clinical officers. 
Essential critical care skills were included in this training program.  
Routine documentation of essential clinical data of critically ill patients enabled the ICU-team to 
establish an on-going audit process. Data of this documentation have been published in a previous 
study.141 Paper 2 is a result of this audit-process. These activities contributed to improvements of 
clinical practice on the ICU.  
 Of note, Lacor-hospital was one of the FEAST-study sites. In this context the hospital’s paediatric 





FEAST- study sites in Uganda, Kenya and Tanzania benefited from the following interventions: 
Ͳ Formal ETAT- trainings38 were conducted in participating units in Uganda and Kenya prior to 
the start of recruitment of patients. On the job training/coaching in aspects EPECC took place 
during the preparation of the RCT and during the recruitment phase. 
Ͳ Patient circuits were optimized, especially in the Ugandan study sites Soroti, Mbale and Lacor-
hospital. These activities contributed to improved triage, emergency and critical care. Study 
procedures were integrated in routine processes of the participating units. 
Ͳ Additional nurses and doctors recruited for the RCT were responsible for identification, 
recruitment and treatment of study patients, including further specific study procedures (e.g., 
consent, documentation). These colleagues were integrated in clinical teams of participating 
units and contributed to general paediatric care. 
Ͳ Some essential equipment and consumables were financed via the FEAST-study budget (e.g., 
O2 concentrators, SpO2 monitors, NIBP-machines, basic resuscitation equipment). 
All patients treated on the participating units benefited from these activities. The author 
substantially contributed to these processes between 2007 and 2009 (page 12 of the initial 
publication).131 
Patients recruited in the Malawian cohort in Queen´s Elizabeth Hospital were treated on a specific 
research unit: A well-equipped level 1-unit (Table 1) with a good nurse to patient ratio and senior 
supervision. Patient cohorts in the studies conducted in Cape Town and London/UK were recruited 
in well-equipped high-resource settings.  
Datacollection
Paper1BubbleCPAP:datacollection
A case record form (CRF), an observation chart and a patient register were used for data collection. 
Data were entered into an Excel database. Collected data were based on essential clinical observation 
and information used in routine practice. Data-collection performed for study purposes therefore 
contributed to improved quality of patient surveillance on the unit. This study was done in a routine 
clinical setting and did not have a target sample size. The sample included most patients treated with 
bCPAP between 26 February and 15 April 2014. Only isolated, CPAP-runs of short duration (less 
than 12 hours) might have been missed. Of these isolated cases, all children survived as all files of 





This observational study was designed as a retrospective analysis of a prospectively collected 
database which included all patients admitted to the ICU of Lacor-hospital between January 1, 2006 
and November 30, 2017. From this database, all patients admitted to the ICU because of snakebite 
envenomation were included into the analysis. No exclusion criteria were applied. Selected data of 
139 study patients were included in a previous analysis reporting admission diagnoses, use of 
mechanical ventilation and outcome of critically ill patients treated at the study ICU.141  
Paper3Fluidresuscitation:RandomizationanddataͲcollection
The initial FEAST- study was conducted between 13 Jan 2009-13 Jan 2011.131 
FEASTͲstudy:randomization
Randomization procedures for the FEAST-trial were conducted by the trial statistician at the 
Medical Research Council Clinical Trials Unit, London/UK. Each clinical trial center received a list 
of trial numbers and the randomly assigned intervention. Randomization procedures were introduced 
at each study site.131  
FEASTͲstudy:datacollection
Children recruited in the study followed the same patient circuit as any other child treated in the 
participating units. Study procedures (e.g., recognition critical illness, immediate initiation of 
emergency treatment, consent procedures and randomization) were integrated in routine processes of 
the units. Also “study interventions” assigned by the randomization process and data collection were 
integrated in essential critical care management. This process of integration assured that data-
collection and trial monitoring was well accepted by communities, health professionals and 
contributed to the quality of study procedures.  
A structured CRF was completed at defined time-points: 
Ͳ Vital signs were documented at following time points in the CRF: baseline, 1 h, 4 h, 8 h, 24 h, 
48h and in addition essential clinical interventions, including trial interventions. 
Ͳ Hb, plasma lactate was measured at baseline, at 8 h, at 24 h and base excess, pH and 
electrolytes were assessed at baseline and at 24 h. 
Adverse events were recorded and reported to the Clinical Trials Facility in Kilifi, Kenya, within 
2 days. Documentation of study procedures (e.g., identification of patients, consent, randomization, 
trial interventions), data collection as well as recording of adverse events were reviewed regularly by 




independent clinician. In case neurological sequelae were detected a further assessment was 
conducted at 24 weeks.131 
Statisticalanalysis
Paper1BubbleCPAP:statisticalanalysis
A CRF, an observation chart and a patient register were used for data collection. Data were entered 
into an Excel database. The proportion of bCPAP cases who survived by risk group, sex, age, 
complications, HIV status and treatment methods were described. Univariable logistic regression to 
determine if the odds of bCPAP survival were higher in particular subgroups was conducted. In view 
of the relatively small number of recruited patients no further multivariable analysis could be 
conducted. Additionally, the following analysis is described: survival and death (treatment failure) by 
HIV status, severe malnutrition and the presence of organ-dysfunction other than respiratory failure 
including shock, malaria, anaemia (MOF). This study was done in a “real life” clinical setting without 
dedicated funding and did not have a target sample size. All analyses were done in Stata V.14.2 for 
Mac (paper 1). 
Paper2Mechanicalventilation:statisticalanalysis
All statistical analyses were performed using the IBM SPSS Statistics (former PASW), (IBM 
Software 20.0; IBM, Vienna, Austria). We compared survivors and non-survivors as well as patients 
presenting with different snakebite envenoming syndromes (paralysis/neurotoxicity; coagulopathy/ 
shock/hemolysis; extensive tissue damage) using the Chi²-, Mann-Whitney U-rank sum, and Fisher’s 
Exact test, as appropriate. P-values <0.05 were considered to indicate statistical significance (paper 
2). 
Paper3Fluidsresuscitation:statisticalanalysis
Statistical methods of re-analysis of FEAST trial data were complex and were led by an 
experienced statistician. For more details, please see the methods section of paper 3 and annex 1.  
Paper 3 represents a hypothesis-based reanalysis of FEAST data. The primary hypothesis was that 
IV fluid bolus administration is associated with considerable changes in cardiovascular, respiratory 
and neurological function as well as O2-carrying capacity, biochemical and acid-base status. 
The secondary hypothesis of paper 3 was that if these changes are detectable, they can explain the 




To evaluate these two hypothesis, multiple analyses were conducted in paper 3 in order to describe 
if organ-function at baseline had an impact on risk of mortality in the different intervention arms. 
Additionally, further analysis were conducted to detect changes in organ-function over time (48 
hours) and to assess on how actual volume of IV resuscitation fluid impacted on organ-function and 
clinical outcome. In this context further clinical derangements potentially associated with IV fluid 
bolus administration were evaluated e.g.: Hb levels, electrolyte and acid-base changes as well as 
lactate levels. 
In order to better understand the impact of fluid resuscitation on clinical outcomes of patients with 
different clinical presentation, subgroups of patients presenting with comparable “clusters of patho-






























































To assess severity of respiratory dysfunction, respiratory rate (RR) and SpO2 were used. Vital signs 
were normalised using published age-adjusted normal values (Paper 3 Annex 1, pp 3-6). The 
contribution of SpO2-measurements were “weighted” in order contribute adequately to the 
“respiratory score” in relation to changes in respiratory function. 
Respiratory score=(respiratory rate – mean respiratory rate for age) + 5 × (100 – SpO2). 
If measured RR was less than mean RR for age, the term (RR – mean RR for age) was set to zero, so 
that only increased RRs contributed to the score. 
Use of SpO2/FIO2-ratios could have strengthened the value of the score.87-91 However, in the 
FEAST-study no reliable FIO2-values were documented. Additionally, some participating units 
struggled to ensure reliable provision of O2 as suggested by WHO.93 
CardioͲvascularscore
Physiological responses to developing cardiovascular dysfunction are initially aimed at 
maintaining BP in order to assure perfusion of vital organ functions with vasoconstriction and 
increasing HR. If these compensation mechanisms fail, adequate perfusion of vital organs decreases. 
Age-adjusted degree of tachycardia as well as the degree of hypotension was combined. Together 
with a weighted value of capillary refill time (CRT) these essential clinical data were used to form a 
measure of cardiovascular dysfunction as follows (Paper 3 Annex 1, pp 3-6): 
Cardiovascular score=(heart rate – mean heart rate for age) + (mean systolic blood pressure for age 
–systolic blood pressure) + 25 × (capillary refill time). 
If measured HR was less than mean HR for age the term (HR - mean HR for age) was set to zero. If 
systolic blood pressure (SBP) was higher than mean SBP for age the term (mean SBP for age - SBP) 
was set to zero. 
Integration of Hb levels could have strengthened this cardio-vascular score. In some research 
settings determination of cardiac-output index and oxygen delivery can be of added value.154  
Neurologicalscore
Raised intracranial pressure is associated with decreasing level of consciousness and 
potentially with bradycardia, and hypertension (the latter two are components of Cushing’s triad).155 
The following parameters were combined to a “neurological score”: weighted level of consciousness 




stimulus=1; responds to painful stimulus=2; unresponsive=3)40 and age adjusted degree of 
hypertension, and age adjusted degree of bradycardia (Paper 3 Annex 1, pp 3-6) .  
Neurological score=(SBP – mean SBP for age) + (mean HR for age – HR) + 25 × (AVPU coma 
scale).  
If SBP was lower than the mean SBP for age, the term (SBP - mean SBP for age) was set to zero, so 
that only increased SBP contributed to the score. If HR was greater than the mean HR for age, the 
term (mean HR for age - HR) was set to zero, so that only decreased HR contributed to the score. 
Potential weakness of the score e.g.: Not all patients with increased intra-cranial pressure will 
develop hypertension, especially if a patient presents with haemodynamic instability. Additionally, a 
potentially time-limited period of hypertension might not have been recognised during the FEAST-
study. However, the impact of the AVPU coma score may compensate for this potential weakness.  
In the FEAST-cohort, scores were calculated at baseline and 1 h, 4 h, 8 h, 24 h, and 48 h. From the 
cohorts from Malawi, South Africa and the UK only baseline data were used for the analysis. 
ConsentandIRBapproval;ethicalconsiderations
Paper1CPAP:consent&IRBapproval
Ethics approval was provided by the Malawian National Health Sciences and Research Committee, 
protocol number 941. As the study describes routine clinical management (non-invasive respiratory 
support) of critically ill patients, patient consent for publication was waived. Authors have not 
declared a specific grant for this research from any funding agency. There were no competing interests 
of the authors (paper 1). 
Paper2Mechanicalventilation:consent&IRBapproval
Analysis of the ICU data was approved by the institutional review board (IRB) of Lacor-hospital. 
This study evaluates routine patient care on the ICU. Due to the retrospective design of the study, 
written and oral consent was waived. Data of 139 study patients were included in a previous 
publication. Similar IRB approval procedures were applied in this context (paper 2).141 
Paper3Fluidresuscitation:consent&IRBapproval
All studies were approved by the IRB of the relevant centers. Details of recruitment procedures, 
consent procedures, ethics, and institutional approvals for the FEAST, meningococcal, and Malawian 
cerebral malaria studies have been reported.131,145,146 Access to the FEAST trial data was provided 




St Mary’s Hospital/London cohort were approved by relevant research ethics committees of 
University of Cape Town and UK. In agreement with these approvals, written informed consent was 
taken only for participants from whom additional data or samples were obtained beyond those 
necessary for routine care. Data from each study were made available with agreement of the relevant 
study investigators. Analysis of factors affecting outcome in each study were covered by the ethics 
approval of each study (paper 3).  
StudyoversightoftheinitialFEASTstudy
Ethics committees at Imperial College, London, Makerere University, Uganda, Medical Research 
Institute, Kenya, and National Medical Research Institute, Tanzania, approved the protocol. An 
independent data and safety monitoring committee reviewed interim analyses two times per year.131 
EndpointreviewcommitteeoftheinitialFEASTstudy
An endpoint review committee, reviewed all deaths, neurologic sequelae and adverse events. 
Members of this committee were unaware of the management assigned to individual patients during 
the randomization process.131 Of note, the endpoint review committee had limited diagnostic means 
to determine causes of death (e.g., no routine point of care lung ultrasound or echocardiography or 
imaging options of the central nervous system were available). Accuracy of determination of causes 
of death or adverse events was therefore limited.e  
Patientconsentinaclinicaltrial,assessingcriticalcareinaresourceͲlimitedsetting
An informed consent process assured voluntary participation of patients in this clinical research. 
International guidelines exist to protect patients recruited in emergency and critical care 
research.156,157 In order assure that the consent process does not delay time-critical emergency 
interventions a system of deferred consent was used in the FEAST trial.131 In this context the consent 
process was started during the initial emergency treatment with a verbal assent. After the initial 
stabilisation of the child this process was completed by an informed consent conversation, while 
considering potential cultural and language barriers.158,159  
 






The following measures contributed to quality of care and safety in relation to the observational 
study presented in Paper 1: 
Ͳ bCPAP is a recognised form of non-invasive respiratory support for children and newborns. 
Already in 2012 bCPAP was introduced on the paediatric unit in Lilongwe as part of routine 
care in children with respiratory dysfunction.d110  
Ͳ The device used in the study followed standard set-ups of a bCPAP system. In a biomedical 
review conducted in a respiratory laboratory of Karolinska Hospital, Stockholm/Sweden, it 
performed similarly to a bCPAP system, used in high resource settings.138  
Ͳ A pragmatic “on the job” training program accompanied the introduction of bCPAP.  
Ͳ In the given context of an extremely busy paediatric unit, participation in the observational 
study was associated with additional attention to clinical monitoring and surveillance.  
Paper2Mechanicalventilation:Assuranceofpatientsafety
Medical devices used for mechanical ventilation in the ICU of Lacor Hospital were routinely used 
for anaesthesia and intensive care in multiple countries and by a number of humanitarian 
organisations. Advanced airway management and mechanical ventilation was routinely practiced on 
the ICU and in operation theatres of Lacor Hospital. Experienced clinicians were involved in the care 
of critically ill patients. A senior anaesthetist routinely supported the clinical team.  
The database, from which data were extracted for this study (Paper 2), was routinely used on the 
ICU and enabled the clinical team to maintain an ongoing audit process. 
Paper3Fluidresuscitation:Assuranceofpatientsafety
During the preparation of the RCT and during the time of recruitment, the “paediatric emergency 
triage assessment and treatment training team” as part of the clinical trial team invested enormous 
efforts to integrate study procedures in routine processes (page 12 of the original publication):131 
Ͳ Patient circuits were reviewed in partnership with the institution’s clinical teams and 
administration.  
Ͳ On-going capacity building in combination with the introduction of some biomedical 




critical care adapted to available resources. Health workers recruited specifically for the 
FEAST-trial actively participated in clinical care of all patients treated on the units.  
In this context, the participating paediatric departments generally benefited from quality 
improvement measures associated with the conduction of the FEAST-trial.  
For further details regarding information related to study oversight (independent data and safety 
monitoring committee), please see Annex 2, the original FEAST publication.131 
Results – Main findings 
Paper1BubbleCPAP:Resultsandmainfindings 
Paper1:Clinicaloutcomes
Of note is the good clinical outcome of children with “very severe pneumonia (VSPNA)” and no 
other severe organ dysfunctions (single organ failure, SOF). All 19 children with VSPNA who were 
HIV negative and had no additional comorbidities or organ dysfunctions survived (five children in 
this group had suspected TB). Additionally, 40 from 42 (95%; 95% CI 84% to 99%) children with 
VSPNA (unknown or negative HIV status) and no comorbidities and no other organ dysfunction 
survived (paper 1). 
In children with respiratory failure and further organ dysfunctions (e.g., shock with and without 
severe anaemia, reduced level of consciousness (multi-organ failure, MOF) survival was lower (45%), 
than in those with SOF and no comorbidities (86%; p<0.0001).  
Additionally, survival was significantly lower in children with SAM (36%) as compared to patients 
with no severe malnutrition (81%). Survival was also lower in children with confirmed HIV infection 
or exposure (45%), compared to those with negative HIV-status (81%) or with unknown HIV-status 
(68%). 61% of children with SAM had more than one organ dysfunction (e.g., signs of shock). A 
more detailed sub-analysis was not possible because of the relatively small number of recruited 
patients (N=117) (paper 1). 
Among the 117 patients presenting with respiratory failure, four had congenital heart disease CHD) 
Ͳ Atrio-ventricular septum defect (AVSD): 2 children (1 with clinical features of trisomy 21) 
Ͳ Ventricular septum defect (VSD): 1 child 
Ͳ Persistent ductus arteriosus (PDA): 1 (this child had features of trisomy 21) 
If clinical signs suggesting CHD were noted (e.g., a heart murmur, no improvement with routine 




were initially performed by the author. During the study period the clinical team had the chance to 
confirm echocardiography findings with the support of a trained paediatric cardiologist, who was 
affiliated with Baylor College HIV-services.137 
Three of the 117 children described in Paper 1 had signs of neuro-disability: (cerebral palsy (1), 
hydrocephalus (1), suspected neuromuscular disorder (1) (paper 1).  
Paper1:Technicaldetails&complications
Of the 117 patients, 13 experienced complications related to bCPAP-treatment, including nasal 
obstruction(2), blocked nasal prongs (2), interruption of O2-supply from depleted cylinder (2), lesions 
of the nasal septum (7) and aspiration of enteral feeds (1). Some patients had more than one 
complication. The number of treatment failures among those experiencing complications was 3/13 
patients (paper 1). 
There were no statistically significant differences in survival by bCPAP delivery devices. 
However, the clinical team tried to use dedicated bCPAP set-ups, whenever possible. O2-cylinders 
providing O2-flow for bCPAP were only used if no dedicated bCPAP were available or as back-up in 
case of power cuts (paper 1). 
The average air/O2-flow set at the start of the bCPAP use was 9.1 liters/min (SD 2.0, range 5–16). 
The mean age of patients was 7 months (IQR: 2-15 months) and the mean weight of patients was 6.4 
kg (unpublished dataset of Paper 1). In a bCPAP system air/O2-flow needs to meet the peak tidal 
inspiratory flow (PITF) of patients, which in infants less than 6 months is around 1.7 L/min.160 This 
approach is similar to the practice recommended in the use of High-flow Nasal Cannula (HFNC) 
humidified air/O2 systems.161,162 
The average starting bCPAP pressure was 6.7 cm H2O (SD 1.0, range 4–9). This pressure level is 
similar to the CPAP pressures recommended to achieve adequate reduction of work of breathing 
(WOB) in studies evaluating the treatment of children with bronchiolitis.101,103  
Paper2Mechanicalventilation:analysisandmainfindings
Of the 6 976 patients admitted to the ICU during the study period, 174 were treated for snakebite 
envenomation (2.5%). More than a third of the patients were younger than 18 years (n=67; 38.5%). 
Non-survivors more frequently presented with coagulopathy, shock or haemolysis than survivors. 
Invasive mechanical ventilation was used more often for treating non-survivors than survivors. 
Complications were documented for more non-survivors than survivors. Antivenom (at low and 




of ICU stay was 3 days (interquartile range: 2 – 5 days) and overall mortality was recorded as 8% 
(n=14) (paper 2). 
More detailed information on clinical symptoms at presentation could be determined from the 
ICU-database for 40 patients (23%). The need for invasive mechanical ventilation and subsequent 
ICU mortality differed among snakebite victims who presented with clinical symptoms.  
Sixty patients developed acute respiratory failure (ARF) requiring mechanical ventilation (n=60; 
34.5%). Among these patients, clinical symptoms were documented in more detail in 16 cases. 
Neurotoxicity (fasciculation/paralysis) was the most commonly documented indication for advanced 
respiratory support (87.5%). However, it should be noted that in absence of any other documented 
complication, it is most likely that in this study ARF in patients requiring mechanical ventilation was 
associated with a neurotoxic snakebite syndrome. Antivenom could be administered only to 10 
(16.7%) of the 60 mechanically ventilated patients. Three of these patients died (33.3%). Of the 50 
ventilated patients who did not receive antivenom treatment, seven died (14%). There was no 
statistical difference in mortality between mechanically ventilated patients with or without antivenom 
therapy (p=0.35; Fisher’s exact test) (paper 2). 
The ICU mortality of patients requiring mechanical ventilation was 16.7%. Of the 60 patients who 
required mechanical ventilation, 17 (28.3%) were younger than 18 years. Six of these 17 children 
with ARF died (35.3% mortality). 2 of the 17 children requiring ventilation were younger than 5 
years, both of whom died. Of the 43 patients older than 18 years who required mechanical ventilation, 
four died (9.3% mortality). The difference in mortality rates between children and adults requiring 
mechanical ventilation was statistically significant (p=0.02; Fisher’s exact test) (paper 2). 
Length of ICU stay (Paper 2; Fig. 2A) and mortality (Paper 2 Fig. 2B) were significantly higher in 
patients requiring mechanical ventilation than in those who did not need invasive respiratory support. 
Paper3Fluidresuscitation:analysisandmainfindings
ComparisonofseverityoforganͲdysfunction:FEASTͲstudyandfourothercohorts
For the interpretation of results it is important to note that in the FEAST-study risk of mortality at 
1 hour after randomization was similar in the three study groups (1.2% in the albumin-bolus group, 
1.1% in the saline-bolus group, and 1.3% in the control group).131 After 1 hour, increased mortality 
was documented in patients receiving normal saline or HAS boluses as compared with the control 
group.131 Most deaths among FEAST-study participants occurred before 24 h (259 of 297 deaths 




In the FEAST study, the median organ-function scores were 105 (IQR 86–124) for cardiovascular 
function, 53 (IQR 37–79) for respiratory function, and 25 (IQR 8–47) for neurological function.f 
Patients in FEAST had significantly higher values of all organ-function scores than the cohort of 
patients from the ED in St Mary’s Hospital/London. Respiratory scores at baseline of the FEAST-
cohort was significantly higher than in all other cohorts (p<0ā0001; Paper 3 Annex 1 p 9). As expected 
neurological scores were highest in the Malawian cerebral malaria cohort (median score 75, IQR 55–
78; Paper 3 Annex 1 p 9).146  
Cardiovascular scores of patients evaluated in the FEAST-study were similar to those in the 
meningococcal gram-negative sepsis cohort from the UK (median score 100, IQR 69–157; Paper 3 
Annex 1 p 9).145 Organ function scores in FEAST were highest in the first hours following admission, 
and decreased over the next 48 hours (Paper 3 Annex 1 p 9). It is important to note that patients who 
subsequently died had significantly higher respiratory and neurological scores than survivors at all 
timepoints up to 24 hours (Paper 3 Annex 1 p 9). Cardiovascular scores were significantly higher in 
patients who died than in survivors at baseline. 1 h after administration of initial IV fluid bolus (if 
received) cardiovascular scores were not significantly different between survivors and fatal cases. 
However, after 4 hours or later cardiovascular scores were significantly higher in patients who died 
than in survivors (Paper 3 Annex 1 p 9).  
 In FEAST, odds of death for each ten unit increase in baseline organ function score was 1ā09 (95% 
CI 1ā07–1ā11) for respiratory score, 1ā26 (1ā21–1ā31) for neurological score, and 1ā09 (95% CI 
1ā05-1ā14) for cardiovascular score (all p<0ā0001; Paper 3 Annex 1 p 22). In all four cohorts ten-unit 
increases in baseline scores was at least associated with a trend towards increased risk of adverse 
outcomes (Paper 3 Annex 1 p 22).  
These results suggest that the defined organ function scores are a valuable tool to describe severity 
of illness (SOI) at baseline and in the FEAST cohort in sequential assessments over the following 48 
hours. 
EffectofIVfluidbolusonsequentialorganfunctionscores&laboratoryparameters
In paper 3 linear regression analysis was used to calculate mean differences, adjusted for baseline 
values, between those randomly assigned to receive IV fluid bolus or no bolus in the FEAST-study. 
This analysis was conducted in order to evaluate effects of IV fluid bolus administration on organ 
 




function scores, biochemical parameters and Hb levels. HAS and normal saline IV fluid bolus groups 
were combined, as they had similar effects on mortality in FEAST.131 
Mean respiratory score was 3ā45 (95% CI 0ā90–6ā01; p=0ā0080) higher at 1 h and 2ā3 (0ā31–4ā3; 
p=0ā024) higher at 4 h in IV fluid bolus recipients than in those who received no bolus, but there was 
no significant difference between groups at 12 h (table 2, Paper 3). Fluid bolus administration was 
associated with increased mean neurological scores at 1 h by 2ā64 (95% CI 0ā76–4ā52, p=0ā0060) 
and there was no significant difference at 4 h and 12 h (table 2, Paper 3). In contrast, fluid bolus 
decreased the mean cardiovascular score at 1 h by 2ā17 (95% CI 0ā57–3ā78, p=0ā0080; table 2, Paper 
3). However, later there was no significant difference in cardio-vascular scores between bolus and 
no-bolus groups at 4 h and 12 h.  
In a further post-hoc analysis, HAS and normal saline groups were analysed separately (paper 3 
Annex 1, p 23). Only at timepoint 8 h the respiratory score increased more in HAS recipients than in 
patients receiving normal saline. Otherwise there were no significant differences between FEAST 
study patients who received normal saline or HAS IV fluid boluses (Paper 3 Annex 1 p 23).  
Overall, after 4 h, there were no significant differences in organ function scores compared to earlier 
time-points (table 2, Paper 3).  
IV fluid bolus administration was associated with decreased mean Hb concentration at 8 h by 0ā33 
g/dL (95% CI 0ā20–0ā46, p<0ā0001), which affects O2 carrying capacity (table 2, Paper 3). 
No change in blood lactate was documented in association with IV fluid bolus administration at 8 
h or 24 h. However, fluid bolus was associated with a decrease in mean plasma bicarbonate by 0ā96 
mmol/L (0ā45 to 1ā47, p=0ā0003), a decrease in mean base excess by 1ā41 mEq/L (0ā76 to 2ā06, 
p<0ā0001), and an increase in mean chloride by 1ā65 mmol/L (95% CI 0ā47 to 2ā83, p=0ā0070) in 
patients surviving to 24 h (table 2, Paper 3).  
To assess if IV bolus administration was associated with larger changes of organ dysfunction and 
laboratory markers in some patients, proportions of patients in different sectors of the distribution of 
each variable between fluid bolus and no fluid bolus groups were compared (figure 7g; Paper 3 Annex 
1 p 10). Patients who received IV fluids bolus had an increased risk of a large or very large increase 
in respiratory score and neurological score at 1 h, and of a large or very large decrease in 
cardiovascular score at 1 h (figure 7g). Changes of respiratory score associated with fluid bolus 
 




administration persisted at 4 h (Paper 3 Annex 1 p 10). When absolute values of organ function scores 
at 1 h and 4 h were evaluated, instead of changes from baseline, a bigger proportion of the IV fluid 
bolus group had high respiratory and neurological scores compared to the no bolus group. However, 
a smaller proportion of IV fluid bolus recipients had high cardiovascular score (Paper 3 Annex 1 pp 
11, 12).  
Larger decreases from baseline in base excess and bicarbonate, and larger increases in chloride 
were associated with fluid bolus administration (figure 7:g D–F). Important, at 8 h a greater proportion 













A further analysis conducted in paper 3 evaluated effect of low- or high- IV volume bolus on 
distribution of organ function scores and blood test parameters. At 4 h first vital sign observations 
were documented after administration of high-volume boluses was completed. At this time-point 




were recorded (Paper 3 Annex 1 p13). However, distribution of cardiovascular scores at 4 h was 
similar in low and high- IV volume bolus recipients (Paper 3 Annex 1 p 13). In patients receiving 
high-IV volume bolus lower base excess and bicarbonate, higher chloride, and lower Hb levels (but 
only in non-transfused patients) were documented (Paper 3 Annex 1 p 13). Results were similar when 
changes from baseline were evaluated for these parameters (Paper 3 Annex 1 p14).  
Signsofhyperchloraemicacidosis&respiratoryfunction
Changes of acid-base status and electrolytes observed in FEAST participants suggest that 
administration of IV boluses of HAS or normal-saline can be associated with an hyperchloraemic 
metabolic acidosis (paper 3). To explore this aspect further, a post-hoc analysis was done to evaluate 
the effect of IV fluid-bolus administration on pH and respiratory compensation. Of 2082 FEAST 
participants with pH measurements at baseline, 719 (35%) had acidosis (pH<7ā35; Paper 3 Annex 1 
p 15). Mortality rate among patients presenting with a baseline acidosis was much higher than for 
patients with pH > 7ā35. Among survivors in the IV fluid bolus group, relative risk of being acidotic 
at 24 h was 1ā4 (95% CI 1ā0–1ā9) compared to the no bolus group. There was a significant negative 
correlation between chloride and pH, with a stronger effect of chloride on pH in the IV fluid bolus 
group (Paper 3 Annex 1 p 15).  
Low pH could suggest that respiratory compensation mechanisms had been overwhelmed (paper 
3). In this context respiratory response at early timepoints was evaluated, when the majority of deaths 
occurred in acidotic patients. RRs were increased at baseline and 1 h, relative to normal age ranges. 
SpO2 decreased more in bolus recipients at 1 h, whereas there were no differences between bolus and 
no bolus groups in terms of changes in RR (Paper 3 Annex 1 p 15).  
Documentation of SpO2/FiO2 ratios87-89 potentially allows more subtle evaluation of change in 
respiratory function associated with fluid management and/or transfusion. In this context POC-lung 
ultrasound can be of benefit to detect changes in extra-vascular lung water.164,165 
Evaluationofcriticallyillpatientspresentingwithcomparable“clinicalphenotypes”
In paper 3 three clusters of patients recruited in the FEAST-study with comparable “clinical patho-
physiological phenotypes” were identified on the basis of baseline characteristics (Figure 8h). Cluster 
1 (n=1991) had the least derangement in physiological scores, Hb levels, and lactate. Cluster 2 
(n=795) included patients with severe anaemia (Hb concentration <5 g/dL), high lactate and high 
 




cardiovascular scores. Cluster 2 also had greater base deficit, lower bicarbonate, and high chloride 
concentrations (Paper 3 Annex 1 p 7). Cluster 3 (n=384) was characterised by extremely high 
respiratory and neurological scores, but better maintained Hb levels. The clusters differed markedly 
in mortality (figure 8h). In cluster 1, six (1%) of 658 participants in the non-bolus group died, and 51 
(4%) of 1327 died in the bolus group. In cluster 2, 37 (14%) of 264 patients in the non-bolus group 
died, and 108 (21%) of 518 died in the bolus group. Mortality was highest in cluster 3: 32 (26%) of 
122 participants in the non-bolus group died, and 59 (23%) of 252 in the bolus group died. Analysing 
all study participants, a negative correlation between Hb levels and lactate concentrations could be 





















Associations between IV bolus administration and respiratory score, neurological score, Hb levels, 
and blood biochemistry in clusters 1 and cluster 2 were consistent with those seen in FEAST overall 
(Paper 3 Annex 1 pp 24–26). The association between bolus and changes in blood parameters and 
organ function scores in each cluster are described in detail in Paper 3 Annex-1 (pp 25–27).  

Impactofmultiplephysiologicalchangesonclinicaloutcomes
Authors of Paper 3 rationalized that multiple physiological changes associated with “un-buffered” 
IV bolus administration interact. These fluid induced effects in combination might explain the higher 
mortality observed among IV fluid bolus recipients in the FEAST-study. In this context it is important 
to highlight that in the FEAST-study risk of mortality at 1 hour was similar in the three study groups 
(1.2% in the albumin-bolus group, 1.1% in the saline-bolus group, and 1.3% in the control group).131 
After 1 hour increased mortality was documented in patients receiving normal saline or HAS boluses 
as compared with the control group.131 Most deaths among study participants occurred before 24 
hours (259 of 297 deaths (87%) in stratum A).131 
Among patients recruited in the FEAST-study vital signs were documented in the study CRF at: 
baseline, 1 h, 4 h, 8 h, 24 h and 48 h. Hb levels and plasma lactate were measured at baseline, 8 h, 
and 24 h, while base excess, pH and electrolytes were measured at baseline and 24 h.131 Therefore 
limited biochemistry and Hb values were available for analysis in the first hours after recruitment. 
However, these initial hours were decisive for clinical outcomes in a large number of critically ill 
children.  
A multivariate analysis was performed in order to explore in more detail complex physiological 
mechanisms during the first hours of critical care management (Paper 3 Annex 1 pp 6-8). This analysis 
was based on respiratory, neurological and cardiovascular scores evaluated at 1 hour in the IV bolus 
and non-bolus group. Biochemistry values and Hb levels were affected by administration of normal 
saline and HAS and potentially had considerable impact on organ function. These values were 
therefore crucial for the multivariate analysis. However, besides at baseline these values were not 




patients in the non-bolus group base excess, bicarbonate, chloride at baseline values were used for the 
multivariate analysis (Paper 3 Annex 1 pp 6-8 & Table 9). 
In the bolus group, in order to account for changes in the blood-test parameters associated with 
administration of normal saline and HAS, which were not measured at 1 h, values were adjusted by 
the observed mean shifts at 24 h in biochemical results (base excess -1.41 mmol/l, bicarbonate -0.96 
mmol/l, chloride +1.65 mmol/l) and at 8 hours for Hb levels (-0.32 g/dl) (Paper 3 Annex 1 pp 6-8) . 
This calculation represents a conservative estimation of changes of blood-test parameters in the bolus 
group at 1 h in comparison with baseline values. Patients who were treated with IV fluid boluses, but 
died in the first 24 hours after recruitment are likely to have had the most severe derangements 
potentially associated with administration of normal saline or HAS boluses (paper 3). For this reason 
an additional estimation of biochemical values at 1 h was conducted, using baseline values and data 
derived from the literature (Paper 3 Annex 1 pp 7, 8, 28-31; Table 9). Results of these two different 
estimations are shown in Table 9. For bolus and non-bolus groups, Hb level used for analysis were 
based on baseline levels and the 8 h levels of the data-set from the FEAST-study. 
A principal component analysis using organ-function scores at 1 h and estimated biochemistry and 
Hb levels at this time-point (Table 9) showed that the distribution of fatal cases was distinct from 
survivors, while risk of mortality and derangements of covariates were related to effects of IV fluid 















BaseexcessmEq/l +0,217 Ͳ1,025 Ͳ5
Chloridemmol/l +0,011 +1,577 +10






Multiple further analyses were conducted to evaluate if changes induced by IV fluid bolus 
administration on different covariates at 1 h could explain the increased mortality among bolus 
recipients in the FEAST-study. In addition to a model using baseline variables, four sets of covariate 




Covariate set 1 
The first set of covariate analysis contained the three organ-function scores at 1 h and integrated 
levels for base excess, chloride, bicarbonate based on the levels observed at baseline and 24 h in bolus 
and non-bolus arms. A linear change in the levels from 1 to 24 h was assumed in this context. Hb 
levels used for analysis were based on baseline levels and the 8 h values in FEAST. 
Covariate set 2 
In this set of covariate analysis organ-function scores and Hb estimate were used for analysis as in 
set 1. Additionally integrated in the analysis were levels for base excess, chloride and bicarbonate in 
the bolus arm based on estimates of effects of on “un-buffered” IV fluid bolus (e.g., normal saline) 
on these biochemistry results derived from peer-reviewed literature. Estimates in the no bolus arm 
were the same as those used in covariate set 1. 
Covariate set 3 
The third set of the multivariate analysis evaluated individual components of the organ-function 
scores and used blood levels as described in covariate set 1. 
Covariate set 4 
In this analysis individual components of organ-function score were evaluated as in covariate set 
3. Additionally biochemistry levels (base excess, chloride, bicarbonate) were estimated using results 
from the literature as described in covariate set 2. 
In all four sets of multivariate analysis the impact of fluid boluses as an additional explanatory 
covariate was integrated in the statistical evaluations (paper 3). 
Baseline values of the different covariates could predict mortality in the bolus and non-bolus group, 
but could not completely explain the degree of mortality in the bolus recipients in the FEAST-cohort. 
Subsequent analysis of covariates used estimates to predict 1-hour post-bolus biochemistry values in 
bolus recipients. When these estimates at the time-point 1 hour were integrated in covariate analysis 
no longer significant differences in terms of mortality prediction between bolus and non-bolus group 
could be determined (Paper 3, figure 4; Paper 3 Annex1, p32).  
Overall, results of the post-hoc analysis demonstrates that after fluid bolus administration, 
respiratory and neurological scores as well as base excess were the major determinants of increased 
mortality risk using the two different methods of post bolus biochemical value estimations (Paper 3; 
figure 4A & 4B Paper 3 Annex 1 pp 6-8). When individual components of each score were included 
in the models, post bolus SpO2, AVPU score and base excess made the largest contribution to explain 




chloride levels, bicarbonate and base excess suggest that a hyperchloraemic acidosis was associated 
with “un-buffered” normal saline and HAS administration, which potentially contributed to excess 
mortality in the fluid bolus group in the FEAST-study. These findings were summarised in a 
physiological model proposing how adverse effects of IV fluid bolus could increase mortality (Paper 
3; figure 5). 
Paper 3 describes complex interactions of different physiological mechanisms as well as impact of 
fluid resuscitation on vital organ functions in critically ill children with haemodynamic instability. 
Clinical outcomes of critically ill patients can potentially be improved by a comprehensive, critical 





Paper 1 is an observational study describing treatment and clinical outcomes of 117 children with 
acute respiratory dysfunction treated with bCPAP in a large paediatric unit in Lilongwe/ Malawi. 
Among HIV-negative children with acute respiratory dysfunction and no further organ failure (single-
organ failure/SOF) treated with bCPAP, mortality was low (mortality: 0%). These results correspond 
to outcomes reported from a RCT conducted in a paediatric critical care unit in Bangladesh where the 
study mortality rate was 4% among children with respiratory dysfunction (SOF) treated with bCPAP, 
while mortality among patients treated with low-flow O2 was significantly higher, 15%.166 A previous 
study conducted in the paediatric unit in Lilongwe among critically ill patients with respiratory 
dysfunction using an improvised bCPAP set-up describes improvement of physiological parameters 
(respiratory rate, SpO2) after commencement of bCPAP.d110 Safe introduction of CPAP was also 
described in other paediatric units in SSA (e.g., Ghana).167,168  
These results suggest that non-invasive respiratory support has the potential to contribute to 
improvements of critical care in resource-constraint settings. However, the experience outlined in 
Paper 1 emphasizes the importance to introduce bCPAP in conjunction with sustained efforts directed 
to improve quality of essential paediatric hospital care e.g.: 
Despite considerable resource limitations, important elements of a patient circuit were strengthened 




reliable during the study period allowing safe use of bCPAP set-ups. In case of power-cuts and 
problems with the back-up generator, O2-cylinders could be used. 
A number of health workers previously developed competencies in the use of bCPAP,110 while 
continuous inter-professional on-the-job training in essential paediatric critical care was conducted. 
Training programs associated with the Malawian College of Medicine (e.g. medical student training, 
bachelor training program for clinical officer)26 contributed to improvements of clinical competencies 
among health workers. In this context senior clinicians participating in medical education were 
involved in routine, clinical supportive supervision. 
bCPAP:TreatmentofchildrenwithmultiͲorganfailure(MOF)
In Paper 1 a cohort of children with a high mortality risk is described. In view of resource 
limitations, children with the most severe clinical presentations benefited from non-invasive 
respiratory support via bCPAP. No severity of illness (SOI) scores were used in this study, which 
limits the possibility to compare clinical outcomes with other patient cohorts. In this context, the use 
of SpO2/FIO2 ratios could have helped to better define severity of respiratory dysfunction.89  
Critically ill children with acute respiratory failure and further organ dysfunctions (e.g., 
haemodynamic instability) had a significantly higher mortality risk, than children with SOF (45% 
survival among children with MOF). SAM and/or HIV infection or exposure was also associated with 
lower survival rates. Of note, 17 out of 28 children with SAM presenting with respiratory dysfunction 
treated in this study had further organ dysfunctions (e.g., signs of shock).  
Malnutrition and HIV have been identified as important risk factors associated with increased 
mortality among hospitalised children treated in SSA.135,169-171 Another study conducted in Blantyre, 
Malawi among children with respiratory dysfunction treated with bCPAP also identified HIV-
infection as an important risk factor for mortality.172 
An increased mortality risk among children with severe acute respiratory infections associated with 
additional organ dysfunctions (e.g. haemodynamic instability) has been reported in further studies 
conducted in resource-limited contexts.74,173 A survival rate of 45% was described in a study from 
Papua New Guinea among 64 children with respiratory dysfunction treated with bCPAP. This patient 
cohort was characterized by the presence of important risk factors, similar to patients described in 
Paper 1 (e.g., septic shock (12.5 % of patients), anaemia (20.3%), signs of heart failure (28.1%), HIV 




A RCT conducted in a district hospital in Malawi did not show any benefit of bCPAP treatment as 
compared to supplemental O2 in the treatment of high-risk children with signs of severe pneumonia.174 
Different factors might have contributed to this outcome e.g.: severity of illness and co-morbidities 
of enrolled patients (e.g., HIV-infection/exposure, SAM, multi-organ dysfunction), lack of daily 
supervision by senior physicians, aspects related to the bCPAP system used in the study.174  
Mortality rates for children with sepsis reported in the literature from high resource settings ranges 
from 4% up to 50%, depending on severity of illness, associated risk factors as well as geographical 
location.85 Refractory shock and/or associated multi-organ dysfunction (e.g., neurological 
complications, AKI) are factors associated with high mortality risk.85 In this context, many of the 
reported deaths among children with severe sepsis occur in the first 48-72 hours of onset of critical 
care treatment.85,175-177 Acute respiratory distress syndrome (ARDS) is a common complication 
among critically ill children with severe infections.87,88 Khemani et al describe a mortality risk of 
more than 35% among mostly mechanically ventilated children with severe ARDS (e.g. SpO2/FIO2 
ratio < 150). The majority of these patients had further organ-dysfunctions and/or other risk factors.89  
These results emphasize the importance of early identification of signs of critical illness and 
initiation of efficient treatment in order to reduce risk of disease progression towards severe multi-
organ failure.85 Therefore, essential pediatric emergency and critical care needs to be improved on 
different levels of referral pathways in resource-limited settings.24 Non-invasive respiratory support 
(including bCPAP) has the potential to play an important role in this context. However, limitations of 




The majority of HIV-infections among children can be avoided by efficient prevention of mother 
to child transmission (PMTCT). Despite considerable improvements in countries in sub-Saharan 
Africa (including Malawi), a considerable number of HIV-infected, pregnant mothers are not enrolled 
in PMTCT programs or are not retained in these programs during follow-up.178,179  
Early infant diagnosis of HIV and early initiation of anti-retro-viral treatment (ARV) in children is 
part of the WHO strategy to prevent progression to advanced HIV-disease and death.180 Critically ill 
children with HIV exposure and/or proven HIV-infection carry an increased mortality risk, in high 




critically ill HIV-infected children can improve considerably with adequate critical care management, 
pro-active treatment of opportunistic infections and initiation of ARV-treatment.183 Therefore, HIV 
testing and counselling needs to be integrated in routine practice of paediatric critical care units. 
Presumptive diagnosis of HIV-infection in young children needs to be considered in certain 
emergency situations until HIV-status can be reliably determined.38,75 This approach is particularly 
relevant in children with ARF requiring supplemental O2 or non-invasive respiratory support. Besides 
treatment of potential bacterial respiratory infections, rapid initiation of presumptive treatment for 
pneumocystis jirovecii pneumonia (PJP) needs to be considered: 
Ͳ High dose cotrimoxazole according to WHO guidelines.38  
Ͳ Steroids were found to be beneficial in the management of HIV-infected children with 
potential PJP in a study conducted in Malawi, in a setting where co-infection with 
cytomegalovirus and other opportunistic infections cannot be excluded.76  
Tuberculosis needs to be considered in all children with confirmed or suspected HIV and 
respiratory failure. POCUS offers opportunities to improve quality of clinical diagnosis of TB in adult 
patients with HIV. This approach is particularly important in settings with limited access to other 
forms of imaging and microbiological diagnostics.184 Even with additional microbiological diagnostic 
options a definitive diagnosis is achieved only in a certain percentage of children with actual TB.75,185 
In case of clinical suspicion a pro-active approach to presumptive TB-treatment is needed.75,185 
Additionally, in HIV-negative children with respiratory dysfunction, TB is among the potential 
differential diagnoses. Especially in malnourished children screening for TB needs to be part of 
routine clinical evaluation.38,185  
Respiratorydysfunctionandcardiacconditions
 4 out of 117 children with signs of respiratory dysfunction described in paper 1 had congenital 
heart disease (CHD), highlighting the fact, that acquired or congenital cardiac conditions need to be 
considered as a differential diagnosis among children requiring non-invasive respiratory support 
treatment in resource limited settings.186,187. POCUS can play an important role in diagnosis and 
management of these children.154,164 More specific diagnosis and management of acquired and 
congenital heart diseases should be performed with the input of clinicians trained in paediatric 





Three of the 117 children described in Paper 1 had signs of neuro-disability. Experience from 
PICUs in high-resource settings shows that children with neuro-disability present a considerable 
proportion of patients requiring prolonged PICU admission in case of critical illness, including the 
need for respiratory support.188 If units in low-resource settings improve options of respiratory 
support, health facilities need to prepare for the care of children with particular needs.  
RespiratorydysfunctionandfurthercoͲmorbidities:Sicklecelldisease(SCD),malignancies
SCD considerably contributes to paediatric morbidity and mortality in SSA. SCD needs to be 
considered as an important co-morbidity in critically ill children presenting with respiratory 
dysfunction and other associated clinical features (e.g., severe anaemia, cardio-vascular dysfunction, 
neurological complications).77,78 In the clinical setting, in which the presented bCPAP-study (Paper 
1) was performed access to reliable SCD-testing was limited. Point of care-SCD tests are important 
and pragmatic diagnostic tools in emergency and critical care settings in SSA.77 Access to good 
quality supportive care can improve outcomes among critically ill children with SCD.78 Reliable O2-
supply and non-invasive respiratory support plays an important role in this context. Improved critical 
care for children with SCD needs to be linked to comprehensive follow-up arrangements.77  
In the cohort described in Paper 1 no patients with malignancies were included. However, context-
adapted supportive care, including non-invasive respiratory support has the potential to improve 
outcome of some children with malignancies presenting with an acute illness.189 190 
bCPAP:TechnicalaspectsofbubbleCPAPdevices
In order to explore the full potential of bCPAP and prevent complications certain technical and 
clinical aspects need to be taken into account.  
Air/O2ͲflowusedinbCPAPsetͲups
Air/O2 flow used in bCPAP devices needs to match “peak tidal inspiratory flow (PTIF)” of patients 
in order to prevent the risk to impose additional work of breathing during the respiratory cycle. In this 
context the same principles apply as in high flow-nasal cannula (HFNC) set-ups.  
Milesi et al performed spirometry measurements in 44 children (< 6 months of age; median weight: 
4.3 kg (interquartile ranges: 3.5-5.0kg) treated with HFNC for acute viral bronchiolitis. PTIF in these 
young children was 1.68 liters/min/kg (95% CI: 1.51-1.85; min-max: 0.67-3.00 liter/min/kg). In this 
study PTIF did not correlate with clinical signs of respiratory distress, respiratory rate, required FIO2 
or pCO2.160 Additional studies also suggest that optimal HFNC flow rate to reduce work of breathing 




to be used in bCPAP set-ups. Additionally, the air/O2 flow in bCPAP set-ups needs to be adapted to 
assure continuous “bubbling” at the level of the resistor through-out the respiratory cycle to 
compensate for leaks at the level of the interface or associated with mouth opening. A study conducted 
in newborns treated with bCPAP documented required air/O2 flow of > 2 liters/min per kg, while 
flows needed to be increased with increasing pressure settings.191 
The bCPAP device used in Paper 1 had a maximum flow of 16 liters/min (8 liters air/min and 8 
liters oxygen/min). This device is therefore able to provide adequate flows for children with a weight 
up to around 11-12 kg, if required flows are estimated for children above 6 months of around 1.5 
liters/min per kg. Similar bCPAP devices with a maximum flow of 20 liters/min are available and are 
a better option. However, also these bCPAP devices should only be used in children weighing up to 
13-14 kg in order to match patient’s inspiratory demands. In the study presented in Paper 1, the mean 
age of the patient was 7 months and the mean weight was 6.4 kg (unpublished data).  
Like in HFNC-treatment, nasal prongs used in bCPAP set-ups needs to cover around 75% of the 
nostrils and should not completely seal the nostril, in order to allow entrainment of ambient air, in 
case provided air/O2 flow does not match PTIF. If ambient air is entrained during peak inspiratory 
phases it needs to be assumed that FIO2 of the actually inspired air/O2 will be different during these 
phases, than the FIO2 set at the bCPAP machine. Using interfaces sealing the nostrils, like suggested 
in a bCPAP-study conducted in northern Uganda,192 can expose patients to flow restriction during 
phases of inspiration when the provided air/O2 flow does not match peak inspiratory flow demands. 
In an RCT conducted in a district hospital in Malawi the maximum flow of 10 liters/min of bCPAP 
set-ups used for the care of children with respiratory dysfunction might not have been sufficient to 
match PTIF of children weighing more than 6-7 kg. In this study at times non-vented nasal masks 
were used as interfaces which might not have allowed entrainment of ambient air during phases when 
inspiratory demands were not matched.174  
Future research can help to better determine optimal air/O2 flow needed in bCPAP, especially in 
older children. bCPAP devices able to provide higher flows, matching peak inspiratory demands of 
older children (>13-15 kg) may be beneficial. In order to provide optimal support by bCPAP it is 
important that set-ups follow the conventional set-up for bubble CPAP (see figure 6) in order to 
guarantee pressure stability and low flow resistance withing the system. Alterations of known 





WHO recommends to use heated humidification in children requiring O2 flow of >4 liters/min via 
nasal cannula for more than 1-2 hours.39 High air/O2 flow used in bCPAP or HFNC devices needs to 
be warmed and humidified (conditioned) to avoid drying of nasal secretions, maintain mucosal 
integrity and muco-ciliary function of the upper and lower respiratory tract.39,193 Cold “bubble 
humidification devices” may have limited efficiency to humidify air/O2 flow.194 
Studies using specific simulation techniques show that during normal spontaneous inspiration of 
newborns, an important part of the warming process of inspired ambient air takes place in the anterior 
part of the nasal cavity.195 Nasal airflow dynamics is an important element in the use of nasal bCPAP 
or HFNC.196 In this context mouth leaks and flow rates need to be considered in the evaluation of 
flow dynamics of nasal air/O2 flow.197 Additionally, the degree of humidification and temperature of 
air/O2 flow also depends on the ambient temperature.198 
Humidifier and humidification fluid needs to be changed daily or during each shift in order to 
prevent nosocomial infections. The humidifier in the bCPAP set-up used in Paper 1 is warmed by the 
heat of the compressor of the bCPAP-set-up. However, further efforts need to be undertaken to 
optimize affordable options for warming and humidification of air/O2 flow in bCPAP devices. 
Oxygenconcentration
In healthy children an SpO2 >95% and PaO2 between 80 and 100 mmHg should be expected.98 
While hypoxaemia and associated reduced O2-delivery is associated with an increased mortality 
risk,199,200 there is increasing evidence that extreme hyperoxia should be avoided in critically ill adults 
and children.98,201,202 WHO ETAT guidelines (2016) recommends an SpO2 target > 94% in the 
treatment of critically ill children with more than one organ-dysfunction.39 In children with severe 
pneumonia or acute viral bronchiolitis and no other organ dysfunctions (SOF) SpO2 levels > 90% are 
acceptable according to WHO recommendations.39 These recommendations were followed in the 
Paper 1: SpO2 targets were in general > 94%. In children with SOF SpO2 > 90-92% were accepted. 
FIO2-levels could be titrated accordingly if dedicated bCPAP set-ups were used. However, in view of 
the high-workload and limited number of available SpO2-monitors, SpO2 could often only be 
monitored intermittently. 
The European Society for Paediatric and Neonatal Intensive Care/ESPNIC initiated a consensus 
conference of international experts in paediatric mechanical ventilation (Paediatric Mechanical 




for critically ill children with non-cardiac paediatric ARDS (PARDS) are based on previous 
recommendations (Paediatric Acute Lung Injury Consensus Conference):98,203 SpO2 between 92 and 
97% when PEEP <10 cm H2O and 88–92% for PEEP 10 cm H2O.  
Particularly in preterm infants hyperoxaemia should be avoided in order to prevent development 
of retinopathy of prematurity. SpO2 targets recommended for term and preterm newborns are in the 
range of 90-95%.204,205  
During cardio-respiratory resuscitation (CPR) of children high FIO2 levels should be used (for 
newborn resuscitation see specific guidelines). After resuscitation (return of spontaneous 
circulation/ROSC) FIO2 can then be titrated according to SpO2 targets. 127,206 
A pilot RCT conducted in the UK (“Oxy-PICU”) tested feasibility and safety to conduct a larger 
trial comparing a restrictive SpO2-target (88-92%) with a more liberal peripheral O2-saturation target 
(>94%). No significant difference between the two patient groups was documented.207 Recruitment 
for the larger Oxy-PICU RCT is ongoing.208  
A recent RCT evaluating different SpO2 targets in critically ill adult patients highlights the great 
care that must be taken when evaluating modification of existing SpO2 targets in critically ill 
patients.209 This trial randomized adult patients with ARDS to a conservative O2 arm (target SpO2 
88% to 92%) or a liberal O2 arm (target SPO2 96%). The data and safety monitoring board of this 
RCT stopped investigations early because of safety concerns and a low likelihood to be able to 
determine a significant difference between the study groups in terms of primary outcomes 
(mortality at 28 days). Results of the RCT determined a trend to a higher mortality risk in the 
conservative O2-study group.209 The surviving sepsis campaign expert panel suggests SpO2 targets 
between 92-96% in adult patients treated for severe ARDS due to COVID-19 disease.202 The group 
strongly advices against increasing FIO2 to target SpO2 ௗ>ௗ96%. The panel also issues a strong 
recommendation to avoid SpO2 levels <ௗ90% in critically ill adult patients with severe ARDS.202 
SpO2 targets suggested by WHO for children with respiratory dysfunction with and without 
further organ dysfunction are a pragmatic interpretation of existing evidence.39,210 Research 
evaluating SpO2 targets among critically ill children conducted in low-resource settings needs to 
take into account important factors e.g.: Hb levels, cardio-vascular function, neurological 
complications (e.g. cerebral malaria).210,211 Especially in malaria endemic areas, a considerable 
number of critically ill children present with low baseline Hb levels (see FEAST-study),131 resulting 




associated with increased mortality risk among critically ill children in malaria-endemic regions 
(Paper 3).  
It is important to note that SpO2 levels can overestimate measured arterial oxygen saturation 
especially in SpO2 ranges < 90%.212 A prospective, observational study conducted in 5 paediatric 
intensive care units in North America showed a close correlation between SpO2 and arterial O2-
saturation in ranges between 91% and 97%. However, this relation is less reliable in the range of 
oxygen saturation levels below 90%. In these ranges SpO2 can overestimate arterial oxygen 
saturation levels considerably.212 
In order to follow WHO and international guidelines, bCPAP and other devices used for non-
invasive respiratory support need to have the option to adapt FIO2, in order to achieve recommended 
SpO2 targets with the lowest FIO2 required.39,98 SpO2 levels should be monitored and maintained as 
currently suggested by WHO and international guidelines.39,85,98,210,212 
CPAPpressures
Studies conducted in children with acute viral bronchiolitis demonstrate that pressures of 6-7 cm 
H20 are associated with optimal decrease of work of breathing (WOB) in this clinical condition.101,103 
Average pressures used at the start of bCPAP treatment in Paper 1 was 6.7 cm H2O. bCPAP pressure 
were mostly kept <8 cm H2O and weaned gradually if clinical condition allowed. Baro-trauma and 
air leaks using bCPAP-pressures in these ranges seem unlikely.100 In case of acute clinical 
deterioration in the setting described in Paper 1, children could be evaluated using POC-lung 
ultrasound.164 Mobile CXRs were not available during the study period. 
Interfaces
Well-adapted interfaces are needed to provide efficient respiratory support via bCPAP devices. 
These interfaces should have the following characteristics: 
Ͳ Internal diameters of nasal prongs as well as connected inspiratory and expiratory tubing 
should be of adequate size in order to function with minimal flow resistance.138,139,213 
Ͳ bCPAP nasal prongs, as in HFNC, should not occlude more than around 75% of the nostrils in 
order to allow entrainment of ambient air in case inspiratory flow demands are not completely 
matched.160,162 Leaks can be compensated by increasing air/O2 flow.  
Ͳ Design of interfaces and connected tubing should allow easy and quick connection on the 
child´s head and face. No damaging pressure should be exerted on facial skin, nasal septum, 




Ͳ Nasal masks are additional options.214 However, design of masks, associated tubings and 
air/O2 flow provided by the bCPAP device need to ensure that inspiratory phase is 
unrestricted. 
Further research in design of good quality, affordable interfaces is needed in order to optimize 
efficacy of bCPAP systems as well as patient comfort and safety. 
Electricitysupply
The paediatric department in Lilongwe in 2014 had a relatively reliable back-up generator, in case 
of interruptions of the electricity supply via the national grid. In clinical zones where O2-concentrators 
are operated, electrical back-up systems needs to be put in place.93 Otherwise safety of O2-therapy 
and non-invasive respiratory support cannot be guaranteed. Essential biomedical equipment needs to 
be identified (e.g., O2 concentrators, bCPAP set-ups, monitors, emergency light) and needs to be 
connected to reliable electricity supply sources. Units needs to try to establish additional O2-back up 
systems. Portable O2-concentrators with in-built batteries or O2 cylinders can bridge electrical supply 
interruptions.  
Sourcesofoxygen
In case not enough dedicated bCPAP set-ups were available, O2-cylinders were used to provide 
O2-flow required to provide bCPAP. With this suboptimal set-up, FiO2 could not be adapted but O2-
flow could still be humidified. However, humidification of O2-flow was not warmed. Patients were 
switched to dedicated bCPAP set-ups whenever such a device was available. No significant difference 
in outcomes in children treated with the different bCPAP set-ups were documented. However, the 
authors of Paper 1 strongly recommend to use dedicated bCPAP set-ups.  
The use of O2-cylinders as source of supplemental O2-therapy or O2 supply for bCPAP has 
considerable disadvantages: Logistics required to guarantee reliable O2 supply via cylinders needs to 
be well organized. Failures assuring safe and continuous O2-supply can be associated with serious 
risks for critically ill patients.93  
Studies suggest that the use of O2-concentrators with adequate electricity back-up for provision of 
O2 in low-resource settings is a cost-effective option.93,96 Reliable, affordable O2-supply is a major 
challenge in many settings in SSA.82 Deficiency to match O2-demands in resource-limited contexts 
has been highlighted during the SARS-CoV2 pandemic.215-217ai Renewable energy solutions (e.g. solar 
 





systems) offer cost-effective opportunities to provide electricity and the possibility to run O2-
concentrators and other biomedical equipment even in remote settings.42,43 WHO and other agencies 
advice on context-adapted options for reliable O2-supply systems.93,215,217a 
bCPAPtreatmentandadaptationtochangingrespiratoryfunction
Persistentorworseningrespiratorydysfunction
In case of limited improvement of WOB and/or oxygenation after starting bCPAP, only an 
escalation of CPAP-pressure up to 8 cm H2O was recommended in order to avoid risks of 
complications (e.g., air leaks/pneumothorax, reduction of venous return). The objective was to 
provide pragmatic management protocols in a clinical setting with high work-load. Children not 
improving with this level of non-invasive respiratory support would potentially benefit from 
mechanical ventilation in high-resource settings.98 SpO2 targets were in general > 94%. In children 
with SOF, SpO2 > 90-92% were accepted.39  
Managementofacutedeterioration
In the study setting described in paper 1, clinical teams were trained to follow emergency 
procedures outlined in ETAT and other paediatric life support algorithms, in case of any acute clinical 
deterioration.38,40 In addition, training associated with the introduction of bCPAP can follow similar 
principles as clinical crisis management in mechanical ventilation. A systematic approach to the 
assessment of patients and review of biomedical equipment in case of sudden respiratory deterioration 
is outlined in paediatric life support guidelines.40 Vital organ functions of patients need to be stabilized 
immediately, followed by a structured management approach (e.g. using the acronym DOPE):  
Ͳ D: Displacement of the interface 
Ͳ O: Obstruction of airways, interfaces or air/oxygen tubing 
Ͳ P: Problems associated with the patient (e.g., evaluation for pneumothorax, signs of shock) 
Ͳ E: Problems associated with biomedical equipment; leaks in air/oxygen tubing etc. 
If during evaluation of patient and equipment, problems are not immediately identified it is advised 
to rapidly switch to an alternative O2-source, while a team member evaluates air/O2-tubing as well as 
the bCPAP-machine for malfunction. Care-takers and non-clinical staff, working in clinical areas can 
be involved in pragmatic training and should be encouraged to immediately notify clinical teams in 





In Paper 1, FiO2 was reduced when SpO2 in critically ill children was consistently > 94%.39 If signs 
of WOB and RR improved with SpO2 remaining consistently >94% (with FIO2  0.5) bCPAP 
pressures were reduced gradually. If the patient remained stable on a bCPAP level  5 cm H2O (with 
FIO2 <0.3-0.4), a trial “off bCPAP” was started and the child was placed on low-flow O2 (1–2 liters 
O2/min). In cases of clinical deterioration, bCPAP was restarted. The duration of the weaning process 
was guided by the child’s clinical progress.  
NonͲinvasiverespiratorysupport:AlternativestobCPAP
NonͲinvasiverespiratorysupport:HighͲflowͲnasalcannulahumidifiedairoxygen/HFNC
HFNC is an important mode of non-invasive respiratory support in newborns and children, which 
can also be initiated in EDs.97,99,161,218,219 Different HFNC-devices exist and have been compared in 
the care of premature newborns with respiratory dysfunction.220 Trends in certain publications suggest 
that CPAP might be more efficient than HFNC in the treatment of acute respiratory dysfunction, 
particularly in young infants.166,221-223 Some studies in newborns and children indicate that the use of 
HFNC is associated with a lower risk to cause nasal trauma, than the use of nasal CPAP,107,223 
highlighting the importance of good quality interfaces in the use of HFNC or nasal CPAP.  
An important RCT conducted in a critical care unit Bangladesh showed that critically ill children 
with severe pneumonia and hypoxaemia treated with bCPAP had a significantly lower mortality rate 
(4%) compared with a group of patients treated with high-flow O2 (mortality rate 13%) or low-flow 
O2 (15% mortality rate).166,222 However, it needs to be noted that in the high-flow O2 treatment used 
in this study the maximum flow rate was 12 liters/min, which might have been relatively low to match 
peak inspiratory flow demands for children with a weight above 6-8 kg.160-162  
A RCT evaluating benefits of HFNC and CPAP is currently being conducted on several PICUs in 
the UK (“First-ABC”).224,225 This RCT compares clinical outcomes of children (term newborns to 16 
years) with an acute illness associated with respiratory dysfunction treated with HFNC or CPAP. 
Children requiring non-invasive respiratory support post extubation are also included in the study. 
Among the exclusion criteria are: immediate need for intubation and invasive ventilation (e.g. severe 
hypoxaemia, upper airway obstruction, MOF).225 Results of this trial can help to guide future research 





Different forms of non-invasive ventilation are used for treatment of children with respiratory 
dysfunction.97,98 The role of non-invasive bi-level positive airway pressure (BIPAP)j in the care of 
critically ill children is summarized in the PEMVECC recommendation (2017).98 According to 
PEMVECC increasing evidence exists, suggesting the value of non-invasive BIPAP modes in 
different clinical scenarios e.g.: 
Ͳ Respiratory dysfunction in children associated with cardiac conditions and asthma. 
Ͳ Non-invasive BIPAP can be considered in children with less severe PARDS.104  
Ͳ BIPAP is among options for non-invasive respiratory support post-extubation. 
In settings, where mechanical ventilation can be provided, clinicians need to ensure not to delay 
intubation and invasive ventilation in patients who can’t be stabilized with non-invasive respiratory 
support. In this context vital organ functions and response to treatment needs to be monitored 
closely.98 Additionally, PEMVECC identifies important knowledge gaps, regarding use of non-
invasive BIPAP in high-resource contexts:98  
Ͳ More evidence is needed to determine the role of different modes of non-invasive respiratory 
support in different clinical scenarios. Optimal timing of escalation of different modes of non-
invasive and invasive respiratory support needs further evaluation.98 
Ͳ Further research is needed, regarding the use of optimal interfaces for different modalities of 
non-invasive respiratory support in children (e.g. full face mask, oral-nasal masks or helmets). 
Alternating different interfaces in order to reduce risks of skin and mucosal lesions might be 
beneficial.98 
In the care of premature newborns early initiation of nasal intermittent positive pressure ventilation 
(NIPPV) appears to be superior to nasal CPAP in the management of respiratory distress syndrome.226 
Critical care in the context of the SARS-CoV2 pandemic highlights the importance to reduce risks 
of aerolisation and infection control measures (e.g. ventilation of clinical zones, personal protective 
equipment for health workers, adequate adaptation of medical devices and ventilation circuits) during 
the use of non-invasive respiratory support.202,227,228 
 




Future research evaluating the role of non-invasive BIPAP in the management of children with 
acute respiratory failure with or without additional organ-dysfunction treated in resource-limited 
contexts will be of high value.  
 
Paper 2: Mechanical ventilation of patients with acute respiratory failure
followingneurotoxicsnakebites
Of the 174 patients snakebite victims admitted to ICU in Lacor hospital between January 2006 - 
November 2017, 60 (36.5%) patients presented with ARF, requiring mechanical ventilation. Most of 
these 60 patients suffered from ARF with minimal signs of additional organ dysfunction (SOF). ARF 
was mostly caused by transient muscle paralysis associated with neuro-toxic snake-bite 
envenomation. Respiratory dysfunction was not associated with severe primary lung injury. 
Therefore, these patients could be mechanically ventilated with relatively low ventilation pressures 
and FIO2. The clinical team could anticipate that in this specific condition, mechanical ventilation 
needed to be maintained for a relatively short period of time, which is different to a clinical situation 
of patients who suffer from severe ARDS and MOF. 
As diagnostic options were limited in the study context other causes of neurological dysfunction 
like intra-cranial bleeding could not be excluded. However, if there were no focal neurological signs 
suggesting an upper motor-neuron lesion, no signs of raised intra-cranial pressure and no external 
signs suggesting coagulopathy associated with snake-bite envenomation, intra-cranial haemorrhage 
was an unlikely diagnosis.  
WHO management guidelines suggest that neuro-toxic snake bite envenomation in Northern 
Uganda can be caused by different snake species, including black Mambas.121 The medium length of 
stay on the ICU of snake-bite victims, who required mechanical ventilation was 5 days, suggesting 
that the toxin of neurotoxic snakes in this region mostly has a transient effect.  
The mortality of snakebite patients developing paralysis and ARF is likely to be high without 
mechanical ventilation.229-232 As fatality rate of snakebite victims who required mechanical ventilation 
in the reported cohort was as low as 16.7%, it can be assumed that mechanical ventilation was a life-
saving intervention for the majority of study patients with ARF.  
The medium age of the 60 patients requiring ventilation was 28 years (interquartile ranges: 16-35 
years), suggesting that mainly physically active, young people were affected by snake-bites. 17 of 




than among the 43 adult patients (35.3% vs. 9.3%; p=0.02). Two of the 17 children suffering from 
ARF following snake bite envenomation were younger than 5 years, both of whom died. Reported 
snakebite fatality rates are generally higher in children than in adults. Possibly the smaller volume of 
distribution and consequently higher toxin levels in children is one of the factors associated with this 
higher mortality risk.121,233  
Due to challenges in the supply chain and financial constraints, only a small number of study 
patients (16.7%), who required mechanical ventilation received antivenom. The antivenom used 
during the study period is not among products currently recommended by international experts.121,163 
Findings from Sri Lanka showed that snakebite victims presenting with signs of severe neurotoxicity 
progressed to respiratory failure requiring mechanical ventilation even when antivenom had been 
given. These results suggest that antivenom alone is not sufficient to treat critically ill snakebite 
victims.234 A study from India reported no fatalities in 51 patients with neurotoxic snake 
envenomation after they were treated with a combination of antivenom therapy and mechanical 
ventilation.235 In the cohort of patients with ARF in Paper 2, it could not be determined whether early 
administration of adequate doses of appropriate antivenom combined with advanced airway 
management and mechanical ventilation could have improved survival rates or reduced the required 
duration of mechanical ventilation.  
In the study described in paper 2, acetyl-cholinesterase inhibitors (ACHEIs; e.g. neostigmine) were 
not used in the management of patients with neurotoxic snakebite syndromes. ACHEIs might only be 
beneficial in patients exposed to snake-neurotoxins leading to a competitive effect at the post-synaptic 
part of the neuro-muscular junction.121,232,236 Patients exposed to black Mamba bite envenomation can 
present with signs of muscle paralysis, including ARF associated with muscle fasciculation.121,232,236 
The presence of muscle fasciculations can indicate a neurotoxic effect of the snake venom, which is 
associated with a depolarizing effect at the neuro-muscular endplate. It is advised not to use ACHEIs 
in these clinical scenarios.121,232,236 Further research regarding specific benefits of ACHEIs in the 
treatment of neuro-toxic snake-bite envenomation is needed.232,236 
Snake venoms can present diverse mechanisms of action at the level of the neuro-muscular junction 
associated with considerable geographical, interspecies and intraspecies variations.232,236 For critical 
care clinicians it can therefore be difficult to determine in emergency situations to which extent these 




to use non-depolarizing muscle relaxing agents during anaesthetic induction if intubation is needed 
and to avoid the use of suxamethonium (the author’s consideration).  
A strategy to reduce deaths and disability associated with snakebites in SSA needs attention to 
preventive measures. Strengthening of context-adapted treatment of critically ill patients, including 
snakebite victims, on different levels of referral pathways is important.236 Provision of efficient 
antivenoms needs to be integrated in clinical care of snake-bite victims in peripheral health 
facilities.236 Paper 2 indicates that under certain circumstances mechanical ventilation can be provided 
safely on ICUs in rural hospitals in SSA. Non-invasive respiratory support was not available in the 
study setting described in Paper 2. The role of non-invasive BIPAP modes in the treatment of snake-
bite victims could be included in future research. Additionally, ICUs offering advanced respiratory 
support in resource-limited contexts need to be prepared for the care of critically ill children.  
Mechanicalventilation:Qualityandsafetyaspects
SetͲupofanICUinaregionalhospitalinnorthernUganda–someconsiderations
The study setting in Lacor Hospital in northern Uganda is comparable to other rural healthcare 
regions in SSA which are characterized by single hospitals, who support a network of peripheral 
health facilities. In contrast to many other rural health facilities in SSA, Lacor Hospital runs an ICU 
which can provide intensive care interventions including mechanical ventilation.141 237,238 To put this 
into perspective, a recent survey revealed that the density of ICU beds was one ICU bed for every one 
million inhabitants in Uganda.239 In order to provide good quality ICU services sustained multi-
disciplinary efforts are under-taken in Lacor Hospital, including:  
Ͳ EECC services adapted to high workload and resource limitations on all levels of the hospital’s 
patient circuit are strengthened. 
Ͳ The hospital has strong non-clinical supporting services e.g.: biomedical and technical 
department, pharmacy/supplies, laboratory as well as blood bank.  
Ͳ Members of the anaesthetic department lead clinical ICU-services and ensure good interaction 
with other clinical departments (e.g., paediatrics, surgery, maternity). 
Ͳ Efforts are undertaken to provide good working conditions for health workers. Despite rotation 
of staff members, skill levels in the ICU-team are maintained. Clinicians and nurses working 




Additionally, a formal clinical officer training program in anaesthesia was introduced in Lacor 
Hospital. The hospital also runs training programs in nursing and midwifery, besides other training 
modules.240 Lacor Hospital also serves as a teaching hospital for medical students and internes.  
In hospitals providing advanced respiratory support, indications for mechanical ventilation need to 
be carefully considered. Benefits and risks for patients as well as available resources need to be 
balanced.241 In settings with considerable resource limitations the definition of levels of critical care 
(Table 1) can help health facility management teams to define realistic objectives for their institutions. 
The establishment of a “level 3 critical care unit” can be considered if essential levels of EECC are 
strengthened within a referral pathway and hospital patient circuit. A large number of patients can 
benefit from interventions provided on level 1 & 2 critical care units. Multi-disciplinary arrangements 
required to successfully establish good quality level 1 & 2 units are the foundation on which the 
potential set-up of level 3 units can be based on. 
Biomedicaldevicesforrespiratorysupport–someimportantconsiderations
In Paper 2, ventilators capable to provide intermittent positive pressure ventilation (Glostavent; 
Diamedica, Bratton Fleming, UK) were used on the ICU in Lacor Hospital. The Glostavent ventilators 
can be used independent of pressurized medical gases and are compatible with different oxygen 
sources (e.g. O2 concentrators, O2-cylinders).  
WHO suggests technical specifications for ventilators used for non-invasive and invasive 
respiratory support in the context of the SARS-CoV2 pandemic.242 Some of the following elements 
need to be considered in the selection or development of context adapted devices, used for non-
invasive and mechanical ventilation in resource-limited settings: 
Ͳ Inbuilt battery with several hours of autonomy time, allowing use during transfer and power 
cuts. 
Ͳ Inbuilt compressor to ensure independence of pressurized medical air. Ventilators need to be 
compatible with use of low-pressure O2-sources (O2-concentrators) as well as pressurized O2 
sources (O2 cylinders and piped wall O2).93,242 
Ͳ Pressure or volume controlled ventilation modes need to be equipped with adequate alarm 
settings.  
Ͳ In order to allow gradual weaning of respiratory support, ventilators need to allow un-restricted 
spontaneous ventilation. Ideally the ventilator is equipped with a triggered (flow or pressure 




(SIMV)/pressure support. Hybrid techniques like pressure regulated volume control or volume 
assured pressure support are interesting options,243 but might not be an immediate priority 
(author’s opinion). 
Ͳ For non-invasive respiratory support the ventilator needs to have a CPAP/ pressure support 
mode with or without the possibility to set a back-up-rate.  
Ͳ Ventilators need to be set-up for paediatric and adult use. 
For all biomedical equipment energy consumption, maintenance, repair as well as availability and 
costs of spare parts as well as consumables needs to be considered. SOPs need to be put in place to 
guide IPC measures. Biomedical equipment used in low-resource settings, needs to under-go 
thorough biomedical testing. These procedures needs to follow standards for biomedical equipment 
defined by WHO.244 Pragmatic training programs for clinical and biomedical teams need to 
accompany the introduction of biomedical equipment.  
 
Paper3:Managementofhaemodynamicinstability
Paper 3 describes the re-analysis of data from a previous large RCT conducted in East Africa 
(FEAST-study).131 Results of this analysis indicate that in the treatment of critically ill children with 
haemodynamic instability, fluid resuscitation with normal saline and HAS (5%) can be associated 
with respiratory and neurological dysfunction, hyperchloraemic acidosis as well as reduction in Hb 
levels. Fluid resuscitation with unbuffered electrolyte solutions can cause harm and therefore should 
be avoided. The effects of lower volumes of isotonic, electrolyte balanced resuscitation fluids needs 
to be evaluated further. Hb levels need to be monitored carefully in critically ill children receiving IV 
fluid boluses.  
Paper3:Pragmatic,clinicaltrainingassociatedwiththepreparationoftheoriginalstudy
During the preparation of the FEAST-study and during time of recruitment, a paediatric training 
team (page 12 of the original publication) invested considerable efforts to integrate study procedures 
in routine clinical activities of participating units.131, k Health workers recruited for the FEAST-study, 
participated in the care of critically ill patients. On-going capacity building in combination with the 
introduction of some biomedical equipment and consumables ensured that all children treated in 
participating units benefitted from improvements in essential elements of critical care.  
 
k The author contributed substantially to clinical training at the four Ugandan study- sites of FEAST. Units in Uganda recruited 




A protocol amendment was needed in June 2010 to increase the sample size from the initially 
anticipated 2800 to 3600 patients, because the mortality in the cohort of study patients was lower than 
anticipated (page 5 of the original publication).131 Potentially this lower than expected risk of 
paediatric hospital mortality indicated the positive impact of the quality improvement measures in 
essential emergency and critical care associated with the FEAST-study. However, it is important to 
note that multiple factors could have contributed to this lower than expected mortality.  
WHOdefinitionofshockandcirculatoryimpairment
In the revised WHO ETAT-guidelines (2016) important results of the FEAST-study were taken in 
consideration.39 A WHO expert committee reviewed degrees of haemodynamic instability (see Table 
14): Shock was defined as the presence of the following clinical signs: cold extremities, capillary 
refill time > 3 seconds, weak and fast pulse. The term “circulatory impairment” is used if only 1 or 
2 of these clinical signs are detected. While the presence of circulatory impairment needs to be 
considered as a sign of critical illness, these children should not receive IV fluid bolus resuscitation.39 
WHO also gives management recommendation of haemodynamic instability in the presence of 
specific clinical conditions e.g.: severe anaemia, severe dehydration, SAM. Of note, patients with 
severe dehydration as well as patients with SAM were not included in the FEAST-study nor in the 
Paper 3 analysis.131 Further details, regarding the management of children with haemodynamic 
instability treated in resource-limited contexts are discussed in the following paragraphs.  
Clinicalphenotypesinchildrenpresentingwithhaemodynamicinstability
In Paper 3, 1991 out of 3141 patients (stratum A) recruited in the FEAST study were classified in 
cluster 1. These patients had the least derangement in terms of respiratory, cardio-vascular and 
neurological function as well as Hb concentration and lactate levels, compared with other study 
participants. The mortality risk among patients classified in cluster 1 was low (around 1% mortality 
in the non-bolus group and 4% in the bolus-group). According to the revision of WHO Guidelines 
(2016) for the treatment of critically ill children, the circulatory status of most patients in cluster 1 
could be classified as “impaired circulation”. According to these guidelines it is not recommended to 
administer rapid IV fluid infusion in this clinical context (Appendix, Table 14).39 
Paper 3 identified two further clusters of patients with certain clinical phenotypes who showed 
comparable response to clinical management and outcomes. Patients in these clusters had 




Cluster 2 (n=795) consisted of patients with severe anaemia (Hb levels <5 g/dL), high lactate-
levels and high cardiovascular scores. The mortality in this group of patients was high (14% in the 
non-bolus group and 21% in the bolus group). An inverse relationship was observed in cluster 2 
between low Hb levels and high lactate concentrations. Additionally, low bicarbonate levels and low 
base excess were documented. These results suggests that baseline hyperlactataemia and metabolic 
acidosis was largely caused by impaired O2 carrying capacity and reduced O2 delivery. In cluster 2, 
administration of fluid blouses was associated with worsening respiratory as well as neurological 
function. These important results of the FEAST-study were taken in consideration in revised WHO 
ETAT-guidelines (2016): Patients with severe anaemia and haemodynamic instability should not 
receive IV fluid boluses before transfusion. Maintenance fluids can be started during preparation of 
safe blood transfusions (Appendix, Table 14). 
Cluster 3 (n=384) was characterised by extremely high respiratory and neurological scores, but 
better maintained Hb levels. Among the three clusters mortality was highest in cluster 3 (26% in the 
non-bolus group and 23% in the bolus group). 
The results from Paper 3 indicate that context-adapted support of all vital organ-functions is needed 
in order to substantially improve clinical outcomes in critically ill children with haemodynamic 
instability treated in resource-limited contexts.  
Respiratorysupportforchildrenwithhaemodynamicinstability
Paper 3 describes the impact of fluid resuscitation on vital organ functions. In IV bolus recipients 
cardio-vascular scores decreased transiently at 1 h after admission. However, during later 
measurements this effect on cardio-vascular function was not sustained. Importantly, respiratory and 
neurological scores, Hb levels as well as bicarbonate, chloride levels and base excess worsened in the 
early hours after fluid bolus administration (Paper 3, table 2).  
The endpoint review committee in the FEAST study had only limited information to judge if fluid 
resuscitation contributed to increased “extra-vascular lung water” and associated deteriorating 
respiratory function. While SpO2 was monitored, no SpO2/FiO2 ratios were documented.87-89 No POC-
lung-ultrasound or echocardiography was available in the FEAST-study.131,164,165  
International guidelines suggest a pro-active approach in terms of respiratory support in the 
management of children with septic shock, who require fluid resuscitation.85,98,104 As outlined above, 
mechanical ventilation should only be considered as a safe management option in hospitals with 




respiratory support have the potential to improve clinical outcome of critically ill patients with 
haemodynamic instability and signs of respiratory dysfunction treated in resource-limited settings. 
Further research is needed to optimize benefit of non-invasive respiratory support in children with 
multi-organ dysfunction. 
Fluidresuscitationinshock:Howmuchfluidstogive?
WHO Guidelines 2016 (Appendix Table 14),39 designed for resource-limited settings suggest to 
treat children with signs of shock with 10-20 ml/kg of isotonic fluids infused over 30-60 min. Should 
signs of shock persist a further 10 ml/kg of isotonic fluids should be given over 30 min. Children with 
SAM and signs of shock should receive 10-15 ml/kg over the first hour. In children with 
haemodynamic instability and severe anaemia no pre-transfusion bolus should be given. Maintenance 
fluids can be started for these patients, while rapidly preparing administration of safe RBC 
transfusions. 39 This is a far more cautious approach as the fluid resuscitation of septic shock suggested 
by the “SSC paediatric guidelines (2020)” for high-resource contexts: “In healthcare systems with 
availability of intensive care, we suggest administering up to 40–60ࣟmL/kg in bolus fluid (10–
 mL/kg per bolus) over the first hour, titrated to clinical markers of cardiac output and discontinuedࣟ20
if signs of fluid overload develop, for the initial resuscitation of children with septic shock or other 
sepsis-associated organ dysfunction (weak recommendation, low quality of evidence)”. 85  
The SSC-paediatric guidelines (2020) suggest for healthcare systems with no availability of level 3 
intensive care: “In the absence of hypotension, we recommend against bolus fluid administration 
while starting maintenance fluids (strong recommendation, high quality of evidence). If hypotension 
is present, we suggest administering up to 40ࣟmL/kg in bolus fluid (10–20ࣟmL/kg per bolus) over the 
first hour with titration to clinical markers of cardiac output and discontinued if signs of fluid 
overload develop (weak recommendation, low quality of evidence)”. The SSC expert team 
recommends slightly higher fluid volumes over a potentially shorter period of time as suggested by 
WHO guidelines (2016).39 Paper 3 provides arguments to follow the more cautious approach 
recommended by WHO (Appendix, Table 14).  
In recommendations for hemodynamic monitoring for critically ill children by the European 
Society of Paediatric and Neonatal Intensive Care (ESPNIC) a less aggressive approach to fluid 
resuscitation with smaller boluses (5-10 ml/kg) is suggested. Careful monitoring of haemodynamic 
parameters is recommended in order to assess fluid responsiveness.154 Using small bolus volumes of 




haemodynamic parameters, Hb levels, neurological function, urine output) may be an appropriate 
approach for the treatment of critically ill children with signs of shock in resource-limited settings. 
Children who do not show all clinical signs of shock and are not hypotensive should not receive 
fluid boluses. Maintenance fluids should be started in these patients (WHO Guidelines 2016).39,85,128 
Fluidresuscitation:WhichIVfluidstouse?
Paper 3 indicates that hyperchloraemic acidosis associated with administration of normal saline or 
HAS 5% (constituted in “un-buffered” electrolyte solutions) is an important factor contributing to 
adverse outcomes among critically ill children with haemodynamic instability treated in malaria-
endemic low-resource contexts. Further studies conducted in high-resource settings suggest that the 
use of electrolyte balanced IV crystalloids as compared to unbuffered IV solutions in seriously ill 
adults and children is associated with improved clinical outcomes (e.g. in-hospital survival, level of 
vaso-pressor support, renal function).245-248 Several studies evaluating critical care in adult and 
paediatric cohorts confirm that administration of normal saline is associated with increasing chloride-
levels and reduction of bicarbonate concentrations as compared to the use of electrolyte balanced 
resuscitation fluids.245,246,248,249 Additionally, SSC – paediatric guidelines (2020) advocate the use of 
electrolyte balanced crystalloids, rather than 0.9% saline, for resuscitation of children with septic 
shock or other sepsis-associated organ dysfunctions.85 Of note, a study from Weiss et al, analysing 
data from multiple hospitals in north-America did not show differences in outcome among children 
with sepsis managed with Ringer’s lactate as compared to the treatment with normal saline.250 
Furthermore, Paper 3 and FEAST study results indicate that in resource-limited, malaria-endemic 
settings the use of HAS 5% does not contribute to improved clinical outcome of critically ill children 
with haemodynamic instability.131 In a previous smaller clinical trial in Kenya, reduced mortality was 
reported in children with severe malaria treated with HAS 4.5% as compared to children treated with 
Gelofusin.251 Supporting results of Paper 3, SSC-paediatric guidelines (2020) did not identify at this 
stage convincing evidence suggesting benefits of HAS versus crystalloids as resuscitation fluids in 
septic children with haemodynamic instability.85  
Regarding other colloid IV fluids like starches and gelatines, no benefit in terms of clinical 
outcomes has been demonstrated in the treatment of critically ill patients.85 In adult studies the use of 
hydroxyethyl-starch (HES) was even associated with increased clinical risks (e.g., coagulopathy, 




HES completely.255 The SSC paediatric guidelines (2020) advice against the use of starches and 
gelatines in septic shock and other sepsis associated organ dysfunctions.85  
Paper 3 as well as further studies imply that the use of unbuffered resuscitation fluids should be 
avoided. Future research can be directed to evaluate potential benefit of isotonic, electrolyte balanced 
fluids in the treatment of haemodynamic instability, using lower volume fluid boluses (e.g. 5-10 
ml/kg).154 In case clinical trials are considered to evaluate the use of HAS in certain clinical 
conditions, albumin solutions constituted in electrolyte balanced fluid should be preferred.256  
CumulativeIVfluidadministrationincriticallyillchildren
Paper 3 and the FEAST study focused on the administration of IV fluid resuscitation boluses in the 
treatment of critically ill children with haemodynamic instability. In the FEAST-study over the first 
8 hours after recruitment, the median cumulative volume of fluid documented was 40.0 ml/kg (IQR, 
30.0 to 50.0 ml/kg) in the albumin-bolus group, 40.0 ml/kg (IQR, 30.4 to 50.0) in the saline-bolus 
group, and in the control group 10.1 ml/kg (IQR, 10.0 to 25.9).131 Additionally, 1408 out of 3141 
recruited children (45%) received RBC transfusions (20 ml/kg of whole blood over 4 hours).131  
In order to optimize quality of critical care and prevent complication, any fluid administration 
needs careful attention e.g.: Administration of blood products in case of severe anaemia or coagulation 
disorders, IV maintenance as well as enteral fluids. Additional sources of IV fluid administration can 
be underestimated: 
Ͳ IV fluids used to administer vaso-active drugs or other medicationl can considerably contribute 
to total IV fluid volume as well as sodium and chloride load in critically ill patients (so called 
“fluid creep”).257-259  
Ͳ While at this stage international guidelines recommend boluses of 2 ml/kg of dextrose 10% for 
the correction of hypoglycaemia,40 current WHO ETAT guidelines still suggest 5 ml/kg of 
dextrose 10% (commonly administered without any additional electrolytes).38 Especially in 
children with recurrent hypoglycaemic episodes, hypoglycemia corrections can substantially 
contribute to total daily IV fluid administration.m  
Maintenance fluids need to be monitored carefully and “fluid creep” needs to be included in fluid 
balances.257-259 The “4-2-1” rule suggested by Segar & Holliday (1957) is commonly used to calculate 
 
l In FEAST, quinine was still used in most study sites for treatment of severe malaria. IV quinine was administered according to 
national guidelines. In some settings dextrose 5% without additional electrolytes was used for this purpose. 
m If feasible, IV fluids given for hypoglycaemia correction should be given as an isotonic, electrolyte-balanced, dextrose 10% 




daily fluid requirements.260 However, in critically ill children this “4-2-1” rule can contribute to an 
over-estimation of fluid requirements.261,262 Different mechanisms (e.g., increased secretion of anti-
diuretic hormone) can result in reduced free-water clearance in patients with respiratory failure, severe 
neurological conditions (e.g., meningitis, cerebral malaria) or other critical conditions. 
Besides potentially decreased free water clearance, critically ill children (e.g., septic children) may 
develop increased capillary permeability, renal dysfunction, hypoalbuminemia. In conjunction with 
these factors, inadequately high maintenance fluids can contribute to further complications (e.g., 
respiratory failure).261 It can therefore be advised to reduce daily IV maintenance fluids in critically 
ill children with certain clinical complications (e.g. respiratory or neurological dysfunction) to 50-
70% of the “4-2-1” calculations in order to prevent fluid overload and electrolyte abnormalities.261,262 
Importantly, clinical fluid status and fluid balances need to be monitored regularly. In certain clinical 
conditions fluid administration needs specific adaptation e.g.: acute kidney injury, diabetic keto-
acidosis, burns.262  
Isotonic IV maintenance fluids need to be used to prevent iatrogenic hyponatremia, which can be 
associated with life-threatening complications (e.g. cerebral oedema).263,264 Paper 3 suggests the use 
of electrolyte balanced resuscitation fluid, which is supported by the SSC paediatric guidelines 
(2020).85 As maintenance fluids contribute considerably to total fluid administration in critically ill 
children, the use of isotonic, electrolyte balanced IV maintenance fluids is likely to be beneficial. 
Pre-mixed, isotonic, electrolyte balanced, dextrose containing maintenance fluids exist. Fluid losses 
(e.g., gastric tube drainage, diarrhea) need to be replaced,262 ideally with electrolyte balanced fluids. 
Once critically ill children are stabilized, enteral fluids and enteral nutrition can be introduced 
gradually.265 The “ESICM global intensive care” working group suggest a similar approach 
regarding enteral nutrition for critically adult patients treated in low- resource settings.130 
Managementofhaemodynamicinstabilityandsevereanaemia
Severe anaemia is a frequent complication among critically ill children, treated in malaria endemic 
regions. In the FEAST-study, 32% of patients had Hb levels of less than 5 g/dl and 45% of participants 
required RBC transfusions. Only 23% of patients had Hb levels above 10 g/dl.131 Among patients 
with severe anaemia who received RBC transfusion during the first 48 hours, transfusion were started 
earlier in the control group (non-bolus group). However, by 2 hours the number of children who 
received RBC transfusions as well as volumes of blood administered were similar in all study groups 




In Paper 3, cluster 2 consists of patients with low Hb levels, signs of haemodynamic instability and 
high lactate levels. Overall mortality in cluster-2 was high and administration of IV fluid boluses was 
associated with increased mortality (21% in the bolus group; 14% in the non-bolus group). Paper 3 
suggests that potential transient benefit of improving intra-vascular volume, was outweight by 
dilutional effects on Hb levels, leading to reduction of O2-carrying capacity and O2-delivery. These 
patho-mechanisms were associated with increased lactate concentrations (high anion-gap acidosis). 
Additionally, fluid bolus administration potentially had an impact on respiratory function. 
Furthermore, administration of NaCl 0.9% or HAS 5% was associated with the development of an 
hyperchloraemic acidosis (normal anion gap-acidosis), which was super-imposed on an already 
existing metabolic acidosis. In the most critically ill patients, the combination of adverse effects might 
then have overwhelmed compensatory mechanisms (figure 5, Paper 3). 
Results of the FEAST-study contributed to a review of WHO guidelines (2016) regarding 
management of critically ill children with haemodynamic instability and severe anaemia: no IV fluid 
bolus should be administered to severely ill children with severe anaemia before the start of RBC 
transfusion (Table 14).39 Maintenance fluids can be started before RBC transfusions are available. 
According to WHO guidelines, RBC transfusion (20ml/kg of whole blood or 10ml/kg of RBC 
concentrates) needs to be administered over 3-4 hours. Faster administration is needed in acute 
haemorrhage. WHO guidelines suggest lower volume of RBC transfusion for children with SAM and 
severe anaemia: 10 ml whole blood/kg over at least 3 hours.38,39  
In the revised WHO guidelines (2016), RBC transfusion threshold of Hb 5 g/dl (or 6 g/dl for 
critically ill children according to the WHO pocketbook: hospital care for children) was not 
adapted.38,39 RBC transfusion threshold and transfusion volumes suggested by WHO are debated.266  
Haemoglobintransfusionthresholdsincriticallyillchildren
According to SSC – paediatric guidelines (2020), there is insufficient evidence to define a Hb cut-
off range for RBC transfusion for critically ill children with unstable septic shock during the 
resuscitation phase.85,128 Regarding critically ill children with stable circulation SSC paediatric-
guidelines (2020) follow the view of the “Paediatric Critical Care Transfusion and Anaemia Expertise 
Initiative (TAXI)” from 2018,267 which is based on results of a multi-center study from Lacroix et al 
(TRIPICU).268 TRIPICU study results indicate that in critically ill children managed in PICU settings 
with stabilized organ functions (e.g., on mechanical ventilation, stable doses of inotropes) target levels 




SSC-guidelines suggest RBC transfusion in critically ill adults with Hb levels less than 7 g/dl (in the 
absence of specific circumstances like myocardial ischaemia, severe hypoxaemia, acute 
haemorrhage).86 “Roger´s textbook of paediatric intensive care” suggests to maintain Hb > 8-10 g/dl 
in critically ill septic children with unstable haemodynamics.243 
In low-resource settings risks and benefits associated with RBC transfusions as well as availability 
of blood products need to be balanced. In a review of WHO ETAT guidelines (2016) a transfusion 
threshold of Hb 5 g/dl is recommended.39 The WHO pocket-book (2nd edition, 2013) suggests to 
transfuse in the following clinical scenarios:38 All children with an Hb of  4 g/dl and children with 
Hb 4–6 g/dl with any of the following clinical features: 
Ͳ Deep, laboured breathing 
Ͳ Clinically detectable dehydration or shock; signs of heart failure 
Ͳ Impaired consciousness 
Ͳ Very high malaria parasitaemia (> 10% of red cells with parasites). 
Outcomes of a large prospective, observational study conducted in six tertiary hospitals in The 
Gambia, Malawi, Gabon, Kenya, and Ghana indicate that among children with severe malaria and 
reduced level of consciousness or high lactate levels, RBC transfusion was associated with improved 
survival at Hb levels above the transfusion thresholds currently suggested by WHO.266 Additionally, 
“real-life” clinical situations need to be taken into account. As highlighted in Paper 3, Hb levels in 
critically ill patients can deteriorate considerably during the first hours of critical care treatment, while 
important delays can be associated with the preparation of RBC transfusions in many low-resource 
settings. In this context it is crucial to anticipate preparation of RBC transfusions early.  
RBCtransfusionsvolumesforanaemicchildrentreatedinlowͲresourcesettings
In a large RCT conducted in Uganda and Malawi: “Transfusion and Treatment of Severe Anaemia 
in African Children Trial (TRACT)”, investigators evaluated different interventions in children with 
severe anaemia (Hb < 6 g/dl).269,270 In an essential part of the TRACT study, children with severe 
anaemia and further signs of diseases severity or additional risk factors (e.g. reduced level of 
consciousness, respiratory distress, sickle cell anaemia) were transfused if Hb levels were less than 6 
g/dl. Critically ill children with severe anaemia were assigned to RBC transfusion volumes of 20 or 
30 ml whole blood/kg over 3-4 hours. If packed red blood cells were used, lower volumes were 
transfused over 2-3 hours.269 Overall 28-day mortality did not differ between the two transfusion 




fever at time of recruitment. Children presenting with severe anaemia and fever (39% of patients) had 
higher 28-day mortality rates, when receiving 30 ml whole blood/kg as compared to 20 ml/kg 
currently recommended by WHO. Among afebrile children, higher transfusion volume of 30 ml 
whole blood/kg was associated with higher survival rates and lower rates of re-transfusion.269 Further 
research can help to better understand differences in mortality among subgroups described in the 
“TRACT-study”. 
WHO currently recommends lower volumes for RBC transfusions for critically ill children with 
SAM and severe anaemia (10 ml/kg – over a period of 3 hours). In many cases these volumes of blood 
might not be sufficient to correct severe anaemia. In the TRACT study only 4% of the patients had 
SAM.269 Results of the TRACT study therefore do not answer the question if higher transfusion 
volumes in severely anaemic critically ill children with SAM are safe. Two echocardiography studies 
conducted in East Africa did not demonstrate significant differences in cardiac function among 
severely malnourished and non-malnourished hospitalised children.271,272 Results of these studies 
indicate that RBC transfusion volumes (20 ml whole blood/kg, transfused over 3-4 hours) suggested 
by WHO for non-malnourished children could be evaluated in children with SAM in future research 
projects. POC lung ultrasound and echocardiography can play an important role in this context. 
A further important research topic is to review the benefit of higher Hb transfusion thresholds 
(compared to current WHO guidelines) for critically ill children treated in malaria endemic regions 
(e.g., children with haemodynamic instability, neurological complications).266 Paper 3 highlights the 
importance of sequential POC tests of Hb levels during the critical care phase.  
Neurologicalfunctionandhaemodynamicinstability
Neurological complications are common in critically ill children hospitalised in malaria endemic 
contexts. Hospital mortality as well as post-discharge mortality risk is high among these children.273-
275 In the FEAST-study 15% of recruited patients presented with coma, while in 37% of patients 
seizures were reported during the course of the presenting acute illness.131 More than 50% of patients 
evaluated in the FEAST-study had positive malaria tests and many of these patients had signs of 
cerebral malaria.131 Studies from Malawi show that certain children with severe malaria are at risk to 
develop cerebral oedema, which is associated with a high mortality risk.16,146 Children with 
neurological insults surviving critical illness in these contexts carry a considerable risk to suffer from 




According to international paediatric critical care guidelines, the outcome of children presenting 
with signs of severe non-traumatic neurological insults (e.g., coma, prolonged seizures), in terms of 
neuro-disability-free survival is determined by multiple factors e.g.:40,243,262,277 
Ͳ Respiratory function and oxygenation as well as cardio-vascular stability. 
Ͳ Time to termination of seizure activities. Anti-seizure medication should allow easy 
administration in emergency situations and should be associated with minimal cardio-
respiratory adverse effects. 
Ͳ Cause and severity of the primary neurological insult as well as time to initiation of adequate 
treatment (e.g., bacterial infections, malaria, opportunistic infections in HIV-infected patients).  
Ͳ SCD needs to be considered as a potential co-morbidity in many settings in SSA.77,78 
Paper 3 highlights the need to optimize a comprehensive approach to context-adapted neuro-critical 
care, including stabilization of respiratory and circulatory function, careful fluid management using 
electrolyte-balanced IV fluids as well as maintenance of adequate Hb levels. Preservation of sufficient 
O2-content and O2-delivery needs particular attention in children with neurological complications.210  
In certain settings more advanced respiratory support and administration of vaso-active medication 
can be considered in order to maintain adequate cerebral perfusion and O2-delivery. Improved neuro-
protective measures have the potential to reduce mortality risk of children with acute neurological 
insults, but also the risk of long-term neurological complications.15,16,276  
Renalfunctionandtreatmentofcriticallyillchildren
Acute kidney injury (AKI) is a frequent complication of critical illness in children and is associated 
with an increased risk of poor clinical outcomes.278,279 Among children with severe malaria AKI is a 
common complication and is associated with an increased risk of mortality and long-term 
morbidity.273,280,281 In an additional analysis of the FEAST-study, increased blood urea nitrogen 
(BUN) levels were identified as a risk factor for mortality among critically ill children.147 However, 
monitoring of renal function in the FEAST study was limited: no creatinine levels were measured and 
no urine output measurements were documented. Therefore, commonly used “Kidney Disease: 
Improving Global Outcomes (KDIGO) criteria” could not be determined to define severity of AKI in 
the FEAST-study population.131,282-284  
Management of treatable causes of AKI among critically ill children and context adapted 
management of AKI needs particular attention in future research projects conducted in resource-




offer a pragmatic management approach in settings, where renal replacement therapy is not a feasible 
option.56. Additionally, pragmatic experience exists in the use of peritoneal dialysis in resource 
constraint contexts.59-61  
Criticallyillchildrenwithhaemodynamicinstability–furtherimportanttopics
Several important topics regarding critically ill children with haemodynamic instability managed 
in resource-limited settings, could not be addressed in Paper 3. For example, children children with 
severe dehydration and/or SAM were not included in the FEAST-study nor in Paper 3.131  
CriticallyillchildrenwithoutSAM:severedehydration
Acute gastro-enteritis and associated dehydration is one of the major causes of death among 
children under the age of five years.285,286 In young children, severe diarrheal diseases are among 
common causes of sepsis (see global burden of sepsis estimates).9 Several studies identified severe 
dehydration among hospitalized children treated in resource-limited settings as an important risk 
factor for mortality. Children with severe dehydration and associated HIV-infection or malnutrition 
are particularly vulnerable.170,171,287 Data from Kenya describe a high post-discharge mortality risk 
among children needing hospital treatment for severe diarrheal diseases.171 Severe diarrheal disease 
is frequently associated with further organ dysfunctions (e.g. respiratory dysfunction).81 287,288 
Children with severe dehydration associated haemodynamic instability carry a particularly high 
mortality risk.289,290 
Regarding fluid management for non-malnourished children with severe dehydration WHO 
recommends to administrate a total of 100 ml/kg of Ringer’s lactate (or if not available normal saline) 
over a period of 3 – 6 hours depending on the age of the child (Plan C; Appendix, Table 14).38,39 This 
suggested fluid volume reflects replacement of an estimated fluid loss of 10% body weight. Plan C 
consists of 2 steps of fluid administration: Step 1: 30 ml/kg over 30 min (for children < 1 year over 
60 min); Step 2: 70 ml/kg over 2.5 hours (for children < 1 year over 5 hours). Additionally, in case of 
shock associated with severe dehydration WHO Plan C suggests to administer rapid fluid boluses of 
20 ml/kg of normal saline (up to 3 boluses) followed by step 2 of Plan C (further 70 ml/kg).38 WHO 
guidelines suggest to regularly re-evaluate children during the administration of these large volumes 
of IV fluids. However, as clinical assessment of the degree of dehydration is difficult, risks of fluid 
overload exist. So far there is limited evidence regarding safety and effectiveness of this Plan C 
suggested by WHO.291 A multi-centre open-label phase II RCT focused on the evaluation of two 




dehydration (median lactate-level: 1,3 mmol/litre; 3 of 122 children fulfilled WHO criteria of shock). 
Participants were either treated according to Plan C or with a more careful fluid management plan 
administering 100 ml/kg of Ringer’s lactate over 8 hours. In terms of serious adverse events, there 
were no significant differences in the two groups (mortality 3.3%).292  
As recommended in international guidelines, critically ill child with severe dehydration and 
haemodynamic instability will benefit from a context-adapted approach to the support of all vital 
organ functions (e.g. respiratory support, treatment of neurological complications).85 Paper 3 
advocates the use of isotonic, electrolyte balanced resuscitation fluids in the management of 
haemodynamic instability, which is supported by SSC paediatric guidelines (2020).85 This is of 
particular importance in the treatment of severe dehydration, which often requires administration of 
relatively high volumes of IV fluids. Evaluation of safety and effectiveness of slower rates of IV 
rehydration as currently suggested by WHO needs to be evaluated in further studies. Particularly, the 
approach to patients presenting with anaemia and severe dehydration needs to be reviewed.  
Criticallyillchildrenwithsevereacutemalnutrition(SAM)andhaemodynamicinstability
Children with SAM and acute clinical complications face a particularly high in-patient and post- 
discharge mortality risk.170,171,287,293,294 This particularly vulnerable group of children was not included 
in the FEAST-study and the review described in Paper 3.131 
WHO guidelines suggest a particularly careful approach to IV fluid management in children with 
SAM presenting with haemodynamic instability, including severe dehydration.38,39 These guidelines 
are based on the assumption that children with SAM (particularly children with kwashiorkor) would 
more frequently present with cardiac dysfunction as compared to non-malnourished patients. The 
evidence for this assumption is limited295 and is not confirmed by echocardiography studies conducted 
in East Africa among hospitalized children with SAM.271,272 In view of the high mortality risk in 
critically ill children with SAM and haemodynamic instability, improvements of a comprehensive 
“critical care package” are needed e.g.:  
Ͳ Monitoring of respiratory function (e.g., SpO2/FIO2), reliable O2 supply and if feasible, non-
invasive respiratory support can be of benefit. 
Ͳ The use of isotonic, electrolyte-balanced IV fluids in the treatment of haemodynamic 
instability needs to be considered in children with SAM (see paper 3). Rates and volumes of 




Ͳ WHO suggests relatively low RBC transfusion volumes for children with SAM. In a RCT 
conducted in Uganda and Malawi (TRACT-study), assessing different transfusion volumes, 
mainly non-malnourished children with severe anaemia were evaluated.269 Hb target levels, 
volume and rate of transfusions need further evaluation in critically ill children with SAM. 
Further important knowledge gaps exist in the care of critically ill malnourished children: Children 
recovering from severe dehydration and/or shock might not tolerate enteral fluids or nutrition for a 
period of time. Administration of enteral therapeutic feeds in a child with SAM just recovering from 
shock can potentially be associated with serious complications (e.g., regurgitation of gastric contents). 
Careful administration of IV maintenance can be beneficial, while enteral fluids and enteral nutrition 
is introduced gradually, as suggested for critically ill patients in high-resource settings.265 On-going 
fluid losses need to be compensated. Nutritional rehabilitation according to WHO – guidelines38 can 
be initiated after the “critical care phase”, when vital organ functions have been stabilized.  
WHO guidelines suggest to use ReSoMal (an oral rehydration solution/ORS for the treatment of 
malnourished children), which has lower sodium (45 mmol/l) and higher potassium content (40 
mmol/l), than ORS suggested by WHO for use in non-malnourished children. Some studies describe 
a considerable risk of hyponatraemia associated with the use of ReSoMal.296 The composition of oral 
rehydration fluids used in children with SAM needs to be reviewed in future research.296 To 
potentially harmonize electrolyte-composition of ORS used in children with and without SAM would 
facilitate pragmatic clinical care. 
Criticallyillchildrenwithhaemodynamicinstability:useofvasoͲactivemedication
The care package provided in units participating in the FEAST-trial was guided by WHO 
guidelines (pocket book: hospital care for children, ETAT), which do not include the use of vaso-
active medication.38,39,131 If haemodynamic instability persists, despite optimization of intra-vascular 
fluid status, further fluid bolus administration can be associated with serious adverse effects (e.g., 
respiratory, neurological dysfunction).85,297,298  
The SSC paediatric guidelines (2020) suggest adrenaline or noradrenaline as first-line vasoactive 
medication for treatment of fluid-refractory septic shock.85 Panel members of these guidelines prefer 
to use adrenaline in case of presence of myocardial dysfunction and low cardiac output and 
noradrenaline in case of signs of decreased systemic vascular resistance.85 Dopamine can be used as 




In case of fluid refractory shock, the use of continuous infusions of vaso-active medication can be 
considered in resource-limited settings as part of an improved critical care package if adequate 
equipment and clinical competencies are available (Table 15). Low-dose, diluted adrenaline or 
noradrenaline infusions can initially be administered via well monitored peripheral lines.85 This 
approach was practiced on treatment units during the Ebola outbreak in the eastern Democratic 
Republic Congo, guided by pragmatic WHO guidelines.56, n The “European Society of Intensive 
Care Medicine (ESICM) Global Intensive Care” working group suggests to use a similar approach 
for the management of adult patients with septic shock.299  
Future research projects, can help to evaluate safety and clinical benefit of low-dose infusions of 
vaso-active medication in the context of an “improved care package” for the treatment of children 
with fluid refractory shock, treated in resource-limited contexts. POC-lung ultrasound and 
echocardiography can help to improve haemodynamic monitoring.154,164 
Monitoringofvitalorganfunctions
Papers presented in this thesis describe treatment of respiratory and haemodynamic instability 
among critically children. These efforts need to be accompanied by pragmatic monitoring of vital 
organ functions in routine clinical practice and clinical research. 87% of deaths in the FEAST-study 
occurred in the first 24 hours.131 Paper 3 highlights that in order to describe physiological mechanisms, 
impact of critical care interventions and interaction of different co-variates a more complete data-set 
is beneficial. This is particularly important in the first 24-48 hours of critical care management, when 
there is a high risk of clinical deterioration. Modern, affordable essential monitoring tools (e.g., SpO2 
& HR-monitors; POC-Hb & biochemistry-tests, POCUS) are valuable in this context. 
Monitoringofrespiratoryfunction
Routine assessment includes: Respiratory rate; assessment of respiratory effort and work of breathing 
and further clinical examination. 
SpO2/FIO2 ratio is a pragmatic parameter to define severity of respiratory dysfunction.87-89 FIO2 can 
be estimated in children treated with nasal prongs or face masks.94,300 Biomedical devices providing 
non-invasive respiratory support need to allow adaptation of FIO2. SpO2/FIO2 ratios were not 
determined in the FEAST-study and were therefore not available in the data-set of Paper 3.131 Also in 
 




Paper 2 and 3 SpO2/FIO2 ratios were not documented. However, sequential evaluation of SpO2/FIO2 
ratios needs to be considered as a crucial parameter in essential critical care and future research.  
Capnography (end-tidal CO2 monitoring) is needed in units providing advanced airway management 
and mechanical ventilation and contributes to improved quality and safety of care.143,301  
MonitoringofCirculationandHblevels
Routine assessment : WHO suggests to assess circulatory function in children with the following 
clinical parameters: palpation of central and peripheral pulses, CRT and assessment of temperature 
gradient (Table 14). Evaluation of additional parameters are needed to guide clinical care according 
to WHO guidelines: signs of dehydration, pallor and screening of nutritional status (e.g., MUAC).38,39 
While physical examination of cardio-vascular function has its limitations,154,302 sequential 
assessment of response to interventions (e.g., small volume fluid boluses) is important. Clinical 
evaluation needs to include the impact of circulatory function on other vital organs (e.g., level of 
consciousness, Hb levels, urine output).40,85,154 
Non-invasive blood pressure (NIBP): FEAST-study results highlight that hypotension is a late 
sign of circulatory decompensation in critically ill children. Children classified in Stratum B, 
presenting with hypotension had a high mortality risk (18 from 26 children in this group died).131 In 
the FEAST-study systolic BP levels below the 5th centile were chosen to define hypotension: <50 mm 
Hg in children younger than 12 months of age, <60 mm Hg in children 1 to 5 years of age and <70 
mm Hg in children older than 5 years of age. “Moderate hypotension” was defined in this study as 
systolic BP values around the 5th centile of normal levels for different age ranges.131,262 This level of 
moderate hypotension was detected in 6% of patients at the time of recruitment.
Adult international recommendations suggest to target a mean arterial blood pressure (MAP) above 
65 mm Hg (5th percentile) in adults and children above the age of 12 years with septic shock.86,154 The 
expert panel of the SSC-paediatric guidelines (2020) did not identify clear evidence regarding age-
adapted MAP targets in the management of children with septic shock and associated organ 
dysfunction.85 However, recognized practice is to target MAP levels between the 5th and 50th 
percentile or greater than 50th percentile for age.85  
According to WHO guidelines, basic clinical assessment remains the priority in the assessment of 
cardio-vascular function.38,39 However, if low-dose infusions of vaso-active medication are used, 
automated NIBP at short intervals needs to be included in the routine monitoring (Appendix, Table 




age-adapted BP-cuff sizes). If measurements of MAP are not feasible, monitoring of systolic BP is 
an acceptable alternative.85 
Safe use of invasive BP measurements needs specific clinical skills, equipment and supplies.154 
Potential complications need to be considered. Therefore, introduction of invasive BP monitoring is 
not among priority interventions in essential paediatric critical care (authors comments; Table 1). 
Further non-invasive monitoring of cardio-vascular function can be considered, depending on 
clinical settings or in the context of research projects e.g.:154 POC lung ultrasound, echocardiography 
and suprasternal doppler. Other forms of cardiac-output monitoring, near infrared spectroscopy 
(NIRS) and micro-circulation assessment may be used in research contexts.154  
Haemoglobin levels: Sequential point of care Hb measurements are important to guide clinical 
management of patients with haemodynamic instability, particularly in malaria-endemic regions 
(Paper 3). The need for potential RBC transfusions in case of low Hb levels on admission or 
worsening Hb level during the course of critical care management needs to be anticipated.  
TheroleofPOCUSͲmonitoringofrespiratoryandcardioͲvascularfunction
In the preparation period of the FEAST-study a small POC echocardiography study among 30 
children with severe malaria was conducted in a paediatric unit in coastal Kenya.303o Two further 
echo-cardiography studies, conducted in East Africa evaluated cardiac function among children with 
SAM.271,272 The inclusion of POC-lung ultrasound could have added further important value to these 
three studies.154 However, these examples demonstrate that it is feasible to conduct echocardiography 
and supra-sternal doppler assessments at the bed-side of critically ill children in low-resource 
contexts. Experience from pragmatic POCUS training programs indicate that clinician can acquire 
important ultrasound skills in challenging resource-limited settings.304  
Panels of echocardiography assessments need to be pragmatic. Qualitative and semi-quantitative 
assessments allow critical care clinician to perform echocardiography evaluations rapidly at the bed-
side.154,164 Supra-sternal doppler examination adds further value to the haemodynamic evaluation (in 
association with Hb & SpO2 measurements O2-delivery can be estimated and monitored).154,303,305 
Lung ultrasound gives the opportunity to evaluate signs of extravascular lung-water.164,165 
Additionally, lung ultrasound and can support clinicians to recognize pleural space pathologies (e.g., 
pleural effusions, pneumothorax) as well as lung consolidation.164  
 




POCUS findings need to be interpreted in conjunction with vital signs and clinical assessment. 
Sequential evaluation of clinical signs and POCUS findings allows dynamic monitoring of clinical 
progress and response to critical care interventions (e.g., fluid boluses, transfusions, vaso-active 
medications).154 Additionally, POCUS can contribute to safety and quality of clinical interventions 
(e.g., thoracocentesis, peri-cardiocentesis, chest drain placement, central line insertion).164 
Monitoringoflactatelevels
Elevated lactate levels (> 3 mmol/l) and especially persistently high or increasing lactate levels are 
associated with increased mortality risk among critically ill children.85,154 39% of patients (1159 out 
of 2981 cases with available results) in the FEAST-study had lactate levels > 5 mmol/l at the time of 
recruitment, describing severity of illness among these study participants.131  
The SSC paediatric guidelines (2020) and other international recommendations highlight that 
blood lactate levels in septic children can be affected by multiple mechanisms besides tissue hypoxia. 
Therefore, blood lactate results need to be interpreted in conjunction with further clinical parameters 
assessing systemic perfusion. High and especially persistent elevation in lactate levels need to prompt 
thorough clinical evaluation of patients.85 154 Different factors associated with critical illness need to 
be considered in this context:306 
 High lactate levels can be associated with tissue hypoxia and anaerobic metabolism. Tissue 
hypoxia is associated with reduced O2-delivery, which is determined mainly by cardiac output, 
respiratory function (oxygenation) as well as Hb levels/O2-carrying capacity. Complex mechanisms 
affecting micro-circulation can further affect tissue perfusion in septic patients.306-308 Paper 3 
describes the inverse association of low Hb and high lactate levels in critically ill children treated in 
malaria-endemic settings.  
Decreased lactate clearance in patients with hepatic dysfunction and/or decreased hepatic blood 
flow (associated with shock) can contribute to elevation of blood lactate.306  
Severe acute lung injury associated with inflammatory processes (e.g., sepsis) can be associated 
with considerable regional lactate production.306  
Inflammatory processes can accelerate aerobic glycolysis, without the initial presence of anaerobic 
conditions associated with tissue hypoxia. In the context of inflammatory processes, wight blood cell 
metabolism as well, can contribute to increased lactate production, which is not necessarily associated 




Pyruvate-dehydrogenase function on mitochondrial level can be altered by complex mechanism 
associated with inflammatory processes.306 In this context, thiamine deficiency can be considered as 
a contributing factor in some settings (e.g. critically ill children with severe acute malnutrition).309 
In clinical practice and future research evaluating paediatric critical care in low-resource settings, 
sequential lactate levels can contribute to describe disease severity and monitor response to treatment. 
Monitoringofneurologicalfunction
Mental status, level of consciousness (e.g., AVPU-scale) and a basic neurological assessment needs 
to be monitored. This assessment includes evaluation of patient comfort and pain-control.Additional 
techniques (e.g., electro-encephalogram/EEG, transcranial dopplers) can be considered in specific 
projects and research contexts.310,311 
Renalfunction,fluidbalanceandelectrolyteabnormalities
AKI is a common complication of critical illness in children and is associated with an increased 
mortality risk and long-term morbidity.273,278-281 International consensus definitions of AKI by the 
“Kidney Disease Improving Global Outcomes (KDIGO) working group” are based on creatinine 
levels, changes of creatinine-levels from baseline and urine output measurements.283,312 ”KDIGO-
criteria” highlight the importance of basic urine output monitoring to determine renal function.282,284 
In order to prevent nosocomial infections and avoid urethral injuries, non-invasive methods of UO-
monitoring are beneficial (e.g., use of urine bags, weighing of nappies).p Despite limitations of serum 
creatinine measurements to detect early stages of renal dysfunction, sequential measurements allow 
to describe renal function during the course of critical illness.283 Monitoring of renal function and 
classification according to KDIGO-criteria needs to be considered in future research projects 
evaluating treatment of critically ill children in resource-limited settings. 
Administration of all IV and enteral fluids needs to be monitored. Fluid balances need to be 
completed by estimation of fluid losses. Body weight needs to be documented regularly. 
Testing of creatinine, electrolyte or blood gases might not be an initial priority in the set-up of 
essential paediatric emergency and critical services, but can be considered in more advanced settings 
(Table 1). Introduction of monitoring and correction of electrolyte abnormalities adds considerable 
complexity to essential critical care, and if not done correctly can be associated with additional clinical 
risks. The following aspects can be considered in this context e.g.: 
 




Ͳ Pragmatic management guidelines are provided by WHO (WHO guidelines: “optimised 
supportive are for Ebola Virus Disease”).56 Adequate training is needed in this context. 
Ͳ POC-testing is important as results need to be available as soon as possible after correct blood 
sampling in order to be of optimal clinical value.  
Further laboratory tests, including liver function, full blood count, coagulation, microbiological 
investigations, inflammatory biomarkers are of value in certain contexts (Table 1), but are not the 




Interpretation of results is limited by the basic observational set-up of the study. The small sample 
size limited more detailed subgroup analyses.  
Qualityofdatacollection
Data quality (e.g., frequency of vital signs monitoring) was affected by limited human resources, 
limited monitoring equipment (e.g., SpO2-monitors) as well as very high workload. Sequential 
documentation of SpO2/FiO2 ratios in association with CPAP-pressure documentation could have 
improved description of severity of respiratory dysfunction and response to treatment.87,88 
 Human resource gaps contributed to the fact that most, but not all, children who were managed 
with bCPAP during the study period were included in the analysis. Only isolated, CPAP-runs of short 
duration (less than 12 hours) might have been missed during week-ends. Of these isolated cases, all 
children survived as all files of children, who died on the unit were screened specifically.  
Limitationsofthestudy
During the study, the clinical team faced considerable resource-limitations and high workload. The 
following measures could have improved quality of non-invasive respiratory support e.g.: 
Ͳ Improved nurse to patient ratio can improve quality of care (e.g., monitoring of respiratory 
support, fluid management, progressive introduction of enteral feeds).  
Ͳ Better supply of essential equipment is important (e.g., adequate number of dedicated bCPAP 
set-ups, SpO2-monitors).  
Ͳ Strengthening of blood transfusion service can contribute to improved clinical outcomes of 




Anthropometric measurements were suboptimal in our survey. Length measurements were not 
done in a large number of patients. We therefore used weight/age as a marker of nutritional status.  
Methodologicalconsiderations:Paper2Mechanicalventilation
Studydesign
A cohort study, designed as a retrospective analysis of a prospectively collected database. The non-
randomized study design limits conclusions on the true outcome effects of intensive care 
interventions, including mechanical ventilation in snakebite victims with acute respiratory failure. 
Datacollection
Unfortunately, the hospital information system of Lacor-hospital did not provide data on the 
number of patients referred from peripheral facilities or hospitalized patients with snakebites, who 
did not need ICU admission. A better epidemiological assessment of snake-bites in the region could 
help to improve organisation of preventive measures as well as referral pathways and improvement 
of pre-referral management of snake-bite victims and other critically ill patients.  
The analysis was designed retrospectively which explains why the presenting clinical symptoms 
of snakebite victims could be determined in only 23% of study patients. Paper 2 can, therefore, give 
only limited insight into the differences in management and outcome of patients presenting with 
different snakebite-associated clinical syndromes. Among 60 patients requiring mechanical 
ventilation, clinical symptoms were documented in more detail in only 16 cases. Neurotoxicity 
leading to ARF was the most commonly documented indication for advanced respiratory support 
(87.5%). It can be emphasized that in the absence of any other documented complication patients with 
ARF requiring mechanical ventilation most likely had a neurotoxic snakebite syndrome.  
Limitationofresourcesandimpactonqualityofcare
Monitoring of patients could have been improved by the availability of capnography. Capnography 
needs to be considered as an essential monitoring devices in units offering advanced airway 
management and mechanical ventilation.143,301  
In Paper 2 only a small number of patients with ARF, who required mechanical ventilation received 
anti-venom (10 out of 60 ventilated patients). The anti-venom used during the study period is not 
among the products currently recommended by international specialist.121,163 It can therefore not be 
determined if in patients with ARF early administration of adequate doses of good quality anti-venom 
in combination with advanced airway management and mechanical ventilation could have improved 






The initial FEAST study was a RCT conducted in 6 different paediatric departments in three East 
African countries. Different aspects of essential paediatric emergency and critical care were improved 
in the participating units prior to the start of recruitment of study patients. In this context study 
procedures were integrated in routine clinical processes.131  
Monitoring of study procedures and data collection was conducted at all participating sites on a 
regular basis.131 The statistical analysis was done by experienced statisticians and the study oversight 
was in-line with international standards.131  
An endpoint review committee, reviewed all deaths, adverse events and neurologic sequelae. 
However, diagnostic means were limited at the study sites.131 It was therefore difficult to clearly 
define causes of death in a considerable number of patients.  
The FEAST-study demonstrates that it is feasible to conduct good-quality clinical trials in 
emergency and critical care in low-resource settings. Future research projects evaluating critical care 
in comparable contexts, need to conduct a careful needs assessment in order to strengthen essential 
emergency and critical care standards in participating units. 
Paper3:Identifiedlimitations
In Paper 3 some limitations were identified which can lead to future research opportunities: 
In the care of critically ill children with haemodynamic instability associated with respiratory 
dysfunction, treated in a low-resource setting, the role of non-invasive respiratory support needs 
further evaluation.  
The respiratory organ function score, presented in Paper 3 can be strengthened by sequential 
documentation of SpO2/FIO2 ratios. This approach is in-line with international standards to define 
severity of PARDS.88 Also in resource-limited settings, where access to blood gases and imaging is 
difficult SpO2/FIO2 ratios can be monitored.89,91,300 
Critically ill children with signs of severe dehydration as well as children with SAM were not 
included in the FEAST-study. Paper 3 could therefore not address questions related to these 
particularly vulnerable patient populations.  
Low-dose infusions of vaso-active medication have not been used in the FEAST-study. This is a 
further element in context-adapted paediatric critical care, which can be considered in future practice 




AKI is a common complication of critical illness in children and is associated with an increased 
risk of poor clinical outcomes.278,279 AKI is also described as a complication in children with severe 
malaria.273,280,281 Blood urea nitrogen levels (BUN) were measured at different time points during the 
FEAST-study.131 However, no urine output and creatinine levels were documented. Therefore, 
“KDIGO criteria” could not be used to describe renal function in the study population.131,283,284  
POCUS was not used in the FEAST study. However, POC lung ultrasound, supra-sternal doppler 
and a pragmatic application of bed-side echocardiography have the potential to contribute to 
improvements of quality of care and diagnostic processes.154,164,303 
Paper 3 highlights the importance that research projects evaluating paediatric critical care in 
resource-limited settings need to ensure frequent, sequential vital sign documentation as well as 
review of the most important blood results (e.g., electrolytes, acid-base, Lactate, Hb), particularly in 
the first 24-48 hours of critical care, when patients have a high risk of clinical deterioration. 
Methodologicalconsiderations:Contextadaptedseverityofillness(SOI)scores
A detailed discussion on outcome measures in critical care is beyond the scope of this thesis. 
However, papers 1, 2 and 3 describe clinical care of critically ill children in low-resource settings 
with a high mortality risk. In Paper 1 and 2 no SOI scores were used, which limits the possibility to 
compare clinical outcomes described in other publications.  
SOI scores allow description and comparison of cohorts of critically ill patients. 243,262 Scores like 
Paediatric Index of Mortality 2 & 3 (PIM)/Pediatric Risk of Mortality Score III (PRISM) used in 
PICUs in high-resource settings are based on parameters describing the degree of acute organ-
dysfunctions and chronic health variables.243,262 Sequential assessment of SOI-scores like paediatric 
logistic organ function-score (PELOD) allows to analyse trends regarding clinical progress of patients 
and response to treatment.243,313-315 Different clinical severity scores have been evaluated in low-
resource settings in paediatric and adult populations. 147,316,317 Organ function scores described in 
Paper 3 used basic clinical parameters to describe severity of acute organ dysfunction. These 
assessments can be strengthened, examples: 
Ͳ SpO2/FIO2 ratio is a pragmatic and important marker to assess respiratory function.87-89  
Ͳ  Assessment of organ-function can be adapted to different contexts and can be strengthened by 
POC- laboratory parameters (e.g., blood gases, Lactate, Hb, renal function).154,283,284  
Ͳ POCUS and supra-sternal doppler can contribute to description of respiratory and cardio-




Chronic health variables influence clinical outcomes of critically ill children and need to be 
included in the description of SOI of patient cohorts.243,262 Nutritional status and HIV-status are 
important factors in this context.135,170,171 Sickle cell disease is a further important co-morbidity in 
critically ill children, particularly in SSA.77 Other chronic health variables (e.g., cardiac or renal 
conditions, malignancies, neuro-disability) need to be considered.190,243,262 SOI-scores do not replace 
triage systems. WHO and partners recommend a pragmatic interagency triage tool.45 
Outcomemeasures:economic,clinicalandhumanisticoutcomes243
Sequential assessment of SOI-scores (e.g., context-adapted PELOD) can facilitate estimation of 
required resource allocation in health facilities and patient transfer systems, considering seasonal 
variation of activities as well as disease outbreak preparedness. Additional information can contribute 
to a further needs assessment associated with efforts to improve comprehensive EECC services e.g.:  
Ͳ Post-discharge mortality and morbidity as well as quality of life of critical care survivors can 
be assessed, which allows to plan future support strategies. 
Ͳ Perception of patients and families regarding critical care can be evaluated. 
Ethicalconsiderations:AdvancedcriticalcareinlowͲresourcesettings
AdvancedcriticalcareinresourceͲlimitedsettings–example:mechanicalventilation
Setting-up a level 3 critical care unit in resource-limited contexts with the ability to provide 
mechanical ventilation needs a sustained multi-disciplinary effort, requiring considerable resources 
and clinical capacity. Critical reflection on resource allocation and ethical decision making is 
required.241 Additionally, mechanical ventilation can be associated with considerable risks e.g.:243,262  
Ͳ Haemodynamic instability during the intubation process; failed intubations. 
Ͳ Complications associated with mechanical ventilation e.g.: dislocation and obstruction of 
endo-tracheal tubes as well as problems with ventilation circuits, equipment failure, ventilation 
associated lung injury (VALI), pneumothoraxes, ventilation associated pneumonia (VAP). 
Patients with ARF and a potential to recover relatively quickly with adequate critical care support 
might benefit most from advanced airway management and mechanical ventilation in low- resource 
contexts e.g.: upper airway obstruction, post-operative care, prolonged seizures or ARF due to 
transient muscle paralysis caused by neurotoxic snake bite envenomation (Paper 2 & Table 13). 
Therefore, benefits, clinical risks for patients as well as available resources need to be balanced. 
Exposed to these challenges, considerable ethical dilemmas arise for critical care teams. A PICU-




guide “fair and equitable” utilization of limited critical care resources.241 Institutional guidelines 
should be introduced to guide rational decision-making processes in stressful emergency situations. 
These arrangements can help to identify patients, who are most likely to benefit from mechanical 
ventilation, while considering available resources.241,318  
Palliative care for critically ill patients not responding to intensive care measures needs to be 
included in these guidelines and support structures can be developed in this context.319  
Guideline development processes need to be transparent. Clinical decision-making and outcomes 
of critically ill patients needs to be audited, while encouraging trust-full discussions among health 




Paper 1 and 2 are observational studies. Observational studies are considered as “low-level 
evidence” in the pyramid, grading the level of evidence provided by clinical research.320 However, 
observational studies can be conducted at comparably low-costs and can be set-up relatively quickly, 
as compared to RCTs. Paper 1 and 2 are examples on how pragmatic studies can be integrated in 
routine clinical processes. In this context observational studies can contribute to quality of care 
improvement in participating units.  
Essential principles of clinical research need to be respected in the set-up and conduction of 
observational studies as well as documentation, analysis of data and interpretation of results. 
Frameworks provided by international experts can guide this process (e.g. Enhancing the QUAlity 
and Transparency Of health Research Equator Network ).321-323 While observational studies can’t be 
used to the same extend as RCTs to state facts regarding efficacy of interventions, these studies can 
still describe feasibility to introduce certain clinical interventions (e.g., bCPAP) in “real-life clinical 
contexts”.322 Additionally, results described in observational studies are useful to identify pragmatic 
future research opportunities and quality improvement measures. Well-conducted observational 
studies, therefore have the potential to contribute to agility and flexibility of clinical research in “real-
life contexts”. Especially in resource-limited settings this form of pragmatic research has the potential 





The FEAST-study evaluated elements of EECC among children with signs of haemodynamic 
instability. An informed consent process assures voluntary participation of patients in clinical 
research. This process reflects respect of patient´s rights and contributes to adequate ethical conduct 
of clinical research. International guidelines exist to protect patients recruited in emergency and 
critical care research.156,157  
Implementation of good quality consent processes in paediatric critical care research conducted in 
resource-limited settings needs careful planning.158,159 During the FEAST trial a system of deferred 
consent was adopted during the recruitment process.131 Trained staff was allocated to conduct a verbal 
assent conversation with care-takers at the time of recruitment, while deferring complete informed 
consent. The process of “verbal assent”, did not delay or interfere with clinical emergency care. 
During the process of verbal assent care-takers were assured that quality of care for their children was 
independent of their decision to participate in the research.  
Once emergency procedures were initiated and a degree of clinical stability was achieved the 
consent process was continued. Health workers conducting the “clinical consent conversation” had 
the same cultural and linguistic background as the child´s care-takers. To maintain voluntariness 
among care takers in the process of verbal assent and consent is particularly challenging in clinical 
trials evaluating care of critically ill children in resource limited settings.159 This reflection highlights 
the importance to ensure adequate context-adapted standards of care for all children admitted to 
participating paediatric units. 
Despite considerable challenges associated with verbal assent and consent in the FEAST-study, 
important lessons were learned and reviewed. This review included perceptions among guardians and 
health workers.159 Consent processes need to be adapted to particular studies, clinical conditions of 
patients as well as cultural contexts.159 In this process staff members, parent and community 
representatives need to be consulted.159 Opinions of children and parents with experience of their 
children requiring emergency treatment can provide valuable input to optimize conduct of research 
and consent processes in paediatric emergency and critical care.325,326 
Conclusion 
The high survival rates among HIV-negative children with acute respiratory dysfunction and no 
other severe organ dysfunctions in Paper 1, indicate that bCPAP can be used efficiently in resource-




forms of non-invasive respiratory support as part of a care package for critically ill children with 
multi-organ dysfunction (e.g., haemodynamic instability) needs further evaluation. Children with 
malnutrition or HIV infection need particular attention in this context. 
Paper 2 suggests that provision of basic intensive care, including advanced airway management 
and mechanical ventilation, is a feasible treatment option for critically ill snakebite victims presenting 
with acute respiratory failure in a rural hospital in sub-Saharan Africa. Most of these patients showed 
signs of a neuro-toxic snake-bite envenomation, which led to acute respiratory failure without severe 
acute lung injury and no other associated severe organ-dysfunctions. The set-up of an intensive care 
unit, able to provide this level of advanced respiratory support requires a sustained multi-disciplinary 
effort. 
Paper 3 highlights that critically ill children with signs of circulatory impairment, who do not fulfill 
WHO definition of shock should not receive fluid boluses. Additionally, children with signs of shock 
and severe anaemia should not receive pre-transfusion IV fluid boluses, while blood transfusions need 
to be initiated as soon as possible. Fluid resuscitation of critically ill children with normal saline and 
HAS (5%) can be associated with severe adverse events like respiratory and neurological dysfunction, 
hyperchloraemic acidosis as well as reduction of Hb levels. These findings suggest that fluid 
resuscitation with un-balanced electrolyte solutions may cause harm and should be avoided. A more 
cautious approach to fluid resuscitation using smaller volumes of electrolyte balanced IV fluids needs 
to be evaluated. Future pragmatic research needs to be directed to optimize a comprehensive approach 
to paediatric emergency and critical care adapted to resource-limited contexts, with attention to all 
vital organ-functions.  
Implications and future perspectives 
Implicationsforpolicy:contextͲadaptedpaediatriccriticalcare
AccesstoEECCondifferentlevelsofreferralpathwaysinresourceͲlimitedsettings
Access for populations living in resource-limited settings to essential paediatric emergency and 
critical care needs to be strengthened on different levels of referral pathways. Populations exposed to 
acute humanitarian crisis need particular attention. Population-based research on epidemiology of 
severe infections (e.g., sepsis) can describe disease burden and facilitate evaluation of needs 
associated with prevention and treatment of critically illness.327 However, particular efforts need to 





Sustainable O2-provision is an integral part of EECC. Multi-disciplinary efforts are required in 
low-income countries to strengthen health systems to effectively and safely provide medical O2 on 
different levels of referral pathways. 
Non-invasive respiratory support has the potential to improve quality of critical care for children 
with acute respiratory dysfunction. Biomedical equipment used for respiratory support, needs to be 
adapted to resource-limited contexts and needs to undergo thorough biomedical testing. Strengthening 
of biomedical engineering services, able to test, maintain and repair medical devices is an important 
element in efforts to improve quality of EECC in low-income countries.  
SafeadministrationofIVfluids,bloodproductsandmonitoring
Safe administration of IV fluids is a major challenge in resource-limited settings. International 
guidelines can only be implemented if adequate supplies and materials are available (e.g. paediatric 
giving sets, infusion/syringe pumps). Safe and efficient blood transfusion services need to be 
strengthened. 
 Availability of context-adapted modern clinical monitoring devices as well as good quality point 
of care tests needs to be assured in order improve quality of EPECC.  
Essentialbiomedicalequipmentandneedforsustainableenergysolutions
O2 concentrators and other medical devices (e.g., for non-invasive respiratory support, essential 
monitoring) need reliable and affordable electricity supply. Development of sustainable energy 




In the discussion of this thesis, important knowledge gaps were described in relation to 
improvements of a comprehensive approach to EPECC provided in low-resource settings. Several 
research questions can be related to elements highlighted in international recommendations and 
“translated to clinical realities” in resource limited settings (table 10) e.g.:  
Ͳ International guidelines for the management of sepsis-associated organ dysfunction in children 




critically ill children from the “Paediatric Mechanical Ventilation Consensus Conference 
(PEMVECC 2017)”, recommendations of the WHO sepsis expert technical group.85,98,327 
Ͳ Recommendations summarized by working groups of the European society of paediatric 
neonatal and intensive care (ESPNIC) e.g.: hemodynamic monitoring for critically ill children 
and international guidelines on POCUS for critically ill neonates and children 154,164 as well as 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































An efficient patient circuit and support of essential paediatric emergency and critical care can 
substantially reduce preventable paediatric hospital mortality.19,49 Important elements of a patient 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 13 gives an overview of suggested aspects, which need to be considered if a unit introduces 
advanced airway management and mechanical ventilation. As outlined previously risks and benefits 
of mechanical ventilation need to be balanced, while considering resource limitations. Guidelines 
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ABSTRACT
Introduction In low-resource countries, respiratory 
failure is associated with a high mortality risk among 
critically ill children. We evaluated the role of bubble 
continuous positive airway pressure (bCPAP) in the 
routine care of critically ill children in Lilongwe, Malawi.
Methods We conducted an observational study 
between 26 February and 15 April 2014, in an urban 
paediatric unit with approximately 20 000 admissions/
year (in-hospital mortality <5% approximately during 
this time period). Modified oxygen concentrators or 
oxygen cylinders provided humidified bCPAP air/oxygen 
flow. Children up to the age of 59 months with signs of 
severe respiratory dysfunction were recruited. Survival 
was defined as survival during the bCPAP-treatment 
and during a period of 48 hours following the end of the 
bCPAP-weaning process.
Results 117 children with signs of respiratory failure 
were included in this study and treated with bCPAP. 
Median age: 7 months. Malaria rapid diagnostic tests 
were positive in 25 (21%) cases, 15 (13%) had severe 
anaemia (Hb < 7.0 g/dL); 55 (47%) children had 
multiorgan failure (MOF); 22 (19%) children were HIV-
infected/exposed. 28 (24%) were severely malnourished. 
Overall survival was 79/117 (68%); survival was 54/62 
(87%) in children with very severe pneumonia (VSPNA) 
but without MOF. Among the 19 children with VSPNA 
(single-organ failure (SOF)) and negative HIV tests, all 
children survived. Survival rates were lower in children 
with MOF (including shock) (45%) as well as in children 
with severe malnutrition (36%) and proven HIV infection 
or exposure (45%).
Conclusion Despite the limitations of this study, the 
good outcome of children with signs of severe respiratory 
dysfunction (SOF) suggests that it is feasible to use bCPAP 
in the hospital management of critically ill children in 
resource-limited settings. The role of bCPAP and other 
forms of non-invasive ventilatory support as a part of 
an improved care package for critically ill children with 
MOF at tertiary and district hospital level in low-resource 
countries needs further evaluation. Critically ill children 
with nutritional deficiencies and/or HIV infection/exposure 
need further study to determine bCPAP efficacy.
INTRODUCTION
In 2015, 5.9 million children died before the 
age of 5 years with approximately 50% of 
these deaths occurring in sub-Saharan Africa 
(SSA).1 Very severe pneumonia (VSPNA) 
based on the WHO classification remains a 
leading cause of child mortality.1 Although 
there has been a considerable decline in 
mortality in hospitalised Malawian children 
between 2000 and 2012, mortality remained 
high in 2012 in critical subgroups including 
those with VSPNA (12%), severe undernu-
trition (15%) and severe acute malnutrition 
(35%).2 Despite the introduction of Haemo-
philus influenzae B and pneumococcal conju-
gate vaccines, severe respiratory infections 
(bacterial and viral) are likely to remain a 
major cause of morbidity and mortality in 
Key messages
 Ź The high survival rates among children with very se-
vere pneumonia and no other severe organ dysfunc-
tions, documented in this study, indicate that bCPAP 
can be used safely and efficiently in resource-limited 
but well-supervised paediatric units in SSA.
 Ź Multiorgan failure, malnutrition and HIV infection/ex-
posure were associated with an increased mortality 
risk. The role of bCPAP and other forms of NIV as a 
part of an improved care package for malnourished 
and non-malnourished critically ill children (includ-
ing shock ± anaemia) needs further evaluation.
 Ź The study highlights the importance of a multidisci-
plinary approach in the implementation process of 
basic paediatric critical care measures like bCPAP, 
e.g.: efficient logistic set-up of patient circuits, re-
liable oxygen systems including reliable electricity 
supply, cost-effective, good quality medical equip-
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SSA. Paediatric emergency and critical care, adapted 
to available resources, is therefore essential in order to 
achieve further reductions in child mortality. Improve-
ments of non-invasive respiratory support can play an 
important role in this context.
Respiratory failure is also a common feature of criti-
cally ill children with severe sepsis.3 Severe infections 
can lead to a complex systemic inflammatory response, 
and a variety of conditions such as pneumonia, bacter-
aemia and malaria can coexist.4 5 Without early, efficient 
management, these infections can progress to significant 
organ dysfunction, including acute respiratory distress 
syndrome and respiratory failure.3 Respiratory support 
is therefore an essential element in the management of 
critically ill, septic children.6–8
Improved paediatric emergency care in health facilities 
and streamlined referral pathways can have a significant 
impact on child survival. Improvement of oxygen delivery 
and respiratory support plays an important role in this 
context. A recent study conducted in Malawi showed 
that the use of pulse oximetry in peripheral outpatient 
health facilities and village clinics can help clinicians 
and community health workers to identify children with 
severe pneumonia and hypoxaemia.9 A study in Papua 
New Guinea demonstrated that the reliable supply of low 
flow oxygen can reduce mortality among children with 
signs of severe pneumonia.10 Oxygen concentrators in 
conjunction with reliable electricity systems associated 
with ‘uninterruptable power supply' are cost-effective 
and provide a reliable method of oxygen supply in low-re-
source settings.11 12 Installation and maintenance of these 
‘oxygen systems’, however, remain a challenge in many 
health facilities in African countries.13 The combination 
of solar-powered energy systems and the use of oxygen 
concentrators can be an option to improve oxygen supply 
in health facilities in remote settings.14
Non-invasive respiratory support has the potential to 
improve the outcome of critically ill children managed 
in low-resource settings, and notably, the role of non-in-
vasive ventilatory (NIV) support in the management 
of septic children with ‘less severe Acute Respiratory 
Distress Syndrome (ARDS)’ is also under evaluation in 
high-resource settings.15
Different forms of NIV exist: continuous positive airway 
pressure (CPAP), high-flow of warmed and humidified 
air/oxygen via nasal cannula, bilevel positive airway pres-
sure and neuronally adjusted ventilatory assist.16 17
CPAP has been used efficiently for the treatment of 
children with respiratory dysfunction in high-resource 
settings (eg, viral bronchiolitis).18–20 It has been shown 
that bubble CPAP (bCPAP) administered through nasal 
prongs offers a good quality, relatively low-cost alterna-
tive to ventilator-delivered CPAP on neonatal units.21 
Feasibility and safety of bCPAP use on neonatal units in 
middle-income and low-income countries have also been 
evaluated.22
A recent randomised controlled trial (RCT) conducted 
in Bangladesh showed that children with VSPNA treated 
with bCPAP had a significantly lower mortality rate (4%) 
compared with a group treated with low-flow O2 (15%).
23 
A further study conducted in Ghana demonstrated that 
CPAP can be used efficiently in the management of chil-
dren with respiratory distress in SSA.24
A smaller study described the use of an improvised 
bCPAP set-up (mostly non-humidified flow) on an 
extremely busy paediatric unit in Malawi for children (29 
days to 59 months) with VSPNA and children presenting 
with signs of respiratory dysfunction in the context of 
critical illness (eg, severe malaria) including shock and 
severe anaemia.25 Several months later, the authors had 
the opportunity to introduce a better adapted bCPAP 
set-up in the same clinical environment. Its use with a 
larger and better-described cohort, and its success or 
failure dependent on patient risk characteristics and 
their association with death while on bCPAP, is reported 
here.
METHODS
Study population and setting
We conducted an observational study of all children 
0–15 years treated with bCPAP between 26 February and 
15 April 2014 in the paediatric department at Kamuzu 
Central Hospital in Lilongwe, Malawi. In 2014, this 
department had approximately 20 000 paediatric admis-
sions of infants and children ages 0–15 years. This obser-
vational study was conducted during the peak of the 
malaria season in 2014, with >3000 admissions/month in 
March and April 2014 and a mortality rate of approxi-
mately 4%.26 Most newborns were treated on a dedicated 
neonatal unit. A small number of newborns born outside 
Kamuzu Central Hospital, received respiratory support 
with bCPAP on the paediatric unit. Only these newborns 
were included in the study.
Patients were initially screened in a triage/admis-
sion zone. Critically ill children with emergency signs27 
were managed in a ‘resuscitation zone (4 beds for 4, 
sometimes up to 16 patients)’. This area was directly 
connected to a ‘critical care/emergency zone’ (approx-
imately 16–18 beds—for up to 30–60 patients), where 
further basic critical care, according to WHO guide-
lines27 (including management of airway and breathing, 
intravenous or intraosseous fluids, blood transfusion, 
nutritional support, oral and intravenous medications), 
was provided. Approximately eight oxygen concentra-
tors, backed up with oxygen cylinders, were available. 
The oxygen flow provided by each of these devices can 
be split to deliver low-flow O2 to up to five patients.
This centralisation of basic critical care enabled a 
limited number of staff to provide the best possible 
management (including vital signs approximately 2–3 
times per day and more frequent monitoring in very 
sick patients) to a large number of critically ill children 
(nurse to patient ratio: 1:15–30, doctors/clinical officers: 
2–4 (day) and 1–2 (night); supervision by at least one 
consultant on site for 12 hours per day). In a six-bed ‘high 
Protected by copyright.
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dependency unit (HDU)’, closer observation of selected 
critically ill children could be provided (spot-checks of 
vital signs approximately 2–4 hourly). The number of 
HDU beds was insufficient for the management of the 
large number of critically ill children.
Survival was defined as survival during the bCPAP treat-
ment and during a period of 48 hours following the end 
of the bCPAP-weaning process.
The unit’s policy was to offer HIV testing and counsel-
ling to every hospitalised child. However, because of the 
high workload and limited numbers of HIV counsellors 
not all admitted children were tested prior to death or 
discharge.
Basic ‘point of care tests’ were usually available, 
including malaria rapid diagnostics tests (MRDT), 
haemoglobin tests and blood sugar analysis. Further labo-
ratory tests like blood gases, electrolytes, renal and liver 
function, and full blood counts were not available. The 
blood bank was able to provide urgent whole blood trans-
fusions generally within 2–4 hours but at times there was 
more of a delay.
Basic bedside ultrasound and echocardiography 
helped to define thoracic and abdominal pathologies, 
cardiac function and congenital heart diseases. Access to 
chest X-rays was inconsistent.
Definitions and comorbidities
VSPNA was diagnosed by the presence of cough or diffi-
culty breathing with either SpO2 <90%, central cyanosis, 
severe respiratory distress (very severe chest indrawing), 
danger signs such as inability to drink or breast feed, 
lethargy, and reduced level of consciousness. Multiorgan 
failure (MOF) was defined as having respiratory dysfunc-
tion with either cardiovascular dysfunction (including 
severe anaemia) or central nervous system dysfunction at 
the time of bCPAP initiation. Severe anaemia was defined 
as an Hb <7 g/dL or clinically when rapid point-of-care 
testing was not available. Central nervous system dysfunc-
tion was defined as a Blantyre Coma Scale ≤3 or status 
epilepticus.
HIV status was defined as ‘infected’ if a child <2 years 
had a positive DNA PCR test or a child ≥2 years had a 
positive rapid test. A child was considered to be HIV 
‘exposed’ if there was a positive rapid test for a child 
<2 years or a documented maternal positive test, but no 
DNA PCR had yet been performed.
Malaria was diagnosed by MRDT, and all children with 
malaria receiving bCPAP would have been found to have 
severe malaria by virtue of their respiratory distress, shock 
or neurological dysfunction.
Nutritional status was described as either normal, 
moderate acute malnutrition or severe acute malnutri-
tion by WHO guidelines when data—usually mid-upper 
arm circumference (MUAC)—were available.
Other comorbidities included congenital heart defects 
diagnosed by bedside echocardiography, cerebral palsy, 
spina-bifida, hydrocephalus, neuromuscular disorders 
and other forms of neurodisability, sickle cell disease, 
malignancy or clinically suspected tuberculosis.
Inclusion criteria and initiation of bCPAP
Critically ill children of any age were initiated on bCPAP 
if, after initial resuscitation, they were found to have 
severe respiratory distress with or without further organ 
dysfunctions like shock, severe anaemia or neurological 
dysfunction. bCPAP could be initiated in the emergency 
zone or HDU depending on bed availability.
Fluid resuscitation
Children with signs of shock and no signs of dehydra-
tion received only careful fluid resuscitation (10 mL/
kg isotonic crystalloid solution). After re-evaluation, one 
further fluid bolus was administered in some children 
(a third bolus was only given very rarely). Malnourished 
children with signs of shock and no dehydration received 
only one fluid bolus. If possible, haemoglobin (Hb) was 
rechecked after each fluid bolus.
Children with severe anaemia did not receive a 
pre-transfusion bolus. In case of severe anaemia, 20 mL/
kg whole blood was transfused over 3–4 hours if HBs were 
<5–6 g/dL. This practice is in line with the latest WHO 
recommendations from 2016.28
In case of severe dehydration, WHO guidelines for the 
management of malnourished and non-malnourished 
children were followed as well.28
bCPAP device (see figure 1)
The low-cost bCPAP devices used in this study were modi-
fied oxygen concentrators with a maximum air/oxygen 
flow of 16 litres per min (LPM) (maximum oxygen flow: 
8 LPM, maximum air flow: 8 LPM; http:// go. gomango. 
co. uk/ diamedica. co. uk/ english/ product_ details_ 
diamedica. cfm? id= 1562). The FiO2 could be determined 
by adjusting the ratio of oxygen/air flow. The blended 
flow was humidified and in some devices could be 
warmed using the heat produced by the compressor of 
the oxygen concentrator. The pressure was determined 
by the distance of the distal part of the expiratory limb of 
the ventilation circuit below the water surface of a water 
bottle (‘resistor’).
In case not enough ‘bCPAP set-ups’ were available, 
oxygen cylinders were used to provide O2 flow required 
to provide bCPAP. With this ‘suboptimal set-up’, the 
FiO2 could not be adapted but oxygen flow could still 
be humidified. Patients were switched to the described 
‘modified oxygen concentrator’ whenever such a device 
was available.
Basic further care of critically ill children managed with bCPAP
Additional aspects of care for patients on bCPAP 
included head-up positioning, nasogastric tube (NGT) 
insertion for initial gastric decompression and drainage, 
intravenous maintenance fluids initially at 2/3 of the 
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Figure 1 Bubble continuous positive airway pressure (bCPAP) set-up. (With permission of Diamedica: http://go.gomango.
co.uk/diamedica.co.uk/english/product_details_diamedica.cfm?id=1562)
‘4-2-1 rule’29 were administered. Isotonic electrolyte 
solutions (Ringers lactate and dextrose)30 were used as 
maintenance fluids. Once vital organ functions were 
stabilised, 3-hourly NGT feeds were introduced gradu-
ally with expressed breast milk for infants, F-75 for chil-
dren>6 months with SAM. Regarding enteral nutrition 
of critically ill children without severe acute malnutri-
tion (SAM): Not enough therapeutic nutrition (F75 or 
F100) was available for the nutrition of critically ill chil-
dren without SAM. No other specific enteral nutrition 
was available for this purpose. Therefore ordinary milk 
products or porridge were used for gastric tube feeding 
of these critically ill children. In many cases, tolerance 
of enteral feeds was initially tested with the administra-
tion of oral rehydration fluids via NGTs. The maximum 
volume of enteral feeds administered during this ‘critical 
care phase’ for malnourished and non-malnourished 
children was 100% according to the ‘4-2-1 rule’29.
National and WHO guidelines were applied to treat 
tuberculosis, HIV, malnutrition and common condi-
tions like severe malaria, respiratory infections, diarrheal 
diseases, meningitis and bacterial sepsis.27
Monitoring and vital signs
Rapid clinical screening was done to triage patients 
requiring non-invasive respiratory support. Basic vital 
signs (heart rate (HR), respiratory rate (RR), oxygen 
saturation (SpO2), temperature) were monitored usually 
2–3 times per day by vital signs assistants31 or qualified 
nurses.
CPAP settings
bCPAP pressure was commenced at 6–7 cm H2O.
19 The 
initial FiO2 was set at approximately 0.6%. Pressure 
and FiO2 were adjusted depending on signs of work of 
breathing and peripheral oxygen saturation measure-
ment by pulse oximetry (SpO2). The aim was to maintain 
SpO2 >94%. bCPAP pressure was usually kept ≤8 cm H2O 
and only in rare cases increased to 10 cm H2O. Humidi-
fied air/oxygen flow was used for all children.
bCPAP weaning protocol
When using the modified oxygen concentrator set-up, 
FiO2 was reduced when SpO2 was consistently >94% 
(FIO2 could not be adapted if O2 cylinders were used as 
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flow generator). If work of breathing and RR improved 
with SpO2 remaining consistently >94% (with an FIO2 
≤0.5%) bCPAP pressures were reduced gradually. If the 
patient remained stable and the bCPAP level was ≤5 cm 
H2O (with an FIO2 <0.3-0.4), then a trial ‘off bCPAP’ 
was started and the child was placed on low-flow oxygen 
(1–2 LPM). In cases of clinical deterioration, bCPAP was 
restarted. This clinical scenario was not considered as a 
‘treatment failure’. In the data analysis, this additional 
phase of ‘bCPAP management’ was considered as part of 
the ‘bCPAP weaning process’ and the initial treatment. 
The duration of the weaning process was depending on 
the child’s clinical progress. In the data analysis, the end 
of the weaning process was documented as the end of the 
bCPAP treatment.
Data collection and analysis
A case record form, an observation chart and a patient 
register were used for data collection. Data were entered 
into an Excel database. We describe the proportion 
of bCPAP cases who survived by risk group, sex, age, 
complications, HIV status and treatment methods. We 
conducted univariable logistic regression to determine 
if the odds of bCPCP survival were higher in particular 
subgroups. The small number of cases precluded multi-
variable analysis. We also present a breakdown of survival 
and death (failure) by HIV status and comorbidities 
including shock, malaria, anaemia, MOF and severe 
malnutrition, and describe the reasons for complications 
of treatment. This study was done in a routine setting 
without dedicated funding and did not have a target 
sample size. The sample includes most bCPAP cases seen 
between 26 February and 15 April 2014. All analyses were 
done in Stata V.14.2 for Mac.
RESULTS
A total of 117 patients were included and 79 (68%) 
survived (table 1). Survival was similar among males and 
females, and did not differ statistically by age group, 
though there were small sample sizes in each group. 
Survival was lower in those with MOF (45%) than those 
with single-organ failure (SOF) and no comorbidities 
(86%; p<0.0001, table 1). Survival was also significantly 
lower in those with severe acute malnutrition (36%) than 
with no severe or moderate malnutrition (81%; table 1), 
and in those with confirmed HIV infection or exposure 
(45%) than those who were HIV negative (81%) or with 
an unknown HIV status (68%; table 1). There were no 
statistically significant differences in survival by bCPAP 
delivery device or treatment initiation location (table 1).
All 19 children with VSPNA who were HIV negative 
and had no comorbidities and no other organ dysfunc-
tions survived (five children in this group had suspected 
TB). Also, 40/42 (95%; 95% CI 84% to 99%) of children 
with VSPNA (unknown or negative HIV status) and no 
comorbidities and no other organ dysfunction survived. 
Children with VSPNA and HIV infection/exposure and/
or malnutrition had significantly increased mortality risk 
(see table 2). Respiratory failure with additional organ 
dysfunctions (shock, anaemia) was associated with lower 
survival rates.
In total, 14/15 (93%) children with severe anaemia 
were transfused. Four out of seven with severe anaemia 
and shock survived. Also, 6 out of 14 children with 
anaemia who were transfused died. The one patient with 
severe anaemia who was not transfused survived. And, 
11 out of 15 children with severe anaemia had positive 
malaria tests. Also, 7 of these 11 children survived.
Among the 31 children with severe malaria, 24 had 
multiorgan dysfunction. In total, 14 of these 24 children 
survived. Of children with positive malaria tests, 11/31 
(35%) had signs of shock. Also, 5 of these 11 children 
survived.
Technical issues and complications
The average flow set was 9.1 LPM (SD 2.0, range 5–16). 
The average starting pressure was 6.7 cm H2O (SD 1.0, 
range 4–9).
In total, 13/117 patients experienced equipment-re-
lated complications, including blocked nostrils (2) or 
nasal prongs (2), interruption of oxygen supply from 
depleted cylinder (2), nasal septum lesions (7) and aspi-
ration of feeds (1). One parent refused the continuation 
of bCPAP. Some patients had more than one complica-
tion. The total number of treatment failures among those 
experiencing complications was 3/13 patients.
DISCUSSION
This basic observational study was conducted on a very 
busy paediatric unit in Malawi during peak malaria 
season.
We describe a group of children with a high mortality 
risk. Because of resource limitations, we took the 
approach of offering bCPAP to those children having the 
most severe clinical presentations.
In high-resource settings, a considerable number of 
the 62 children with respiratory dysfunction and the 55 
children with MOF potentially would have been mechan-
ically ventilated and would have received further critical 
care interventions in a paediatric intensive care unit 
(PICU).7
Context-adapted disease severity scores (comparable to 
Paediatric Index of Mortality (PIM)32/Pediatric Risk of 
Mortality Score (PRISM)33 -scores used in PICUs) based 
on parameters describing acute physiological status and 
underlying conditions (eg, HIV infection, nutritional 
status) can help to describe and compare cohorts of crit-
ically ill children and adults managed in low-resource 
settings. Further research in this context is needed.34–37
In the study setting, only some children could benefit 
from intubation and ventilation. Surveys highlight the 
challenges associated with the set-up of intensive care 
units providing mechanical ventilation of children. 
Significant resources will be directed to only a small 
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(%)* OR of death (95% CI)
Total 117 79 (68%) 38 (32%)
Demographics 
  Male† 58 40 (69%) 18 (31%) 1.00
  Female† 51 34 (67%) 17 (33%) 1.11 (0.50 to 2.49)
  Median (IQR) age in months 7 (2– 15) 6 (2–15) 7 (4–14)
Age (months)† 
  <1 6 3 (50%) 3 (50%) 1.00
  1–12 76 53 (70%) 23 (30%) 0.43 (0.81 to 2.31)
  13–24 23 17 (74%) 6 (26%) 0.35 (0.06 to 2.25)
  25–48 10 5 (50%) 5 (50%) 1.00 (0.13 to 7.57)
Organ failure 
  VSPNA 62 54 (87%) 8 (13%)
  VSPNA no comorbidities‡; including 
children<1 month
59 51 (86%) 8 (14%) 1.00
  VSPNA with comorbidities‡ 3 3 (100%) 0 (0%)
  VSPNA no comorbidities; no HIV 
exposure/infection, no malaria, no 
suspected TB‡
14 14 (100%) 0 (0%)
  VSPNA; no comorbidities; no HIV 
exposure/infection, no malaria; 
including suspected TB
19 19 (100%) 0 (0%)
  MOF >1 organ dysfunction‡: 
respiratory dysfunction and at least 
one further organ dysfunction
55 25 (45%) 30 (55%) vs VSPNA: 8.10 (3.25 to 
20.18)¶
  MOF >2 organ dysfunctions‡: 
(respiratory dysfunction and at least 
two other organ dysfunctions)
21 9 (43%) 12 (57%)
Malnutrition† 
  SAM 28 10 (36%) 18 (64%) 7.59 (2.88 to 19.97)§
  MAM 13 8 (62%) 5 (38%) 2.63 (0.75 to 9.29)
  No MAM or SAM 73 59 (81%) 14 (19%) 1.00
HIV status 
  Infected or exposed 22 10 (45%) 12 (55%) 4.97 (1.53 to 16.13)¶
  Negative 36 29 (81%) 7 (19%) 1.00
  Unknown 59 40 (68%) 19 (32%) 1.97 (0.73 to 5.29)
bCPAP delivery device 
  Cylinder 50 35 (70%) 15 (30%) 1.00
  Concentrator 48 30 (62%) 18 (38%) 1.40 (0.60 to 3.25)
  Unrecorded 17 12 (71%) 5 (29%) 0.97 (0.29 to 3.25)
Treatment initiation location 
  High dependency unit 29 17 (59%) 12 (41%) 1.55 (0.65 to 3.70)
  Emergency zone 83 57 (69%) 26 (31%) 1.00
Intubation** 
  No 100 77 (77%) 23 (23%) 1.00
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(%)* OR of death (95% CI)
  Median (IQR) treatment duration 
(hours)
24 (24–60) 24 (24–60) 24 (24–48)
Comorbidities: congenital heart diseases (4 (children with congenital heart diseases: AVSD: 2 (1 with trisomy 21), VSD: 1; PDA: 1 (and 
trisomy 21))), neurodisability (cerebral palsy (1), hydrocephalus (1), neuromuscular disorder (1), severe thorax wall infection/defect (1). 
bCPAP,bubble continuous positive airway pressure; HB, haemoglobin; MAM, moderate acutemalnutrition; MOF, multiorgan failure; SAM, 
severe acute malnutrition; TB,tuberculosis; VSPNA, very severe pneumonia. AVSD, Atrio-ventricular Septum Defect; VSD, Ventricular Septum 
Defect; PDA, Persistent Ductus Arteriosus
*The percentages given in column 3 and 4 describe the ratios to the subtotals documented in column 2.
†Information on sex (male/female) was not recorded for eight patients. Information on age was not recorded for two patients. Information on 
malnutrition (MAM or SAM) was not recorded for three patients.
‡Organ dysfunction: respiratory failure (signs of very severe pneumonia50, signs of shock or ‘impaired circulation’28, severe anaemia (HB< 7 
g/dl), coma/prolonged convulsions, clinical signs of liver/renal failure.
§p<0.0001.
¶p=0.008.
**In 2 of the 117 patients the information on potential intubation and ventilation was not documented.
††p<0.000.
bCPAP, bubble continuous positive airway pressure; HB, haemoglobin; MAM, moderate acutemalnutrition; MOF, multiorgan failure; SAM, 
severe acute malnutrition; TB, tuberculosis; VSPNA, very severe pneumonia.
Table 1 Continued
number of critically ill patients and specific skill levels 
are required.38–40 Routine mechanical ventilation of criti-
cally ill children is therefore not yet a feasible option for 
a large number of paediatric units in SSA.
A survey conducted on the same unit in 2012 using an 
improvised bCPAP set-up showed the following survival 
rates: overall survival—41/77 (53%), survival among chil-
dren with VSPNA—19/26 (73%) and VSPNA in HIV-neg-
ative children—14/17 (82%).25
Several factors could explain the improved outcome 
of patients with respiratory failure managed with bCPAP 
described in this publication. The disease severity of the 
cohorts described in this publication and the study from 
2012 are difficult to compare. Furthermore, in the 2-year 
interval between the studies training, senior supervision 
and paediatric emergency care was improved on the unit 
in Lilongwe. Introduction of conjugated pneumococcal 
vaccine in the routine vaccination schedule in Malawi in 
the time period between 2012 and 2014 could have had 
an impact on the spectrum of pathogens causing severe 
respiratory infections and other severe bacterial infec-
tions in young children. However, the improved bCPAP 
set-up including the use of humidified air/oxygen might 
have contributed to improved outcomes as well. There is 
considerable evidence indicating that the relatively high 
air/oxygen flow used in NIV should be ‘conditioned 
(warmed and humidified)’.41 42
The outcome of HIV-negative children with severe respi-
ratory dysfunction (SOF) managed with bCPAP in this 
study (mortality rate in this subgroup: 0%) is comparable 
to outcomes of children with respiratory failure managed 
with bCPAP in the context of an RCT recently conducted 
in Bangladesh (mortality rate: 4%).23 Outcomes of this 
subgroup indicate that the use of bCPAP as a form of NIV 
is feasible on a busy paediatric critical care department 
in SSA.
In high-resource settings, proactive respiratory 
support is standard care in the management of multi-
organ dysfunction.8 In this context, the role of NIV in 
less severe ARDS requires further evaluation.15 In low-re-
source settings, NIV has the potential to improve respira-
tory care for critically ill children, where options for safe 
mechanical ventilation are extremely limited.
An increased mortality risk among children with respi-
ratory dysfunction associated with severe malnutrition 
and/or HIV infection/exposure is suggested by this 
survey, as demonstrated in other studies.43 In total, 17 out 
of 28 children with SAM treated in this study had more 
than one organ dysfunction (eg, shock).
An RCT is currently being conducted in Malawi 
comparing the use of bubble CPAP and low-flow oxygen 
in children with respiratory failure with and without 
further organ dysfunctions, including children with HIV 
and malnutrition.44
Children who had their treatment initiated in the 
emergency zone had a higher survival rate than chil-
dren treated in the HDU. This difference was not statis-
tically significant. This ‘trend’ is likely to be explained 
by a significant selection bias with much sicker patients 
being treated in the HDU. The six-bedded HDU was 
certainly too small for a paediatric unit with around 20 
000 admissions per year. Following rapid identification 
further ‘context adapted’ critical care management in a 
‘HDU- setting’ is very likely to improve survival chances 
of critically ill children.
One child in this study suffered an episode of aspira-
tion. A recent study conducted in Australia showed that 
children requiring CPAP did not have an increased risk 
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of aspiration, apnoeas/hypoxic events when managed via 
NGT feeding compared with intravenous maintenance 
fluids.45 Because of limited monitoring options, we could 
not determine if some of the children had episodes of 
desaturation associated with NGT feeds. Careful moni-
toring of maintenance fluids and feeding practices are 
important elements to consider in the care of critically ill 
children in low-resource settings. We suggest that intro-
duction of enteral feeds in critically ill malnourished and 
non-malnourished children managed in low-resource 
settings should follow basic principles used in paedi-
atric intensive care. Enteral feeds for malnourished and 
non-malnourished children can be introduced gradually 
after stabilisation of vital organ functions (eg, stabilisa-
tion of respiratory function on O2 or bCPAP, correction 
of shock, anaemia and dehydration as well as a phase of 
stability of the child’s neurological function, even if still 
comatosed) and the absence of contraindications (eg, 
abdominal pathologies, large gastric aspirates).
In total, 11/117 children developed nasal prong-asso-
ciated problems such as obstruction of the nostrils/nasal 
prongs (4) or injury of the nasal septum (7). Improved 
interfaces can help in this context. Good nursing care 
and adequate nurse to patient ratios in a HDU setting 
are essential in order to reduce complication rates and 
achieve good outcomes in critically ill children treated 
with bCPAP. Efficient and sustained training programmes 
need to accompany the introduction of bCPAP. Care-
takers should be integrated in the care and should be 
encouraged to notify any concern regarding the condi-
tion of their child or any malfunctioning equipment.
Devices used for bCPAP and other forms of NIV in low 
resources need to be of good quality and should undergo 
independent biomedical review procedures.46 Biomed-
ical repair and maintenance arrangements need to be 
put in place. Infection prevention and control measures 
need to be established.
Limitations
Interpretation of results is limited by the basic observa-
tional set-up of the study. The small sample size limited 
more detailed subgroup analyses. Data quality (eg, 
frequency of vital signs monitoring) was affected by 
limited human resources and equipment as well as the 
extremely high workload. Limited human resources also 
contributed to the fact that most, but not all, children 
who were managed with bubble CPAP during the study 
period were included in the analysis. Some ‘CPAP-runs’ 
of short duration might have been missed during week-
ends. However, we do not think that this contributed to 
a selection bias, which affected the outcome of the study.
Monitoring of essential elements of critical care 
management (eg, fluid management) was also affected 
by low health worker to patient ratio. Adequate numbers 
of well-trained health workers and basic equipment (eg, 
SpO2 monitors) can improve care packages and the 
potential positive impact of bCPAP on the outcome of 
critically ill patients with respiratory dysfunction. Labora-
tory tests allowing more detailed evaluation of renal and/
or hepatic dysfunction were not available. This might 
have contributed to an underestimation of the number 
of children presenting with MOF. Renal dysfunction is an 
important parameter determining mortality risk among 
critically ill children, including children with severe 
Malaria.47–49
Anthropometric measurements were suboptimal in 
our survey. In many children, we therefore used weight/
age as a marker of nutritional status.
Conclusion
Despite the limitations of this study, the good outcome of 
children with signs of VSPNA suggests that it is feasible 
to use bCPAP in the hospital management of critically ill 
children in low-resource settings.
BCPAP and other forms of NIV can potentially play an 
important role in the improvement of care for critically 
ill children with respiratory failure and further organ 
dysfunction (eg, shock, severe anaemia) managed in 
low-resource settings. Further research is required in this 
context. Children with malnutrition and HIV infection 
or exposure need particular attention. Different disease 
processes like malaria, bacterial sepsis and dengue fever 
need to be considered.
The impact on patient outcome of different forms of 
NIV should be evaluated. Adapted, good quality equip-
ment with associated maintenance systems is required as 
well as adequate numbers of health workers and efficient, 
sustained training activities.
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Approximately 5.4 million people are bitten by snakes annually, with up to 
half of these victims experiencing signs of envenomation. This results in an 
estimated 138 000 deaths per year.[1] Only limited data exist on the long-term 
morbidity of snakebites, but one study suggested that between 5  900 and 
14 600 amputations per year may be attributed to snakebites in sub-Saharan 
Africa (sSA) alone.[2] However, accuracy of epidemiological data is limited 
owing to under-reporting, patients’ poor access to healthcare facilities and 
many victims attending traditional healers rather than health centres or 
hospitals.[1-3]
The burden of snakebites is unevenly distributed across the globe, 
with 95% of cases encountered in low- and middle-income countries 
in Africa and Asia.[4,5] Even in those areas, the health effects of 
snakebites are disproportional, with the poorest of the poor generally 
experiencing poor outcomes.[6,7] Rural sSA is specifically vulnerable 
owing to limited availability of healthcare services. In 2017, the World 
Health Organization (WHO) recognised snakebite envenoming as a 
neglected tropical disease.[7] Accordingly, snakebite antivenoms are 
included in the WHO’s list of essential medicines.[8]
Common acute medical conditions arising from snakebites depend on 
the species, but include neurotoxicity, coagulation failure accompanied 
by shock or organ dysfunction, and local tissue destruction.[9] Multiple 
factors, including delayed presentation to healthcare facilities, adversely 
affect the management and outcome of snakebite victims.[2] Inadequate 
regulatory frameworks that result in ineffective or unsafe antivenom 
products being available, restricted access and high costs are crucial 
challenges limiting the use of antivenoms, particularly in sSA.[10,11] 
Supportive measures are often the only therapeutic options for patients 
presenting with snakebite envenoming in sSA.
In this study, we report the intensive care unit (ICU) management and 
outcomes of 174 snakebite victims who were treated mainly with basic 
intensive-care interventions (e.g. mechanical ventilation) in a rural sSA 
hospital where adequate doses of antivenom were not available. 
Intensive-care management of snakebite victims in rural 
sub-Saharan Africa: An experience from Uganda
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Background. Antivenom is rarely available for the management of snakebites in rural sub-Saharan Africa(sSA). 
Objective. To report clinical management and outcomes of 174 snakebite victims treated with basic intensive-care interventions in a rural sSA 
hospital.
Methods. This cohort study was designed as a retrospective analysis of a database of patients admitted to the intensive care unit (ICU) of St. Mary’s 
Hospital Lacor in Gulu, Uganda (January 2006 - November 2017). No exclusion criteria were applied. 
Results. Of the 174 patients admitted to the ICU for snakebite envenomation, 60 (36.5%) developed respiratory failure requiring mechanical 
ventilation (16.7% mortality). Results suggest that neurotoxic envenomation was likely the most common cause of respiratory failure among 
patients requiring mechanical ventilation. Antivenom (at probably inadequate doses) was administered to 22 of the 174 patients (12.6%). The 
median (and associated interquartile range) length of ICU stay was 3 (2 - 5) days, with an overall mortality rate of 8%. Of the total number of 
patients, 67 (38.5%) were younger than 18 years.
Conclusion. Results suggest that basic intensive care, including mechanical ventilation, is a feasible management option for snakebite victims 
presenting with respiratory failure in a rural sSA hospital, resulting in a low mortality rate, even without adequate antivenom being available. 
International strategies which include preventive measures as well as the strengthening of context-adapted treatment of critically ill patients at 
different levels of referral pathways, in order to reduce deaths and disability associated with snakebites in sSA are needed. Provision of efficient 
antivenoms should be integrated in clinical care of snakebite victims in peripheral healthcare facilities. Snakebite management protocols and 
preventive measures need to consider specific requirements of children.
Keywords. Africa, essential emergency and critical care, ICU management, mechanical ventilation, snakebite. 
S Afr J Crit Care 2020;36(1):39-45. https://doi.org/10.7196/SAJCC.2020.v36i1.404
Contribution of study
It is estimated that up to 138 000 people die each year following snakebites. Currently, reliable provision of efficient snake-bite antivenom is 
challenging in many rural health facilities in sub- Saharan Africa (sSA).  Our results suggest that basic intensive-care interventions, including 
mechanical ventilation, is a feasible management option for critically ill snakebite victims in a rural sSA hospital, resulting in a low mortality rate, 
even without adequate antivenom doses being available. 
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Methods
This cohort study was designed as a retrospective analysis of a 
prospectively collected database of patients admitted to the ICU of 
St.  Mary’s Hospital Lacor in Gulu, Uganda, between 1 January 2006 
and 30 November 2017. All patients from this database admitted to the 
ICU because of snakebite envenomation were included in the analysis. 
No exclusion criteria were applied. The analysis of the ICU data was 
approved by the institutional review board of the hospital. Owing to the 
retrospective design of the study, written and oral consent was waived. 
Selected data of 139 patients were included in a previous analysis 
reporting on admission diagnoses, use of mechanical ventilation and 
outcomes of critically ill patients treated at this ICU.[12]
Study setting
St. Mary’s Hospital Lacor is a private, non-profit (former mission) 
hospital located in the north of Uganda, serving ~700 000 inhabitants 
in a poor, post-conflict area. It has 476 beds and six operating rooms, 
with ~5  000 surgeries being performed per annum. Using subsidised 
external funding, the hospital’s objective is to provide barrier-free access 
to healthcare, particularly to the poorest of the community. The hospital 
also runs an eight-bed ICU where critically ill patients are admitted. The 
unit has eight trained nurses and four assistant nurses (with one nurse 
attending to between four and eight patients per shift). The medical 
responsibility for an ICU patient is shared by one anaesthetic officer and 
a physician. This team was assisted by a senior anaesthetist from 2002 to 
2016. Table 1 outlines the operational features of the unit, as described 
previously.[12]
Patient management
Patients with snakebite envenoming account for 2 - 3% of the ICU 
population at this centre.[12] General principles of critical care were 
applied to stabilise vital organ functions. Specific treatment of snakebites 
was provided with available resources according to WHO guidelines.[9] 
All snakebite victims were continually monitored using non-invasive 
measurements (e.g. electrocardiogram, respiratory rate, peripheral 
oxygen saturation, non-invasive blood pressure and temperature). 
Respiratory support included the provision of supplemental oxygen and 
advanced airway management, as well as invasive mechanical ventilation 
for airway protection or in the case of respiratory failure. Mechanical 
ventilation was initiated when the attending anaesthetist judged patient 
survival to be at risk within an hour of assessment.
Adequate antivenom doses could not be provided in the majority of 
cases because of limited availability of appropriate antivenom. Safety 
and efficacy of the antivenom available at the ICU during the study 
period (VINS Bioproducts, India) has not yet been confirmed for use 
in Africa by the WHO validation processes. Experts from the WHO, 
the Global Snakebite Initiative and Médecins sans Frontières (MSF) 
recommend using products with better neutralisation capacity, such as 
the South African Institute for Medical Research (SAIMR) polyvalent 
antivenom;[9,13] however, this is more expensive than the VINS antivenom. 
The MSF Operational Centre in Geneva recently recommended a new 
algorithm for the management of snakebite victims in South Sudan, 
namely the use of Echitab-Plus for cytotoxic and haemotoxic envenoming 
(vipers and spitting cobras) and the SAIMR polyvalent antivenom for 
neurotoxic envenoming (cobras and mambas).[13] 
When antivenom was available for the treatment of critically ill 
snakebite victims described in this study, usually only one vial could 
be administered; in special cases, two vials could be administered 
if indicated. WHO and MSF guidelines indicate that in persisting 
snakebite syndromes, several vials of antivenom are needed to achieve 
adequate neutralisation of snake toxins and clinical stabilisation.[9,13] 
In view of the limited availability of effective antivenom, advanced 
airway management and mechanical ventilation were prioritised over 
antivenom therapy in critically ill patients with signs of neurotoxic 
snakebite envenoming (e.g. fasciculation, paralysis and respiratory 
failure).
The snake could rarely be identified by patients or relatives. No DNA 
sequencing techniques from swabs of bite sites could be performed for 
identification purposes.[14]
Data analysis
The following data were collected from all patients included in this 
analysis: gender, age, therapeutic interventions (continuous monitoring; 
endotracheal intubation and mechanical ventilation; tracheostomy; 
antivenom therapy), complications, length of ICU stay, and mortality. 
Clinical symptoms of patients documented in the database were 
categorised as fasciculation/paralysis (due to neurotoxicity), 
coagulopathy/shock/haemolysis, or extensive tissue damage.
All statistical analyses were performed using the PASW statistical 
software package (version 20.0) (IBM Corp., Austria). We compared the 
occurrence of and variables related to different envenoming symptoms 
(fasciculation/paralysis, coagulopathy/shock/haemolysis or extensive 
tissue damage) between survivors and non-survivors using chi-squared, 
Mann-Whitney U-rank sum and Fisher’s exact tests, as appropriate. 
Data are presented as absolute values with percentages in parentheses, 
or median values along with interquartile ranges (IQRs). A significance 
level p<0.05 was used.
Results
Of the 6 976 patients admitted to the ICU during the study period, 174 
were treated for snakebite envenomation (2.5%). More than a third 
of the patients were younger than 18 years (n=67; 38.5%) (Fig.  1). 
As shown in Table  2, non-survivors more frequently presented with 
coagulopathy, shock or haemolysis than survivors. Invasive mechanical 
ventilation was used more often for treating non-survivors than 
survivors. Complications were documented for more non-survivors 
than survivors. Antivenom (at low and probably inadequate doses[9,13]) 
was administered to 12.6% of patients (n=22). The median (IQR) length 
of ICU stay was 3 (2  - 5) days and overall mortality was recorded as 
8% (n=14).
Information on clinical symptoms at presentation could be extracted 
from the database for 40 patients (23%) (Table 3). The need for invasive 
mechanical ventilation and subsequent ICU mortality differed among 
snakebite victims who presented with clinical symptoms. 
Table  4 summarises the characteristics of patients who required 
mechanical ventilation (n=60; 34.5%). Among these, clinical symptoms 
were documented in more detail in only 16 cases. Neurotoxicity 
(fasciculation/paralysis) was the most commonly documented indication 
for advanced respiratory support (87.5%). However, it should be noted 
that in the absence of any other documented complication, it can be 
assumed that patients with respiratory failure requiring mechanical 
ventilation experienced neurotoxic snakebite syndrome. Antivenom 
could be administered only to 10 (16.7%) of the 60 patients who 
required mechanical ventilation; three of these patients died (33.3%). 
Of the 50 ventilated patients who did not receive antivenom treatment, 
seven died (14%). There was no statistical difference in mortality 
between mechanically ventilated patients with or without antivenom 
therapy (p=0.35; Fisher’s exact test). 
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Table 1. Operational characteristics of the intensive care unit at St. Mary’s Lacor Hospital, Uganda[12]
Characteristic Description
Admission criteria Patients with life-threatening conditions requiring immediate intervention
Patients with abnormal vital signs or other clinical concerns requiring close observation and treatment
Postoperative care in case intensive care or close observation is required.
These criteria were also applied to snakebite victims.
Beds 8 permanent beds; additional beds can be added if needed.
Nurse:patient ratio 1 nurse for every 4 - 8 patients
Doctors/clinical officers One anaesthetic officer and the admitting physician share the medical responsibility for the ICU patients. 
A senior anaesthetist dedicated full clinical responsibility to the ICU (full-time consultant from 2002 to 2008; part-time 
consultant from 2009 to 2016).
Monitoring Pulse oximeters: 2 
Non-invasive blood pressure machines: 3
Multiparameter monitors: 1
12-lead electrocardiograph: 1 
Capnography: not available (end-tidal CO2 monitoring should be considered as an essential element during intubation and 
surveillance of mechanically-ventilated patients)
Equipment – examples Basic resuscitation equipment 
Equipment for advanced airway management
Ventilators capable of providing intermittent positive pressure ventilation (Glostavent; Diamedica, UK): 3
Oxygen concentrators (10 l/min): 3
Oxygen cylinders: limited supply
Equipment for chest drain insertion
Single-lumen central lines (as well as peripheral venous and intraosseous access)
Management options Routine resuscitation measures
Respiratory care
Basic and advanced airway management
Insertion of chest drains (e.g. for management of empyema, pneumothoraces) and aspiration of pleural effusions
Low-flow O2 and O2 supplementation via face mask
 Advanced airway management and mechanical ventilation; non-invasive respiratory support was not available during 
the study period.
Circulation
Fluid management and blood transfusions
Peripheral and central line insertion; no arterial lines used. 
Occasional adrenaline or dopamine infusions
Management of 
neurological emergencies 
Management of comatose patients and status epilepticus
No intracranial pressure monitoring
Medication
Enteral and intravenous medications (based on national guidelines and the WHO list of essential medications[8])
Essential antibiotics, including ceftriaxone, ciprofloxacin (no carbapenems, amikacin or vancomycin)
Nutrition
Enteral nutritional support; parenteral nutrition not routinely used.
Renal replacement therapy
 Peritoneal dialysis could be performed by the end of the study period, on rare occasions; not used in the patients 
described in this study.
Laboratory Point-of-care tests: malaria rapid diagnostic tests (available later during the study period); blood glucose, urine analysis
Blood films (e.g. for detection of malaria parasites), haemoglobin and full blood count
Analysis of CSF
Rapid tests: HIV, hepatitis B and C, syphilis
Sputum: tuberculosis smears (no Gen-Xpert was available during the study period)
Not routinely available: electrolyte analysis, blood gas analysis, renal or liver function tests, clotting tests, no blood or CSF 
cultures.
Blood bank Blood bank: rapid and safe blood transfusion services
Not available: Tranexamic acid, fresh-frozen plasma, platelet concentrates 
Imaging Portable X-ray
Ultrasound by a radiologist (no routine availability of point-of-care ultrasound)
Protocols General principles of anaesthetics and critical care were followed. 
WHO management guidelines were followed for children. 
WHO protocols for snakebites[9]were followed with available resources (e.g. antivenom was administered only in a minority 
of patients).
Training The clinical staff consist of nurses, anaesthetic officers who receive regular on-the-job training and coaching by an 
experienced senior anaesthesist, and visiting critical care doctors. The hospital invested in the training of nurses and 
anaesthetic clinical officers for several years. These training programmes are recognised by the Ugandan Minstry of Health.
Logistics, pharmacy and 
biomedical support
The hospital has a strong logistics and pharmacy team. Cleaners and ICU staff ensure infection prevention and control measures.
Reliable maintenance and repair services are provided by a skilled and supportive biomedical department.
Electricity The hospital has a reliable electricity system.
CSF = cerebrospinal fluid; ICU = intensive care unit; WHO = World Health Organization.
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The ICU mortality of patients requiring 
mechanical ventilation was 16.7%. Of the 60 
patients who required mechanical ventilation, 
17  (28.3%) were younger than 18 years; six 
with respiratory failure died (35.3% mortality). 
Among these 17 patients were two children 
younger than 5 years, both of whom died. 
Of the 43 patients older than 18 years who 
required mechanical ventilation, four died 
(9.3% mortality). The difference in mortality 
rates between children and adults requiring 
mechanical ventilation was statistically 
significant (p=0.02; Fisher’s exact test).
Length of ICU stay (Fig. 2A) and mortality 
(Fig. 2B) were significantly higher in patients 
requiring mechanical ventilation than in 
those who did not need advanced respiratory 
support.
Discussion
This analysis reports the ICU management 
and outcomes of 174 snakebite victims, of 
whom approximately a third were younger 
than 18 years, in a rural hospital in northern 
Uganda. The study setting appears comparable 
to other rural healthcare regions in sSA, which 
are characterised by single hospitals that 
serve large catchment areas and support a 
number of peripheral healthcare facilities. In 
contrast with many other facilities in sSA,[15,16] 
our centre runs an ICU that can provide 
basic intensive-care interventions, including 
mechanical ventilation.[12] To put this into 
perspective, a recent survey revealed that one 
ICU bed is available per 1 000 000 inhabitants 
in Uganda.[17] 
Snakebite envenoming accounted for 2.5% 
of all ICU admissions at our centre. Clinical 
symptoms, which could retrospectively be 
determined for approximately a quarter of 
the study population, suggest that neurotoxic 
symptoms were encountered most frequently. 
We observed an overall mortality rate of 8%. 
The cohort of 174 patients described in 
this study reflects the most severe cases of 
hospitalised snakebite victims. Unfortunately, 
Table 2. Characteristics of the study population (N=174)
Characteristic All  (N=174),  n (%)* Survivors  (N=160),  n (%)* Non-survivors  (N=14), n (%)* p-value†
Demographics
Male 90 (51.7) 82 (51.3) 8 (57.1) 0.78
Age (years), median (IQR) 24 (12 - 34) 24 (12 - 35) 19 (8 - 29) 0.92
<5 12 (6.9) 9 (5.6) 3 (21.4) 0.06
5 - 10 25 (14.4) 24 (15) 1 (7.1) 0.7
11 - 18 30 (17.2) 27 (16.9) 3 (21.4) 0.71
>18 107 (61.5) 100 (62.5) 7 (50) 0.4
Clinical presentation (N=40) 
Fasciculation/paralysis, n/N (%) 23/40 (57.5) 19/32 (59.4) 4/8 (50) 0.7
Coagulopathy/shock/haemolysis, n/N (%) 5/40 (12.5) 2/32 (6.3) 3/8 (37.5) 0.046‡
Extensive tissue damage, n/N (%) 12/40 (30) 11/32 (34.4) 1/8 (12.5) 0.4
ICU care
Invasive mechanical ventilation 60 (34.5) 50 (31.3) 10 (71.4) 0.006
Tracheostomy 1 (0.6) 0 1 (7.1) 0.08
Antivenom therapy 22 (12.6) 18 (11.3) 4 (28.6) 0.08
Outcome
Any complication‡ 6 (3.4) 3 (1.9) 3 (21.4) 0.007
Length of ICU stay (days), median (IQR) 3 (2 - 5) 3 (2 - 5) 3 (2 - 5) 0.99
ICU mortality 
<18 years, n/N (%) 7/67 (10.4) n/a n/a n/a
>18 years n/N (%) 7/105 (6.5) n/a n/a n/a
IQR = interquartile range; ICU = intensive care unit.
*Unless otherwise specified. 
†Based on comparison between survivors and non-survivors; p<0.05 considered statistically significant. 













Fig. 1. Age distribution of snakebite victims treated at the intensive care unit at St. Mary’s Lacor Hospital, 
Uganda (N=174). 
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the hospital information system does not provide data on the number 
of patients referred from peripheral facilities or hospitalised snakebite 
patients who did not need ICU admission during the study period. 
Although reliable regional epidemiological data regarding snakebites 
are scarce,[2,5] Uganda is considered to have a relatively high incidence of 
snakebite envenomation and faces considerable challenges in providing 
adequate access to basic emergency care for snakebites, especially in 
rural areas.[5] 
All patients included in the study received continuous monitoring 
in the ICU. Approximately a third of the patients required advanced 
interventions, such as invasive mechanical ventilation. As this was a non-
randomised cohort study, it is not possible to determine the true treatment 
effect of mechanical ventilation on mortality in our study population. 
However, the higher mortality rate and longer ICU stays reported for 
patients who required invasive mechanical ventilation compared with 
those who did not need ventilatory support likely reflect the high disease 
severity and risk of death in patients in whom mechanical ventilation 
was instituted. The authors are not aware of existing systematic data in 
peer- reviewed literature describing the clinical outcomes of neurotoxic 
snakebite victims with respiratory failure, treated in healthcare facilities 
without the facilities providing mechanical ventilation. 
The risk of mortality among patients who develop paralysis and acute 
respiratory insufficiency following a snakebite is likely to be very high 
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Fig. 2. (A) Length of stay in the intensive care unit for patients requiring invasive ventilation (n=60) compared with patients not requiring invasive ventilation (n=114). 
(B) Mortality of snakebite victims for patients requiring invasive ventilation (n=60) compared with patients without severe respiratory failure (n=114).





haemolysis (N=5), n (%)*
Extensive tissue damage 
(N=12), n (%)* p-value
Demographics
Male 14 (60.9) 2 (40.0) 7 (58.3) 0.7
Age (years), median (IQR) 28 (12 - 34) 9 (5 - 30) 11 (4 - 35) 0.07
ICU care
Monitoring 23 (100) 5 (100) 12 (100) 1
Mechanical ventilation 14 (60.9) 1 (20) 1 (8.3) 0.007†
Tracheostomy 0 0 0 1
Antivenom therapy 4 (17.4) 2 (40.0) 3 (25.0) 0.53
Outcome
Any complication‡ 3 (13.0) 1 (20.0) 0 0.35
Length of ICU stay (days), median (IQR) 4 (2 - 6) 8 (6 - 11) 4 (3 - 6) 0.16
ICU mortality 4 (17.4) 3 (60.0) 1 (8.3) 0.047†
ICU mortality of ventilated patients, n/N (%) 4/14 (28.6) 1/1 (100) 1/1 (100) 0.15
IQR = interquartile range; ICU = intensive care unit.
*Unless otherwise specified. 
†Statistically significant difference between groups (p<0.05).
‡Complications included acute lung injury (n=1), acute renal failure (n=1), bed sore (n=1) and aspiration pneumonia (n=1).
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victims who received mechanical ventilation in our cohort was low 
(16.7%), mechanical ventilation can be considered to have been a life-
saving intervention for the majority of patients with acute respiratory 
failure, particularly those presenting with neurotoxic symptoms.
Slightly more than one-third of patients in this cohort were younger 
than 18 years, with 7% younger than 5 years (Fig.  1, Table  2). In 
2017, 48% of the Ugandan population was younger than 14 years;[22] 
this age group is slightly under-represented in our cohort. Children 
older than 5 years may be exposed to a higher risk of snakebite 
than younger children owing to the activities they are involved in 
(e.g. exposure during play, on their way to school, assisting the family 
with agricultural work). Adolescents and adults involved in manual 
labour (e.g. in the agricultural sector) seem to carry the highest risk 
for exposure to venemous snakes.[1,9] 
Fatality rates associated with snakebite in children are generally 
higher than in adults, possibly due to the smaller volume of distribution 
and consequently higher toxin levels in children.[9,23,24] Although 
insignificant (p=0.4) in the analysis of the cohort of all 174 patients, 
mortality in children was higher compared with adult patients (10.4% 
v. 6.5%). In the analysis of 60 patients with respiratory failure requiring 
mechanical ventilation, mortality among children >18 years (N=17) 
was significantly higher than among adult patients (35.3% v. 9.3%; p= 
0.02). These findings highlight that interventions to prevent snakebites 
as well as management strategies for snakebite victims need to address 
particular needs of children and adolescents.[25]
Most of the snakebite victims in our cohort did not receive what 
would be regarded as adequate antivenom doses by international 
standards,[9,13] owing to difficulties in the supply chain, poor local 
economic conditions and limited donor capacity. This finding reflects 
and highlights the challenges of provision and use of antivenom in 
rural sSA.[10,11,26] Considering findings from Sri Lanka, which showed 
that snakebite victims presenting with signs of severe neurotoxicity 
progressed to respiratory failure requiring mechanical ventilation even 
when antivenom had been given,[27] it is unlikely that antivenom alone 
is sufficient to treat critically ill snakebite patients. A study from India 
reported no fatalities in 51 patients with neurotoxic snake envenomation 
after they were treated with a combination of antivenom therapy and 
mechanical ventilation.[28] In our study only a small number of patients 
(16.7%) with respiratory failure and who required mechanical ventilation 
received antivenom. The antivenom used during the study period is not 
among the products currently recommended by international specialists 
in this field.[9,13] It could therefore not be determined whether early 
administration of adequate doses of appropriate antivenom combined 
with advanced airway management and mechanical ventilation could 
have improved survival rates or reduced the required duration of 
mechanical ventilation. 
In this study, acetyl-cholinesterase inhibitors (ACHEIs) were not 
routinely used in the management of patients with neurotoxic snakebite 
syndromes. Evidence regarding the role of ACHEIs (e.g. neostigmine) 
in the management of muscle paralysis following neurotoxic snakebite 
is limited.[21] A beneficial role of ACHEIs is not confirmed by WHO 
guidelines for envenomation from possible mamba bites.[9] Mamba bites 
are common causes of severe neurotoxic envenomation in eastern and 
southern Africa.[9]
Study limitations
Important limitations need to be considered when interpreting the 
data of our study. First, our analysis was designed retrospectively, 
which explains why the presenting clinical symptoms of snakebite 
victims could be determined in only 23% of the patients included 
in the analysis. Our findings therefore offer insight merely into the 
differences in management and outcome of patients presenting with 
different snakebite-associated clinical syndromes. Second, the non-
randomised study design precludes conclusions on the true outcome 
effects of intensive-care interventions, including mechanical ventilation, 
in critically ill snakebite patients.
Conclusion
Despite the limitations of this study, our results suggest that provision 
of basic intensive care, including mechanical ventilation, was a feasible 
treatment option for critically ill snakebite victims presenting with 
respiratory failure in a rural sSA hospital when adequate antivenom 
doses were unavailable. An international strategy focused on preventive 
measures and community engagement to reduce deaths and disability 
associated with snakebites in sSA is required. Strengthening of context-
adapted treatment of critically ill patients, including snakebite victims, 
at various levels of the referral pathway is important. The provision and 
administration of efficient and safe antivenoms should be integrated 
in the clinical care of snakebite victims in rural and peripheral 
healthcare facilities. Snakebite management protocols and preventive 
measures need to consider specific requirements of children. Pragmatic 
operational research can contribute to advance strategies aimed at 
integrating prevention of snakebites and improving clinical care of 
snakebite victims.
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Antivenom therapy 10 (16.7)
Outcome
Any complication* 5 (8.3)
Length of ICU stay 5 (4 - 6)
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IQR = interquartile range; ICU = intensive care unit.
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(n=1), ascites (n=1) and aspiration pneumonia (n=1). 
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Effects of saline or albumin fluid bolus in resuscitation: 
evidence from re-analysis of the FEAST trial
Michael Levin*, Aubrey J Cunnington*, Clare Wilson, Simon Nadel, Hans Joerg Lang, Nelly Ninis, Mignon McCulloch, Andrew Argent, Heloise Buys, 
Christopher A Moxon, Abigail Best, Ruud G Nijman, Clive J Hoggart
Summary
Background Fluid resuscitation is the recommended management of shock, but increased mortality in febrile African 
children in the FEAST trial. We hypothesised that fluid bolus-induced deaths in FEAST would be associated with 
detectable changes in cardiovascular, neurological, or respiratory function, oxygen carrying capacity, and blood 
biochemistry.
Methods We developed composite scores for respiratory, cardiovascular, and neurological function using vital sign 
data from the FEAST trial, and used them to compare participants from FEAST with those from four other cohorts 
and to identify differences between the bolus (n=2097) and no bolus (n=1044) groups of FEAST. We calculated the 
odds of adverse outcome for each ten-unit increase in baseline score using logistic regression for each cohort. Within 
FEAST participants, we also compared haemoglobin and plasma biochemistry between bolus and non-bolus patients, 
assessed the effects of these factors along with the vital sign scores on the contribution of bolus to mortality using Cox 
proportional hazard models, and used Bayesian clustering to identify subgroups that differed in response to bolus. 
The FEAST trial is registered with ISRCTN, number ISRCTN69856593.
Findings Increasing respiratory (odds ratio 1·09, 95% CI 1·07–1·11), neurological (1·26, 1·21–1·31), and cardiovascular 
scores (1·09, 1·05–1·14) were associated with death in FEAST (all p<0·0001), and with adverse outcomes for specific 
scores in the four other cohorts. In FEAST, fluid bolus increased respiratory and neurological scores and decreased 
cardiovascular score at 1 h after commencement of the infusion. Fluid bolus recipients had mean 0·33 g/dL (95% CI 
0·20–0·46) reduction in haemoglobin concentration after 8 h (p<0·0001), and at 24 h had a decrease of 1·41 mEq/L 
(95% CI 0·76–2·06; p=0·0002) in mean base excess and increase of 1·65 mmol/L (0·47–2·8; p=0·0070) in mean 
chloride, and a decrease of 0·96 mmol/L (0·45 to 1·47; p=0·0003) in bicarbonate. There were similar effects of fluid 
bolus in three patient subgroups, identified on the basis of their baseline characteristics. Hyperchloraemic acidosis 
and respiratory and neurological dysfunction induced by saline or albumin bolus explained the excess mortality due 
to bolus in Cox survival models.
Interpretation In the resuscitation of febrile children, albumin and saline boluses can cause respiratory and 
neurological dysfunction, hyperchloraemic acidosis, and reduction in haemoglobin concentration. The findings 
support the notion that fluid resuscitation with unbuffered electrolyte solutions may cause harm and their use should 
be cautioned. The effects of lower volumes of buffered solutions should be evaluated further. 
Funding Medical Research Council, Department for International Development, National Institute for Health 
Research, Imperial College Biomedical Research Centre.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Both adult and paediatric resuscitation guidelines 
recommend boluses of intravenous fluid, most commonly 
crystalloid or colloid solutions, with 20–60 mL/kg body-
weight being recommended in the first hour of re-
suscitation.1,2 The practice of volume expansion by rapid 
bolus infusion was introduced not on the basis of 
evidence from randomised trials, but on current 
understanding of the physiology of shock. Patients with 
sepsis or other forms of shock, whether arising from 
external blood or fluid losses, internal fluid loss from 
capillary leakage, or pathological vasodilatation, are 
thought to be hypovolaemic and thus to have diminished 
venous return to the heart. Clinical experience has 
supported this physiological concept because bolus 
resuscitation is usually associated with improved pulse 
pressure, warming of the peripheries, and increased 
urine output. However, clinicians are also aware that 
some patients deteriorate, rather than improve, after 
volume resuscitation. Furthermore, patients receiving 
large volumes of fluid are known to develop generalised 
oedema,1,2 often accompanied by increased requirement 
for high ventilation pressures, unless fluid is removed by 
haemofiltration or diuresis. Despite these known adverse 
effects of fluid, bolus fluid resuscitation is so widely 
accepted in the practice of emergency medicine in 
resource-rich countries that neither clinicians nor 
research ethics committees are likely to agree to test the 
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practice in a randomised controlled trial with a no-fluid 
bolus control.
By contrast with practice in resource-rich countries, 
fluid bolus resuscitation is not routine in Africa 
and other resource-poor regions. There has been an 
equipoise in many African hospitals between clinicians 
who recommend fluid resuscitation and those who avoid 
rapid fluid bolus resuscitation for fear that it might result 
in pulmonary or cerebral oedema. It was this equipoise in 
the use of fluids for resuscitation that motivated the 
FEAST (Fluid Expansion As Supportive Treatment) trial.3 
In FEAST, 3141 febrile children with signs of under-
perfusion in Uganda, Kenya, and Tanzania were randomly 
allocated to receive 20–40 mL/kg of normal saline or 
albumin bolus or maintenance only fluids. There was 
surprise both among the investigators as well as the wider 
Research in context
Evidence before this study
Fluid resuscitation has been recommended initial treatment of 
sepsis and septic shock for more than 40 years. The practice of 
fluid resuscitation in sepsis has strong theoretical and 
physiological justification, because volume expansion is 
believed to correct the hypovolaemia occurring in sepsis due to 
capillary leak and pathological vasodilatation, and thus 
increases cardiac output by achieving a more favourable 
position on the Starling curve.
We searched PubMed from Sept 1, 1974, to July 31, 2018, 
using the search term “fluid resuscitation in sepsis” restricting 
the search to human studies, and English language.
We identified 1827 publications, including reviews, 
observational studies, and clinical trials. We found numerous 
observational studies and randomised trials comparing 
different types of fluid resuscitation, including colloids 
(albumin, gelatin, dextrans, and starch) and different 
crystalloids (normal saline, hypertonic saline, Ringer’s lactate, 
and other balanced salt solutions). We identified only one 
randomised controlled trial (the FEAST trial) in which volume 
resuscitation by itself was compared with maintenance fluids 
alone. In the FEAST trial, more than 3000 children with fever 
and clinical signs of impaired perfusion were randomly assigned 
to volume resuscitation with boluses of 5% albumin or normal 
saline, or maintenance fluids alone. The trial was stopped 
because of increased mortality in the bolus groups. Since FEAST 
is the only randomised controlled trial comparing bolus volume 
expansion with a no bolus control group, and showed harm 
from fluid expansion, it provides unique data through which to 
understand the physiological effects of fluid resuscitation.
Added value of this study
The findings of the FEAST trial—that volume expansion with 
20-40 mL/kg of normal saline or albumin increased mortality in 
critically ill children, compared with no bolus—has been 
intensively debated by the intensive care and resuscitation 
community, and has left practitioners uncertain as to what the 
best resuscitation practice should be. To date, there has been no 
clear explanation as to why volume resuscitation was harmful 
in FEAST. Because FEAST was done in resource-poor hospitals 
in Africa, where other aspects of intensive care were not 
available, including mechanical ventilation and inotropic drugs, 
it provides unique data about the physiological effects of bolus 
volume expansion without the interference of other intensive 
care methods.
We compared sequential haemodynamic and vital sign data, 
haemoglobin, and blood chemistry in the bolus and no bolus 
groups of FEAST. Using novel composite scores to compare 
changes in respiratory, cardiovascular, and neurological 
function between the bolus and no bolus groups, we found 
that volume expansion with either 5% albumin or normal 
saline caused worsening of respiratory function and increased 
signs of raised intracranial pressure, but improved 
cardiovascular function. Bolus recipients had lower 
haemoglobin concentrations at 8 h, lower bicarbonate, and 
increased base deficit and chloride at 24 h after the bolus 
infusion. Regression modelling using the physiological 
variables significantly altered by bolus suggest that the 
increased mortality in FEAST can be explained by 
bolus-induced worsening in respiratory and neurological 
function, haemodilution, and hyperchloraemic acidosis.
Implications of all the available evidence
Despite the universal belief that volume expansion with 
crystalloid or colloidal fluid is beneficial in sepsis, and the 
inclusion of bolus volume expansion in current treatment 
recommendations, the FEAST trial showed fluid bolus 
increased mortality. The results of our analysis of the vital 
signs, haematological data, and biochemical data from FEAST 
provide a biologically plausible explanation for the adverse 
outcomes associated with bolus fluids. A modest bolus 
(20-40 mL/kg) of normal saline or albumin resulted in 
prolonged hyperchloraemic acidosis, reduced haemoglobin 
concentration, and worse respiratory and neurological 
function in the early hours after infusion, despite transient 
improvement in cardiovascular function, and explained the 
increase mortality in bolus recipients. Of these effects, 
saline-induced hyperchloraemic acidosis was a major 
contributor to the adverse outcome in bolus recipients. 
Our data suggest that normal saline and other unbuffered 
crystalloid solutions should be avoided in resuscitating 
seriously ill patients. Because volume resuscitation is 
associated with deterioration of respiratory function and 
neurological function in some patients, caution in use of fluids 
might be needed in patients with respiratory or CNS 
compromise, and trials of lower volumes of buffered solutions 
are now needed to establish whether the beneficial effects of 
fluid on cardiovascular function can be achieved with less risk 
of respiratory and neurological compromise.
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scientific community when the trial was stopped by the 
study data and safety monitoring group after 3141 patients 
had been recruited, because of clear evidence of increased 
incidence of death in the recipients of bolus fluids.3
Since publication of the FEAST trial in 2011, there has 
been extensive debate about the generalisability of the 
findings and their implications for practice.4–14 The 
surprising finding, that a common medical intervention 
increased mortality in the only randomised controlled 
trial ever done to test fluid resuscitation against a no 
bolus control, has raised several important questions. 
What were the mechanisms by which fluid resuscitation 
increased mortality in FEAST? Were the findings specific 
to the population of patients in east Africa included in 
the study, or are they relevant to patients globally? Were 
there subgroups of patients included in the FEAST trial 
who were adversely affected by bolus, whereas others 
experienced benefit? Was the adverse effect due to the 
nature of the fluids used (normal saline and 5% albumin, 
both high chloride solutions) rather than the volume 
infused? Should international recommendations for 
fluid resuscitation be altered on the basis of this trial?
Research ethics committees in Africa and other 
resource-poor regions are unlikely to approve further 
trials of fluid resuscitation in light of the increased 
mortality shown in FEAST. Conversely, neither clinicians 
nor ethics committees in most resource-rich countries 
are likely to approve a trial in which fluid bolus is withheld 
from critically ill patients, because of the widely held 
belief in the benefits of fluid resuscitation. Many 
clinicians involved in emergency care in Europe and 
North America have chosen to disregard the results of the 
FEAST trial as being unique to the African context and 
argue that the findings are not relevant in well resourced 
settings, where the availability of ventilators and inotropes 
can ameliorate any negative effects of bolus fluids.9 The 
findings from FEAST have thus confused current clinical 
practice in resuscitation, raising the question of whether 
the current standard intervention to rapidly expand 
circulating volume is harmful and perhaps increases 
deaths and admissions to intensive care.
In light of the unresolved questions raised by FEAST, 
we believed that there was both a need and an obligation 
to fully use all the available data from the FEAST trial to 
understand why fluid bolus was associated with increased 
mortality. We postulated that the increased mortality in 
bolus recipients resulted from a measurable adverse 
effect of bolus fluids on cardiovascular function, 
respiratory function, raised intracranial pressure or 
neurological function, oxygen carrying capacity, or the 
biochemical and acid base status of bolus recipients. To 
test this hypothesis we developed composite scores to 
measure respiratory function, cardiovascular function, 
and identify raised intracranial pressure, using sequential 
vital sign data from FEAST, and compared the function 
of each system, as well as plasma biochemistry and acid-
base balance, in the bolus and no bolus groups of FEAST.
Methods
Study design
We hypothesised that fluid bolus-induced deaths in 
FEAST would be associated with detectable changes in 
cardiovascular, neurological, or respiratory function, 
oxygen carrying capacity, or blood biochemistry. Several 
scoring systems exist to predict severity and outcome in 
paediatric intensive care.15–18 However, these existing 
scores do not enable evaluation of changes in individual 
organ systems because they combine markers of 
dysfunction of multiple organ systems. Furthermore, 
these scores use blood or intensive care variables that are 
not routinely available in the low-resource settings where 
FEAST was done. There are no reliable and established 
methods to quantify the severity of cardiovascular 
dysfunction, respiratory dysfunction, or raised intracranial 
pressure, outside of an intensive care setting. To analyse 
the effects of fluid bolus on physiological status of each 
organ system, we developed composite scores to describe 
respiratory, cardiovascular, and neurological function. We 
assessed their validity by comparison and analysis of their 
relationships in all available data from FEAST and four 
other cohorts of ill children, and then used the composite 
scores to identify differences in respiratory, neurological, 
and cardiovascular function between the bolus and no 
bolus groups of FEAST. We also compared changes in 
acid-base balance and haemoglobin concentration in 
bolus and no bolus groups of FEAST. The overall structure 
of the study and the pre-planned and post-hoc analyses are 
shown in figure 1.
Participants
We analysed data from FEAST and two published 
paediatric studies of critically ill children (meningo coccal 
disease in the UK, and cerebral malaria in Malawi)3,19,20 
together with data from two unpublished cohorts (one 
from South Africa, the other from St Mary’s Hospital 
emergency department in London, UK).
In the FEAST study,3 between Jan 13, 2009, and 
Jan 13, 2011, 3170 patients with fever, respiratory distress, 
or prostration and impaired perfusion were enrolled. 
3141 were randomly assigned to either maintenance 
fluids only (4 mL/kg per h; n=1044), or to receive boluses 
of 20 mL/kg albumin (n=1050) or normal saline (n=1047) 
in the first hour, with a further 20 mL/kg if signs of 
impaired perfusion persisted.3 Clinical details of patients 
in FEAST have been described in detail.3,21,22 Vital signs 
were assessed in surviving children at 1 h, 4 h, 8 h, 24 h, 
and 48 h after commencing fluid bolus in the albumin 
and saline groups, or after randomisation in the control 
group (appendix p 21).
In the UK meningococcal disease study,19 148 fatal cases 
and 354 survivors with meningococcal sepsis in England 
and Wales were enrolled between Dec 1, 1997, and 
Feb 28, 1999. The cohort has been described previously.19
In the Malawian cerebral malaria cohort, between 
Jan 4, 2010, and June 5, 2011, 448 children with cerebral 
See Online for appendix
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malaria were admitted to Queen Elizabeth Central 
Hospital, Blantyre, Malawi, and reported in a study of 
raised intracranial pressure.20 Vital signs and clinical 
variables recorded on admission were related to outcome.
In the South African cohort, 61 children receiving fluid 
resuscitation for presumed sepsis and gastroenteritis at 
Red Cross Children’s Hospital, Cape Town, South Africa 
were recruited between Feb 1, 2013, and June 1, 2013. Vital 
signs and other clinical details were recorded on 
admission to hospital and related to outcome (admission 
to intensive care or death).
In the St Mary’s cohort, vital sign data and outcome 
(the need for hospital admission or intensive care 
admission) were collected for 18 863 children attending 
the emergency department at St Mary’s Hospital, 
London, UK, from June 10, 2014, to March 9, 2015.
All studies were approved by the institutional review 
board of the relevant centre. Details of the recruitment 
procedure, consent procedures, ethics, and institutional 
approvals for the FEAST, meningococcal, and Malawian 
cerebral malaria studies have been reported.3,19,20 Access to 
the FEAST trial data was provided after a formal request 
to the trial study group. Data collection for the  South 
African sepsis cohort and St Mary’s Hospital cohort were 
approved by the local research ethics committee of 
University of Cape Town (HREC REF 025/2013) and UK 
(14/LO/0266), respectively; in accordance with these 
approvals, written informed consent was obtained only 
for participants who had additional data or samples 
collected beyond those necessary for routine clinical care. 
The data from each study were made available with 
approval of the individual country investigators. The 
Figure 1: Study overview
We developed physiological scores to describe respiratory, neurological, and cardiovascular function, and compared them between FEAST and four additional cohorts 
of ill children. We assessed their relationships with clinical outcomes. We used the scores to describe sequential changes in each organ system in FEAST and to identify 
clusters of participants with differing physiological derangements within FEAST. We then assessed the effect of fluid bolus on subsequent physiological scores, 
haemoglobin, and acid-base biochemistry in FEAST participants using a linear model accounting for baseline values as the primary outcome measure. The proportion 
of individuals with larger, more clinically important changes in physiological scores and blood parameters were compared in a secondary analysis. The effect of bolus 
volume on physiological scores, haemoglobin, and biochemical parameters was assessed in pre-planned exploratory analyses. The combined contribution of the 
effects of bolus on time to death was assessed in a post-hoc analysis.
Develop physiological scores to 
describe respiratory, cardiovascular 
and neurological status based on 
available vital sign data in FEAST
Calculate physiological scores at 
sequential time points in FEAST to 
describe changes in physiology and 
their association with bolus
Evaluate association of physiological 
scores with outcomes in FEAST, 
other cohorts and clusters within 
FEAST
Compare baseline physiological 
scores in FEAST with other cohorts of 
subjects with different severity and 
causes of illness
Use physiological scores, 
haemoglobin and lactate 
measurements to identify clusters of 
subjects in FEAST with different 
baseline features
Linear model analyses of the effect of 
fluid bolus on physiological scores, 
biochemical parameters, 
and haemoglobin
Comparisons of the proportions of 
individuals with larger derangements 
in physiological scores, biochemical 
measurements, and haemoglobin, 
between bolus and no bolus groups
Sequential biochemical and 
haemoglobin measurements in 
FEAST
1. Development and validation 
of physiological scores
2. Pre-planned primary 
analysis
3. Pre-planned secondary 
analysis
4. Pre-planned exploratory 
analysis
5. Post-hoc analysis
Comparisons of the proportions of 
individuals with larger derangements 
in physiological scores, biochemical 
measurements, and haemoglobin, 
by volume of fluid received
Multivariate model to determine 
association between time to death 
and combination of bolus-induced 
changes in physiological scores, 
biochemical parameters, and, 
haemoglobin
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analysis of  factors affecting outcome in each study were 
covered by the ethics approval of each study. 
Outcomes 
We analysed the distribution of respiratory, cardiovascular, 
and neurological function scores among FEAST 
participants and within each of the four cohorts, and for 
FEAST compared scores between those who received 
bolus and those who did not. We used logistic regression 
to calculate the odds of adverse outcome (death in FEAST 
and the UK meningococcal disease cohort, neurological 
sequelae or death in the Malawian cohort, intensive care 
admission or death in the South African cohort, and 
admission to hospital or intensive care admission in the 
St Mary’s cohort) for each ten-unit increase in baseline 
score. Within FEAST participants, we examined the effect 
of bolus on the proportion of patients with extreme 
derangement of vital sign scores or physiological para-
meters, and assessed the effect of volume of fluid 
administered. Finally, we used Bayesian analysis to 
identify subgroups with differing physiological derange-
ment who might differ in response to fluids, and to 
explore how the multiple simultaneous physiological 
changes caused by fluid bolus were associated with excess 
deaths in bolus recipients.
Procedures
The physiological basis and development of composite 
scores for respiratory function, cardiovascular function, 
and detection of raised intracranial pressure and 
neurological function are described in detail in the web 
appendix (pp 3–6).
To assess respiratory compromise we used respiratory 
rate (which increases as respiratory function worsens) 
and oxygen saturation (which decreases as respiratory 
function worsens). Vital signs were normalised as 
described in the appendix, with published normal values. 
We converted age-adjusted degree of tachypnoea and 
pulse oximetry measurements to the same direction of 
effect and weighted the contribution of oxygen saturation:
Respiratory score=(respiratory rate – mean respiratory 
rate for age) + 5 × (100 – oxygen saturation)
Cardiovascular responses to developing shock maintain 
blood pressure with vasoconstriction and increasing heart 
rate. If these fail, blood pressure falls. We combined age-
adjusted degree of tachycardia, age-adjusted degree of 
hypotension, and weighted peripheral capillary refill time 
into a measure of cardiovascular compromise:
Cardiovascular score=(heart rate – mean heart rate for 
age) + (mean systolic blood pressure for age –systolic 
blood pressure) + 25 × (capillary refill time)
Raised intracranial pressure is associated with 
decreasing conscious level, bradycardia, and hypertension 
(the latter two are components of Cushing’s triad).23–25 We 
combined weighted level of consciousness measured on 
the AVPU scale (alert=0; responds to verbal stimulus=1; 
responds to painful stimulus=2; unresponsive=3),26 and 
age-adjusted degree of hypertension, and age-adjusted 
degree of bradycardia:
Neurological score=(blood pressure – mean blood 
pressure for age) + (mean heart rate for age – heart 
rate) + 25 × (AVPU coma scale)
In FEAST, scores were calculated at baseline (before 
commencing fluid administration) and 1 h, 4 h, 8 h, 24 h, 
and 48 h after commencing fluid bolus or maintenance 
fluids. In the other cohorts, only baseline data (ie, at 
enrolment) were used.
In FEAST, haemoglobin concentration and plasma 
lactate were measured at baseline, 8 h, and 24 h; base 
excess, pH, and electrolytes were measured at baseline 
and 24 h.3
Statistical analysis
All available data in each dataset were used 
(appendix pp 21, 22), with the exception of implausible 
blood biochemistry values in FEAST, which were 
excluded (base excess less than –30 mEq/L [n=2]; chloride 
<80 mmol/L [n=1]; bicarbonate=0 mmol/L [n=1]).
We calculated the odds of adverse outcome for each ten-
unit increase in baseline score using logistic regression. 
In FEAST and the UK meningococcal disease cohorts the 
outcome was death; in the Malawi cohort the outcome was 
neurological sequelae or death; in the South African 
cohort the outcome was admission to intensive care, or 
death; in the St Mary’s Hospital cohort the outcome was 
admission to hospital or intensive care.
To show the association of each physiological score 
with disease severity, and to gain insight into the 
association of the scores with specific pathophysiological 
phenotypes such as cerebral malaria and septic shock, we 
compared the distribution of scores between cohorts 
using the Mann-Whitney test.
Saline and albumin bolus were equally associated with 
increase in mortality in FEAST.3 Therefore we compared 
physiological scores and blood parameters between the 
combined group of albumin and saline-randomised 
individuals with those randomised to no bolus in an 
intention-to-treat analysis. For the primary analysis we 
used linear regression, controlling for baseline values 
(before starting fluid), to detect mean differences in 
physiological scores and blood variables between the 
bolus and no bolus groups at sequential timepoints after 
the start of fluid bolus or maintenance fluid (no bolus 
group) administration.
To examine whether bolus was associated with an 
increased proportion of patients with extreme derange ment 
of physiological parameters we created separate bins across 
the distribution of each variable, and then calculated the 
relative risk for bolus recipients versus no bolus recipients 
being in each bin. We did this for both change from baseline 
value, and for absolute values of each parameter.
To assess the effect of volume of fluid administered, we 
did a secondary analysis based on the actual volume of 
fluid boluses received within the first 2 h. On the basis of 
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the bimodal distribution, we categorised low volume as 
less than 30 mL/kg and high volume as 30 mL/kg or more. 
Because the decision to administer more than 20 mL/kg 
(initial bolus) was not randomised but was based on 
clinical assessment of ongoing impaired perfusion, we 
anticipated some bias due to severity of illness at baseline. 
We therefore analysed both change from baseline of each 
physiological score, biochemical variable, and haemo-
globin, as well as the actual distribution observed in high-
volume and low-volume bolus groups.
To identify subgroups with differing physiological 
derangement who might differ in response to fluids, we 
used Bayesian Dirichlet process clustering as implemented 
in the R package PreMiuM,27 applied to baseline physio-
logical scores and haemoglobin concentration and lactate 
measurements in all participants recruited to FEAST 
(appendix pp 6, 7). The modelling assumes variables are 
distributed as multivariate normal distributions within 
each cluster. We applied Cox proportional hazards 
regression to each identified cluster to compare survival 
times between the bolus and no bolus groups. In FEAST 
stratum A, we used Kaplan-Meier plots to visualise survival 
over time. We used Spearman correlation to assess the 
relationship between haemoglobin and lactate. 
To explore how the multiple simultaneous physiological 
changes caused by fluid bolus were associated with excess 
deaths in bolus recipients (the primary finding in FEAST) 
we examined the relationship between death and the 
combination of physiological scores, base excess, 
bicarbonate, chloride, and haemoglobin concentration in 
principal component analysis and Cox proportional hazard 
regression models (appendix pp 6–8). We built Cox 
proportional hazard models for time of death using bolus 
or no bolus, physiological scores, and imputed estimates 
of haemoglobin concentration and biochemical values at 
1 h after bolus administration (appendix pp 7, 8). Full 
details of the imputation and basis for minimal and larger 
estimates of each value are shown in the appendix (pp 7, 8, 
19, 28–31). The initial model included only bolus alone and 
additional covariates were added iteratively to the models 
in order of their association with outcome using a forward 
selection approach. After each iteration, we report the 
resulting hazard ratio for time of death. We repeated the 
procedure using the individual components of each 
physiological score rather than the composite scores, to 
identify the contribution of each variable to the increased 
mortality in bolus recipients. For comparison, we also built 
a multivariable model using measured baseline values of 
physiological scores and blood para meters. All statistical 
analyses were done in R (version 3.2.2). 
The FEAST trial is registered with ISRCTN, number 
ISRCTN69856593.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
Details of each cohort are shown in table 1. In the 
FEAST study, median physiological scores were 105 
(IQR 86–124) for cardiovascular function, 53 (37–79) for 
respiratory function, and 25 (8–47) for neurological 
function. Patients in FEAST had significantly higher 
values of all physio logical scores than the St Mary’s 
Hospital cohort (57 [IQR 50–67] for cardiovascular 
function, 5 (0–12) for respiratory function, and 11 (3–20) 
for neurological function), and they had higher respiratory 
Setting Total (n) Entry criteria Age (months) Sex Outcome





FEAST Kenya, Uganda, 
and Tanzania
3170 Fever and respiratory distress or 
prostration and impaired 
perfusion






502 Neisseria meningitidis culture or 
PCR positive or purpura fulminans 
without other cause
499 39 (13–166) 365 192 (53) 502 Death 148 (29)
Cerebral malaria Blantyre, Malawi 448 Blantyre coma score ≤2 with 
Plasmodium falciparum 
parasitaemia and no other 
discernible cause of coma




South Africa Cape Town, 
South Africa
61 Suspected septic shock or severe 
gastroenteritis and clinician’s 
decision to give fluid resuscitation




St Mary’s Hospital 
emergency 
department
London, UK 18 863 Emergency department 
presentation
18 862 48 (18–110) 18 861 10 467 (55) 18 717 Admission to 




Table 1: Clinical details of cohorts studied
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scores than all other cohorts (p<0·0001; appendix p 9). 
Neurological scores were highest in the Malawian cerebral 
malaria cohort (median score 75, IQR 55–78; appendix 
p 9). FEAST patients had cardio vascular scores similar to 
those in the Gram-negative sepsis meningococcal cohort 
(median score 100, IQR 69–157; appendix p 9).
Physiological scores in FEAST were highest in the first 
hours following admission, and decreased over the next 
48 h (appendix p 9). Median physiological scores, at 
baseline and 48 h, respectively, were 105 (IQR 86–124) and 
52 (39–65) for cardiovascular score, 53 (37–79) and 18 
(11–27) for respiratory score, and 25 (8–47) and 4 (0–13) for 
neurological score. Patients who subsequently died had 
significantly higher respiratory and neurological scores 
than survivors at all timepoints up to 24 h (appendix p 9). 
Cardiovascular score was significantly higher in fatal 
cases than in survivors at baseline, was not significantly 
different at 1 h after administration of initial fluid bolus 
(if received), but was then significantly higher after 4 h or 
more in those dying than in survivors (appendix p 9).
In FEAST, odds of death for each ten-unit increase in 
baseline score was 1·09 (95% CI 1·07–1·11) for respiratory 
score, 1·26 (1·21–1·31) for neurological score, and 1·09 
(95% CI 1·05-1·14) for cardiovascular score (all p<0·0001; 
appendix p 22). The associations between physiological 
scores and outcome measures in the other cohorts are 
shown in the appendix (p 22).
To determine the effect of fluid bolus on physiological 
scores, biochemical parameters, and haemoglobin con-
centration, we used linear regression analysis to calculate 
the mean differences, adjusted for baseline value, between 
those randomly assigned to receive bolus or no bolus in 
FEAST. We combined the albumin and saline groups 
because they had similar effects on mortality in FEAST.3 
Mean respiratory score was 3·45 (95% CI 0·90–6·01; 
p=0·0080) higher at 1 h and 2·3 (0·31–4·3; p=0·024) 
higher at 4 h in children randomly assigned to receive 
bolus than in those who received no bolus, but there was 
no significant difference between groups at 12 h (table 2). 
Fluid bolus increased the mean neurological score at 1 h 
by 2·64 (95% CI 0·76–4·52, p=0·0060) and there was no 
significant difference at 4 h and 12 h (table 2). Conversely, 
fluid bolus decreased the mean cardiovascular score at 1 h 
by 2·17 (95% CI 0·57–3·78, p=0·0080; table 2); there was 
no significant difference between groups at 4 h and 12 h. 
After 4 h, there were no significant differences in 
physiological scores (table 2). In a post-hoc analysis, 
we analysed albumin and saline groups separately 
(appendix p 23). With the exception of respiratory score at 
8 h, which was more increased in albumin recipients than 
in saline recipients, there were no significant differences 
between participants who received saline and those who 
received albumin (appendix p 23). Bolus decreased mean 
haemoglobin concentration at 8 h by 0·33 g/dL (95% CI 
0·20–0·46, p<0·0001). Bolus was not associated with a 
change in blood lactate concentrations at 8 h or 24 h 
but was associated with a decrease in mean plasma 
bicarbonate by 0·96 mmol/L (0·45 to 1·47, p=0·0003), a 
decrease in mean base excess by 1·41 mEq/L (0·76 to 2·06, 
p<0·0001), and an increase in mean chloride by 1·65 
mmol/L (95% CI 0·47 to 2·83, p=0·0070) in patients 
surviving to 24 h (table 2).
To assess whether bolus induced larger changes in 
some individuals, we compared the proportions of 
individuals in different segments of the distribution of 
each variable between the bolus and no bolus groups 
(figure 2; appendix p 10). Compared with those who did 
not receive bolus, individuals who received bolus had an 
increased risk of a large or very large increase in 
respiratory score and neurological score at 1 h, and of a 
large or very large decrease in cardiovascular score at 1 h 
(figure 2). The bolus-associated changes in respiratory 
score persisted at 4 h (appendix p 10). When absolute 
values of scores at 1 h and 4 h were considered, rather 
than change from baseline, a greater proportion of the 
bolus group had high respiratory and neurological scores 
than in the no bolus group, whereas a smaller proportion 
had high cardiovascular score (appendix pp 11, 12). Larger 
n/N (%) Effect size* (95% CI); p value
Respiratory score
1 h 2925/3102 (94·3%) 3·45 (0·90 to 6·01); p=0·0080
4 h 2884/3025 (95·3%) 2·31 (0·31 to 4·31); p=0·024
12 h 2838/2938 (96·6%) 1·58 (–0·29 to 3·46); p=0·10
Neurology score
1 h 2992/3102 (96·5%) 2·64 (0·76 to 4·52); p=0·0060
4 h 2933/3025 (97·0%) 1·05 (–0·68 to 2·79); p=0·23
12 h 2881/2938 (98·1%) 0·322 (–1·30 to 1·94); p=0·70
Cardiovascular score
1 h 3010/3102 (97·0%) –2·17 (–3·78 to –0·57); p=0·0080
4 h 2948/3025 (97·5%) –0·30 (–1·93 to 1·33); p=0·72
12 h 2897/2938 (98·6%) 0·10 (–1·52 to 1·72); p=0·90
Haemoglobin (g/dL)
8 h 2771/2974 (93·2%) –0·33 (–0·46 to –0·20); p<0·0001
24 h 2723/2882 (94·5%) –0·21 (–0·35 to –0·08); p=0·0010
Lactate (mmol/L)
8 h 2737/2974 (92·0%) –0·12 (–0·33 to 0·092); p=0·27
24 h 2657/2882 (92·2%) –0·011 (–0·21 to 0·19); p=0·92
Base excess (mEq/L)
24 h 857/2882 (29·7%) –1·41 (–2·06 to –0·76); p<0·0001
Bicarbonate (mmol/L)
24 h 858/2882 (29·8%) –0·96 (–1·47 to –0·45); p=0·0003
Chloride (mmol/L)
24 h 840/2882 (29·1%) 1·65 (0·47 to 2·83); p=0·0070
Results of linear regression analysis comparing albumin or saline bolus with no 
bolus controls, controlling for respective baseline levels. Times shown are the 
hours after start of infusion. Proportions are given as a percentage of individuals 
with data from those alive at that timepoint. *Mean change in the variable 
relative to the no bolus control. A positive effect size indicates an increase in the 
parameter in bolus recipients; a negative effect size indicates a decrease in the 
parameter in bolus recipients, relative to the no bolus group. 
Table 2: Changes in physiological scores and blood parameters 
associated with fluid bolus in FEAST
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decreases from baseline in base excess and bicarbonate, 
and larger increases in chloride were observed in bolus 
recipients (figure 2D–F). A greater proportion of bolus 
recipients had very low haemoglobin concentration 
(<7·5 g/dL and <5 g/dL) at 8 h (appendix p 11).
In an exploratory analysis, we assessed the effect of low 
or high volume bolus on the distribution of physiological 
scores and blood parameters. At 4 h, the first observation 
after completion of the high volume bolus, there were 
higher respiratory and neurological scores in patients 
who received high volume (≥30 mL/kg) bolus 
(appendix p 13). However, the distribution of cardio-
vascular scores at 4 h was similar in low and high volume 
recipients (appendix p 13). There were lower base excess 
and bicarbonate, higher chloride, and lower haemoglobin 
concentration (but only in untransfused participants) in 
the high-volume bolus recipients (appendix p 13). 
Findings were similar when change from baseline was 
considered (appendix p 14).
The biochemical changes we observed in FEAST 
suggested that boluses of albumin or saline could cause 
hyperchloraemic metabolic acidosis. To explore this 
further, we did a post-hoc analysis of the effect of bolus 
on pH and respiratory compensation. 719 (35%) of 
2082 FEAST participants with pH measurements at 
baseline had acidosis (pH<7·35; appendix p 15), and the 
mortality rate for those with baseline acidosis was much 
higher than for those with pH of 7·35 or higher. Among 
survivors in the bolus group, the relative risk of being 
acidotic at 24 h was 1·4 (95% CI 1·0–1·9) compared with 
the no bolus group. There was a significant negative 
correlation between chloride and pH, with a stronger 
effect of chloride on pH in the bolus group (appendix 
p 15). Low pH suggests that respiratory compensation 
mech anisms have been overwhelmed, so we explored the 
respiratory response at early timepoints, when the 
majority of deaths occurred in acidotic patients. 
Respiratory rates were increased at baseline and 1 h, 
relative to normal ranges for healthy children  (appendix 
p15). Oxygen saturations decreased more in bolus 
recipients at 1 h, whereas there were no differences 
between the bolus and no bolus groups in the change in 
respiratory rate (appendix p 15).
We identified three clusters of patients on the basis of 
their baseline characteristics (figure 3A). Cluster 
one (n=1991) had least derangement in physiological 
scores, haemoglobin concentration, and lactate. Cluster 
two (n=795) comprised patients with severe anaemia 
(haemoglobin concentration <5 g/dL), and high lactate and 
cardiovascular score. Cluster two also had greater base 
deficit, lower bicarbonate, and high chloride concentrations 
(appendix p 17). Cluster three (n=384) was characterised by 
Figure 2: Changes in physiological scores and blood measures associated with fluid bolus
The proportion of individuals in FEAST with different magnitudes of change from baseline in physiological scores and blood measurements are shown according to whether they were randomly assigned 
to receive no fluid bolus (red bars) or fluid bolus (blue bars). Panels A–C show changes in physiological scores between baseline and 1 h after starting fluid infusion. Panels D–F show changes in biochemical 
measures from baseline to 24 h. Panels G and H show change in haemoglobin concentration from baseline to 8 h in non-transfused (G) and transfused (H) participants. Negative values indicate decrease 
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extremely high respiratory and neurological scores, but 
better maintained haemoglobin concentration.
The clusters differed markedly in mortality (figure 3B). 
In cluster one, six (1%) of 658 participants in the non-
bolus group died, and 51 (4%) of 1327 died in the bolus 
group. In cluster two, 37 (14%) of 264 patients in the non-
bolus group died, and 108 (21%) of 518 died in the bolus 
group. Mortality was highest in cluster three: 32 (26%) of 
122 participants in the non-bolus group died, and 
59 (23%) of 252 in the bolus group died.
Considering all participants, there was a negative 
correlation between haemoglobin and lactate concen-
trations (Spearman r=–0·56, p<0·0001; figure 3C). 
Associations between bolus and respiratory score, neuro-
logical score, haemoglobin concentration, and blood 
biochemistry in clusters one and two were consistent with 
those seen in FEAST overall (appendix pp 24–26). The 
association between bolus and changes in  blood 
parameters and physiological scores in each cluster are 
shown in the appendix (pp 25–27).
We reasoned that the multiple physiological changes 
induced by bolus might act in combination to explain 
the higher mortality observed in the bolus group, 
and investigated this in post-hoc analyses. Principal 
component analysis using the physiological scores and 
predicted values of blood parameters at 1 h showed that the 
distribution of fatal cases was distinct from survivors and 
appeared related to the effects of bolus (appendix p 18). 
Baseline values of these variables predicted deaths in both 
bolus and no bolus groups, but there were more observed 
deaths in the bolus group, indicating that the baseline 
values of the covariates did not explain the difference in 
mortality (as expected in a randomised trial; appendix p 32). 
However, when we used the 1 h post-bolus values to predict 
deaths, using either conservative or more realistic 
estimates of the biochemical changes induced by bolus at 
1 hour (appendix pp 7, 8, 28–32), we found that there was 
no longer a significant difference between the bolus and 
no bolus groups (figure 4; appendix p 32). This finding 
indicates that the covariates in the model can explain all of 
the difference in observed mortality between bolus and no 
bolus groups of the trial. We found that after bolus, the 
neurological score, base excess, and respiratory score were 
the major determinants of the increased death rate from 
Figure 3: Bayesian cluster analysis of FEAST
(A) Distributions of the physiological scores, haemoglobin concentrations, and lactate concentrations by cluster. Boxes show median (coloured line) and IQR; 
whiskers extend up to 1·5 times IQR. Cluster one, n=1991; cluster two, n=795; cluster three, n=384. (B) Survival curves for no bolus (red line) or bolus (blue line) 
recipients in each cluster in FEAST stratum A. Cluster one, bolus n=1327, no bolus n= 658; cluster two, bolus n=518, no bolus n=264; cluster three, bolus n=252, no 
bolus n=122. Dotted lines indicate 95% CIs. (C) Correlation between baseline haemoglobin and lactate concentrations (Spearman p<0·0001, rs–0·56) with individual 
participants coloured by cluster (cluster one [red] n=1991; cluster two [green] n=795; cluster three [blue] n=384).
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bolus using either minimal (figure 4A) or more realistic 
estimates (figure 4B) of the post-bolus biochemical values 
(appendix). When the individual components of each score 
were included in the models, the post-bolus AVPU score, 
base excess, and oxygen saturation made the largest 
contribution to explaining the excess deaths (figure 4C, 
4D). We summarised these findings into a physiological 
model proposing how the adverse effects of bolus fluids 
could increase mortality (figure 5).
Discussion
The physiological scores we developed provide a tool to 
quantify changes in respiratory, cardiovascular, and 
neurological function in response to bolus fluids in 
FEAST. The scores discriminated between cohorts of 
patients with infections affecting different organ systems 
and were generally predictive of outcome, showing their 
use as objective measures of organ system derangement. 
Using these physiological scores and available blood 
measurements, we observed six deleterious effects of fluid 
bolus: respiratory and neurological scores increased at 
early timepoints; haemoglobin concentration decreased 
(particularly in patients who did not receive blood 
transfusion); base deficit and chloride concentrations 
increased, and plasma bicarbonate decreased (changes 
consistent with hyperchloraemic acidosis). Although 
the linear regression analysis showed a modest, but 
significant, change in the mean value of each variable, 
there were much greater changes observed in some 
individuals, with increased proportions of bolus recipients 
having extreme adverse physiological derangement in 
physiological scores, haemoglobin concentration, and 
blood chemistry. Most of these changes were greater in 
patients receiving higher fluid volumes. The changes in 
physiological scores were most evident at early timepoints, 
but early deaths and the increased mortality in bolus 
recipients makes evaluation of later timepoints difficult. 
The only beneficial physiological change observed was a 
reduction of cardiovascular score, in keeping with the 
impression of clinicians that perfusion improved during 
fluid resuscitation.
When we included the bolus-induced changes in 
respiratory function, cardiovascular function, neuro logical 
function, and biochemical changes in Cox survival models, 
the increased mortality in bolus recipients in FEAST was 
explained by the physiological changes we identified. 
Analysis of the effect of each component in the models 
showed that the excess deaths in bolus recipients were 
largely explained by worsening neurological score (or 
raised intracranial pressure), increased base deficit, and 
worsening respiratory score. Of the individual components 
analysed, bolus-induced increased base deficit, worsening 
conscious level, and oxygen saturation were the major 
contributors to the excess mortality associated with bolus.
Since the 1990s, there have been increasing reports, 
including small case studies, randomised trials in healthy 
volunteers and patients, and experimental studies in 
animals that have documented hyperchloraemic acidosis 
after infusion of unbuffered salt solutions (appendix 
pp 28–31).30–33 Hyperchloraemic acidosis is an inevitable 
consequence of the infusion of unbuffered sodium 
chloride solutions, predicted by the Stewart equation of 
acid-base balance28,29 and confirmed in the extensive 
literature. Although many small studies comparing 
balanced salt solutions (which contain acetate or lactate 
as a source of anion) with normal saline have documented 
saline-induced hyperchloraemic acidosis, recent large 
clinical trials also reported increased mortality and 
worsening renal outcome in adults receiving normal 
saline as compared with balanced salt solutions.34,35 Our 
finding that the bolus-induced hyperchloraemic acidosis 
and decreased base excess was a major contributor to the 
increased mortality in bolus recipients suggests that 
much of the adverse effect of bolus in FEAST was due to 
the nature of the fluids used.
Worsening respiratory function and increase in signs of 
raised intracranial pressure, which we documented in 
Figure 4: Contribution of physiological derangements to excess mortality due to bolus
In post-hoc analyses, we calculated hazard ratios for bolus versus no bolus on time of death in Cox proportional 
hazard models, sequentially incorporating additional explanatory covariates (in order from top to bottom of each 
list), showing how the effect of bolus on death is mediated by observed changes in physiology and blood 
parameters (A–D). Up or down refers to the direction of change from the age-related mean values, which 
contribute to different physiological scores. (A) The covariate list includes physiological scores at 1 h and 
conservative (data-derived) estimates of the effect of bolus on blood parameters at 1 h. (B) The covariate list uses 
literature-derived values for the changes in acid-base biochemistry parameters. (C) The covariate list includes the 
component variables of the physiological scores at 1 h and conservative (data-derived) estimates of the effect of 
bolus on blood parameters at 1 h. (D) The covariate list uses literature-derived values for the changes in acid-base 
biochemistry parameters. Analyses in A–D are based on 1898 subjects with complete data for physiological scores 
at 1 h and baseline biochemical parameters. AVPU= Alert, Responds to Voice, Responds to Pain, Unresponsive.
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bolus recipients, are well known effects of fluid 
administration in some critically ill patients. Indeed, 
many guidelines for management of shock recommend 
intubation, and elective mechanical positive pressure 
ventilation for patients who remain with signs of shock 
after initial bolus volume infusion because of the 
recognition that continued fluid resuscitation is likely to 
cause respiratory deterioration.1,36 However, our finding 
that small volumes (20–40 mL/kg) of normal saline or 
albumin, which are routinely administered to under-
perfused children in emergency departments, cause 
worsening of respiratory function and decrease in oxygen 
saturation suggest that even modest volumes of fluid 
might have detrimental effects in some children despite 
the observable improvement in perfusion, which was also 
manifested in FEAST as improving cardiovascular score. 
Our findings raise the possibility that administration of 
fluid bolus to underperfused patients might increase the 
need for intensive care admission because of worsening 
oxygenation.
The worsening neurological score in bolus recipients 
and the contribution of deteriorating neurological score 
to the excess mortality in bolus recipients is also an 
expected effect of bolus fluids in patients who have 
increased intracranial pressure. More than 50% of the 
patients included in FEAST had severe malaria, and 
many of these patients had evidence of cerebral malaria. 
Evidence of raised intracranial pressure has been well 
documented in cerebral malaria by direct measurement,37 
MRI scan,20 and by clinical findings.38 Both fluid volume 
and the hyperchloraemic acidosis induced by the saline 
and albumin used in FEAST could have contributed to 
the worsening of consciousness and neurological score in 
bolus recipients (figure 5). Although patients with 
neurological diseases such as cerebral malaria and 
meningitis comprise a smaller proportion of critical 
illness in resource-rich settings, our finding that 
worsening neurological score occurred in bolus recipients 
suggests that volume resuscitation should be used with 
great caution in patients presenting with neurological 
illness, and unbuffered salt solutions should be avoided.
Our cluster analysis revealed heterogeneity within 
FEAST. The majority of patients (cluster one), had least 
severe derangement of all three physiological scores, 
adequate haemoglobin concentrations, and remarkably 
low mortality in the absence of bolus. Fluid bolus in this 
cluster caused worsening of respiratory and neurological 
function, reduced haemoglobin concentration and 
increased acidosis. The second cluster, characterised by 
low haemoglobin concentration, high lactate concen-
tration, and high cardiovascular score, identified patients 
with severe anaemia. The inverse relationship observed 
between haemoglobin and lactate concentrations, and 
lower bicarbonate and base excess suggests that the 
baseline hyperlactataemia and metabolic acidosis is largely 
driven by impaired oxygen carrying capacity. In this cluster, 
Figure 5: Proposed physiological model of the adverse effects of fluid bolus 
Bolus fluid reduces haemoglobin concentration, resulting in decreased tissue oxygenation, increasing anaerobic metabolism, and metabolic acidosis. According to 
the Stewart model, maintenance of normal plasma pH is controlled by (1) the strong ion difference (charge difference between strong cations (Na+, K+, Ca2+, and 
Mg2+), and strong anions (Cl– and lactate–); (2) pCO2 and (3) charge from weak acids (phosphate, albumin).28,29 Bolus of normal saline or 5% albumin (which have 
similar electrolyte content) caused hyperchloraemia and dilution of bicarbonate, resulting in a reduction in the strong ion difference. Hyperchloraemic acidosis 
increases the need for respiratory compensation through increased carbon dioxide excretion to maintain pH. Worsening of respiratory function due to bolus results in 
hypoxia (as evidenced by low oxygen saturation and increased respiratory score). This outcome, together with an inability to increase respiratory rate, impairs 
excretion of carbon dioxide (not shown in our study). Increasing carbon dioxide causes cerebral vasodilation, resulting in increased intracranial pressure. Fluid bolus 
might also directly cause cerebral oedema. The combination of adverse effects on haemoglobin concentration, acidosis, and respiratory and neurological function 
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bolus fluids caused worsening of respiratory and neuro-
logical function and increased acidosis. The third cluster, 
characterised by high respiratory and neurological scores 
had high mortality (23–26%). Patients in the bolus 
group had lower haemoglobin concentrations and higher 
chloride concentrations than those in the non-bolus group.
Identification of clusters within the large FEAST cohort 
of ill children has important therapeutic implications. 
The low mortality in the absence of bolus fluids in cluster 
one suggests that this group did not require any 
additional intervention, and most would recover with 
treatment of the infection alone. In cluster two, in which 
anaemia was the major problem, we believe blood 
transfusion was required, and bolus probably worsened 
tissue oxygen delivery. In cluster three, in which 
respiratory failure and neurological impairment were the 
main physiological derangements, we believe that 
respiratory support was needed to reduce mortality.
Combination of the physiological derangements 
caused by bolus explained mortality better than the pre-
bolus values of the same parameters, indicating that 
through their combined effects, the bolus-induced 
changes plausibly explain the effect of bolus on mortality 
in FEAST (figure 4). Because the physiological changes 
identified are likely to be similar in all settings, our 
findings have implications for fluid resuscitation in both 
developed and resource-limited settings, although the 
magnitude of effect may differ because the severity of 
anaemia in FEAST participants might have increased the 
relative importance of haemodilution.
The findings in our analysis differ from the previous 
analysis of modes of death in FEAST9,22 and an ovine 
model,39 which concluded that worsening cardiovascular 
shock was the major adverse effect of bolus. The earlier 
study22 used increased plasma lactate concentration as 
part of the definition of cardiovascular shock. Our 
analysis found that plasma lactate was negatively 
correlated with haemoglobin concentration, and thus use 
of lactate as a biomarker of cardiovascular shock in the 
previous analysis gave an incorrect indication of the 
prevalence of cardiovascular shock.
Our study has several limitations. Although our physio-
logical scores are associated with outcome in multiple 
different cohorts, they have not been independently 
validated. In particular, the weightings were chosen to 
reflect the perceived importance of each variable as a 
measure of organ system function. They were not derived 
from the data or from previous studies. The scores should 
be seen as means of studying changes in physiology 
between arms of a trial, rather than as outcome predictors, 
for which there are already a number of scoring systems 
available.15–18 FEAST was done in settings in which 
intensive care and mechanical ventilation were not 
available. Although the physiological changes induced by 
bolus are likely to be seen in all settings, caution is needed 
in extrapolating associations with mortality to resource-
rich settings, in which some of the adverse effects of bolus 
fluids could be mitigated by mechanical ventilation and 
neuro-intensive care. Furthermore, because of the design 
of the trial, we cannot exclude that the associations we have 
reported between greater physiological derangements and 
larger volumes of administered fluid are confounded by 
the indication—ie, administration of larger volumes of 
fluid to participants with more deranged physiology. An 
additional limitation is that acid-base balance was only 
measured on admission and at 24 h, by which time most 
deaths had occurred, and many patients had no data at the 
24 h timepoint. To include the effect of bolus on acid-base 
balance, we imputed the earlier timepoints from the 24 h 
differences, and used published values to produce a range 
of estimates of the extent of acidosis at earlier time points. 
We believe the assumptions used in the imputation 
provide reliable estimates of the earlier values.
The FEAST trial included children with widely differing 
diseases and underlying physiology. We found that fluid 
bolus achieved the intended improvement in cardiovascular 
function at the cost of worsening respiratory and neuro-
logical function, acidosis, and reduced haemoglobin. Our 
finding that within FEAST there are clusters with differing 
physiological derangements suggests particular need for 
caution in fluid administration to patients with established 
respiratory failure, neurological failure, severe acidosis, or 
anaemia, and the need for better detection and specific 
management of the physiological derangements in each 
individual patient. The physiological scores we have 
developed might be useful in identifying derangement in 
specific organ systems.
The combination of adverse physiological effects we 
observed, associated with both albumin and saline bolus, 
raises questions about both the volume and type of fluid 
used in resuscitation. Balanced salt solutions such as 
Ringer’s lactate or plasmalyte (which have electrolyte 
compositions closer to plasma than normal saline, and 
lactate or acetate as major anions) are associated with 
more rapid resolution of acidosis than 0·9% saline, and 
in recent clinical trials they were associated with 
improved outcomes.34,35,40 Our finding that worsening 
hyperchloraemic acidosis was a major contributor to the 
excess deaths in FEAST suggests that unbalanced salt 
solutions such as normal saline and 5% albumin should 
be avoided in seriously ill patients and replaced with 
balanced salt solutions. However, other fluids are likely 
to have the same adverse effects on respiratory function, 
oxygen carrying capacity, and perhaps neurological 
function that we have observed with albumin and saline 
in FEAST. Trials are needed to establish if balanced 
electrolyte solutions and lower volumes than currently 
recommended will allow the benefits of fluid on 
cardiovascular function to be achieved without the 
adverse effects observed in FEAST.
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Relationship to the FEAST trial and analysis plan 
The present study was not planned as a pre-specified analysis of the FEAST trial. The present study represents a 
hypothesis-based reanalysis of the trial data. The primary hypothesis was that bolus fluids produce measurable 
changes in cardiovascular function, respiratory function, raised intracranial pressure or neurological function, 
oxygen carrying capacity, biochemical and acid-base status. The secondary hypothesis was that if these changes 
are detectable, they can explain the excess mortality associated with bolus fluid in the FEAST trial. To evaluate 
both of these hypotheses, multiple analyses (detailed below) were performed in order to justify the methodological 
approaches for detection of the changes in organ system function and to assess whether any effects attributed to 
bolus were consistent with expected relationships with the volume of bolus-fluids received, known mechanisms 
of acid-base derangement, and between subgroups of patients.     
 
Assessment of changes in physiology and blood parameters 
FEAST collected data on respiratory rate, pulse rate, blood pressure, capillary refill time and level of 
consciousness sequentially throughout the trial at baseline, 1, 4, 8, 24 and 48 hours1. Haemoglobin and lactate 
concentrations were measured at baseline, 8 and 24 hours.1 Plasma chemistry and acid-base balance were 
measured at baseline and 24 hours.1  
Our first challenge in attempting to establish the mechanisms by which fluid increased mortality in FEAST was 
to identify a methodology for detecting changes in each organ system in bolus recipients using the data available 
from the trial.   
There are currently no “gold standard” methods to quantify respiratory function, neurological function or 
cardiovascular function in critically ill children based on clinical features, although multiple international 
guidelines indicate that respiratory rate, pulse rate, blood pressure, capillary refill time and level of consciousness 
should be used to guide management. We postulated that combinations of these variables would provide objective 
and quantitative indicators of respiratory, neurological and cardiac function, in a similar manner to which 
experienced clinicians subconsciously assimilate them each time they assess a seriously ill patient. As blood 
pressure, heart rate, and respiratory rate vary greatly in children of different age, we adjusted for age by calculating 
the deviation from the age-related mean values for healthy children. Mean values for heart rate and respiratory 
rate and blood pressure were derived from published tables.2, 3  
We note that the intended purpose of each score was to enable comparison of changes in organ function between 
the bolus and no bolus arms of the randomised controlled trial, and to compare physiological derangement between 
different studies. Recognising that there is no absolute measure against which to calibrate each score, the 
weightings of oxygen saturation, coma score and capillary refill time were chosen to reflect the clinical importance 
of each component of the score. We acknowledge that different weightings might enable better prediction of 
outcome in individual studies, however our aim was to develop an objective tool for comparison between arms 
and studies, and not to develop a new predictor of outcome.  
Heart rate and blood pressure deviations from the age-related means were considered to have different 
implications for cardiovascular and neurological status, since low blood pressure and high heart rate are features 
of circulatory failure whilst rising blood pressure and falling heart rate are features of raised intracranial pressure. 
Thus only physiologically adverse deviations contributed to each score, and otherwise the difference was set to 
zero as explained for each score below. 
 
Developing a composite measure for cardiovascular function 
Measurement of cardiac function is routinely undertaken using echocardiography or thermodilution catheter in an 
intensive care setting.  However these methods were not available in FEAST. Furthermore, shock is defined as a 
life-threatening, generalized form of acute circulatory failure associated with inadequate oxygen utilization by the 
cells; a state in which the circulation is unable to deliver sufficient oxygen to meet the demands of the tissues 
resulting in cellular dysfunction.4 Therefore it is not solely defined by or dependent on cardiac output. Remarkably 
neither adult nor paediatric guidelines for clinical recognition of shock have an objective quantification of the 
severity of shock (see table below). In some guidance more severe cases are recognized by being refractory to 
fluid volume expansion5 thus defining severity by the very intervention shown to be associated with increased 
mortality in FEAST. Clinical recognition of shock is based not only on markers of cardiac output (such as heart 
rate and blood pressure) but on evidence of impaired perfusion of tissues and organs, such as change in mentation, 
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oliguria or rising blood lactate.4, 5 Furthermore FEAST included a large proportion of patients with presumed 
cerebral malaria and meningitis1, 6 so changes in mentation may not only be caused by impaired cardiovascular 
function or perfusion but by the underlying disease process. Furthermore, changes in urine output were not 
recorded as this is difficult without indwelling catheters. Lactate, which is the most commonly used marker of 
tissue under perfusion in most shock algorithms, was also found to be unreliable in the African setting because 
we found it was closely correlated with the level of haemoglobin and thus more a reflection of anaemia than 
cardiovascular perfusion. 
 
Criteria for clinical recognition of shock (modified from Houston et al.7) 
Guideline Clinical criteria Age group 
Advanced Paediatric Life 
Support (APLS)8  
 
Compensated: normal blood pressure (BP), but capillary refill time (CRT) >2 s, 
mottled peripheries, peripheral cyanosis 
Decompensated: as above but with hypotension, decreased mental status 
Paediatric 
American Academy of 
Critical Care Medicine – 
Paediatric Advanced Life 
Support (ACCM-PALS)9 
Septic shock: Suspected infection (hypo- or hyperthermia) and clinical signs of 
inadequate perfusion including any of: decreased or altered mental status; CRT >2 s 
(cold shock) or flash CRT (warm shock), diminished (cold shock) or bounding (warm 
shock) peripheral pulses, mottled cool extremities (cold shock), or decreased urine 
output (<1 ml/kg/hr) 
Paediatric 
World Health Organization 
(WHO)10  
Shock: cold hands, capillary refill time longer than 3 s, high heart rate with weak pulse, 
and low or unmeasurable blood pressure 
Paediatric 




History of fever and temperature ≥37·.5 °C or <36·.0 °C and impaired consciousness 
(prostration or coma) and/or respiratory distress 
Stratum A (impaired perfusion) Plus ≥1 of: CRT >2 s; lower limb temperature gradient; 
weak pulse; tachycardia (defined) 
Stratum B (decompensated shock): Systolic BP <50 mmHg if < 12 months old; <60 
mmHg if 1–5 years old; <70 mmHg if > 5 years old  
Paediatric 
International pediatric sepsis 
consensus conference 
definitions11 
Sepsis: SIRS (2 of 4 of: core temp > 38·5 or < 36 °C; tachycardia or bradycardia if 
<1yr; tachypnea; elevated or depressed leukocyte count) in the presence of or as a 
result of suspected or proven infection  
Septic shock: Sepsis and cardiovascular organ dysfunction  
Paediatric 
Sepsis 312 Sepsis: life-threatening organ dysfunction caused by a dysregulated host response to 
infection. Organ dysfunction defined as an increase in the SOFA score of 2 points or 
more 
Septic shock: Sepsis and both persistent hypotension requiring vasopressors and lactate 
³2 mmol/L despite adequate volume resuscitation 
Adult 
Sepsis 213 Sepsis: suspected or documented infection with change to some of the following: 
General variables; inflammatory variables; haemodynamic variables; organ dysfunction 
variables ; tissue perfusion variables. 
Severe sepsis: sepsis complicated by organ dysfunction 
Septic shock: persistent arterial hypotension unexplained by other cause  
Adult 
 
These clinical indicators of cardiovascular system dysfunction are rarely synthesised into quantitative measures 
which would allow comparison of organ function between individuals or sequentially over time. The widely used 
shock-index was devised based on the logical but arbitrary belief that heart rate divided by systolic blood pressure 
should provide a better indicator of cardiovascular status than either alone,14 but was not empirically derived based 
on data. For application to children it has required modifications to account for age-related variation in normal 
values,15 and it does not include any measure of perfusion.   
We concluded there was no optimal or accepted method for quantifying differences in shock or cardiovascular 
function between the bolus and no bolus arms of FEAST, and that we needed to develop novel methods that could 
be used to identify the effect of bolus on shock /cardiovascular function (as well as for each of the other organ 
systems, described below) using the available data. 
We reasoned that an overall assessment of cardiovascular function could be made by combining heart rate and 
blood pressure with capillary refill time, which is a well-established marker of perfusion, as all three variables 
were recorded sequentially in FEAST. Heart rate rises while blood pressure falls as shock evolves, so heart rate 
and blood pressure can be combined as markers of cardiac function by converting them to the same direction of 
effect. As all vital signs are age related we also adjusted blood pressure and heart rate to detect a rise in heart rate 
above the mean normal for age and a fall in blood pressure below the mean normal for age. As capillary refill time 
is typically in the range of 0 to 5 seconds, while heart rate and blood pressure extend over much larger numerical 
ranges, we weighted capillary refill time so that it could make an approximately equal contribution to an overall 
score for cardiovascular function.   
The conventional method for assigning weightings in predictive scores is to derive the weightings from the 
associations between the data and the outcome of interest, and then test the assigned weightings on an independent 
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and external data set. However, as we were aiming to characterise the changes in organ system function induced 
by bolus fluids, rather than aiming to identify the best predictor of outcome (death in the case of FEAST), there 
was no gold standard outcome against which to evaluate the weightings of each variable. The clinical definitions 
of shock listed above include a range of variables, but provide no method for quantifying the severity of 
derangement. We concluded that empiric assignment of weighting for capillary refill time to enable a contribution 
equivalent to that of blood pressure and pulse rate was appropriate. Further evidence on the utility of the score 
could be gained by comparison of the composite score between cohorts, and evaluation of the weightings can be 
achieved in modelling the effect of each variable in survival models (see below).  The composite score we used 
was: 
 
Composite cardiovascular score 
 
Cardiovascular score = (heart rate - mean heart rate for age) + (mean blood pressure for age – blood pressure) + 
25(capillary refill time) 
 
If the heart rate was less than the mean heart rate for age, the term (heart rate - mean heart rate for age) was set to 
zero, so that only increased heart rates contributed to the score. If the blood pressure was greater than the mean 
blood pressure for age, the term (mean blood pressure for age - blood pressure) was set to zero, so that only 
decreased blood pressure contributed to the score. 
 
Developing a composite measure for respiratory function 
Assessment of respiratory function is often achieved by assessment of the adequacy of oxygenation (comparing 
the ratio of inspired oxygen to arterial oxygen in ventilated patients) and of	carbon dioxide excretion. However, 
accurate evaluation of respiratory function is more difficult in patients who are not mechanically ventilated as 
widely differing oxygen concentrations are delivered when using face mask or nasal cannula. Clinical assessment 
of respiratory function in settings other than intensive care units is generally undertaken by observing the rate of 
breathing, respiratory effort and the depth of breathing and by pulse oximetry. Depth of breathing and respiratory 
effort are highly subjective and difficult to quantify but respiratory rate and pulse oximetry are reliably measured 
and were recorded sequentially during the first 48 hours of the FEAST trial.  We reasoned that an overall 
assessment of respiratory function could be made by combining in a composite score, respiratory rate (which rises 
as respiratory function is compromised) with oxygen saturation (which declines) by converting them to the same 
direction of effect. As oxygen saturation declines over a more limited range than the changes in respiratory rate 
and as there may be more clinical significance to a declining oxygen saturation, we weighted contribution of 
declining oxygen saturation in a combined score.  
 
Composite respiratory score 
 
Respiratory score = (respiratory rate - mean respiratory rate for age) + 5(100 - oxygen saturation)  
 
If the respiratory rate was less than the mean respiratory rate for age, the term (respiratory rate - mean respiratory 
rate for age) was set to zero, so that only increased respiratory rates contributed to the score. 
 
Developing a composite measure for raised intracranial pressure and neurological status  	
How to detect raised intracranial pressure (ICP) is the most difficult challenge in evaluating the possible 
mechanisms for increased death in bolus recipients. The only reliable method for detecting raised intracranial 
pressure is by directly inserted intracranial pressure transducer, and there is no established method to detect or 
monitor raised ICP outside an intensive care setting16. Detection of raised ICP using MRI or CT scan is notoriously 
unreliable unless the changes are extremely severe. In practice, suspicion of raised intracranial pressure is raised 
clinically in patients who have declining levels of consciousness and who also show evidence of brainstem 
compression of centers controlling respiration, blood pressure and heart rate. Patients who show paradoxical 
bradycardia, rising blood pressure and declining consciousness or abnormal respiratory patterns (components of 
Cushing’s triad17-19) are considered to have features of raised intracranial pressure and generally managed in 
intensive care units with intracranial monitoring and brain imaging. We postulated that the same clinical variables 
used by clinicians to detect raised intracranial pressure clinically could be combined in a single score combining 
rising blood pressure, falling heart rate and declining consciousness. As with the cardiovascular score, we 
converted the rising blood pressure and falling heart rate to the same direction of effect, and normalized rising 
blood pressure and falling heart rate using age-related means. As coma was measured by the AVPU (awake (A), 
response to voice (V), response to pain (P), unresponsive (U)) scale over a much smaller range than blood pressure 
and heart rate we weighted its contribution in order to capture its contribution to the overall score.   
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FEAST utilised two different coma scores,1 at baseline the Blantyre Coma Score20 was recorded which summates 
three measures of responsiveness: motor (able to localize=2, withdraws from pain=1; unresponsive=0), eye 
movement (follows=1; unresponsive=0), and voice (appropriate response=2, inappropriate or groaning=1, 
unresponsive=0), giving a total score from 0 to 5 which decreases with severity. At later time points the AVPU 
scale was used. In order to contribute to neurological score the AVPU categories were given numerical values 
A=0, V=1, P=2, U=3. In order to enable comparison of baseline with later time points we converted baseline 
Blantyre Coma Score to AVPU as follows: 
 
Blantyre Coma Score AVPU scale Numerical score 
5 A 0 
4 V 1 
3 V 1 
2 P 2 
1 U 3 
0 U 3 
 
We weighted the contribution of AVPU to reflect its expected importance as an indicator of impaired neurological 
function. 
 
Composite neurological score 
 
Neurological score = (blood pressure - mean blood pressure for age) + (mean heart rate for age – heart rate) + 25 
(AVPU score).  
 
If the blood pressure was lower than the mean blood pressure for age, the term (blood pressure - mean blood 
pressure for age) was set to zero, so that only increased blood pressure contributed to the score. If the heart rate 
was greater than the mean heart rate for age, the term (mean heart rate for age - heart rate) was set to zero, so that 
only decreased heart rates contributed to the score.  
 
Clustering algorithm 
Individuals were clustered using their physiological scores and haemoglobin and lactate measures at baseline. 
Treatment and outcome were not included in the clustering. Clustering was implemented using a Bayesian 
multivariate normal mixture of Dirichlet process (MDP) model as implemented in the R package PreMiuM.21,22 
In our implementation each cluster in the mixture is a multivariate normal distribution representing the distribution 
of the measures within the cluster. An advantage of a MDP model is that the number of clusters is unknown and 
inferred from the data and inference is made by sampling from the posterior distribution using Markov chain 
Monte Carlo (MCMC). PreMiuM calculates an optimum single clustering and assignment of individuals to the 
clusters from the posterior samples it simulates; firstly it calculates a similarity matrix between all pairs of 
individuals based on the posterior mean of the number of times each pair is assigned to the same cluster. 
Individuals are then robustly assigned to clusters in a way consistent with the similarity matrix for all possible 
number of clusters. The optimal number of clusters is determined by the partition which maximises the average 
silhouette width. We used the single optimal clusters and assignments in all subsequent analyses. The optimal 
number of clusters determined by the algorithm is driven by the prior distribution assigned to the within cluster 
covariance; the more prior weight assigned to larger variances the fewer the clusters as more variation is allowed 
within each cluster. The default settings of the program resulted in eight clusters, increasing the prior within cluster 
variance by a factor of ten relative to the default values resulted in three clusters which we deemed to be more 
interpretable and therefore used in subsequent analyses. 
 
Principal component analysis 
Principal component analysis (PCA) was performed on the matrix of respiratory, neurological and cardiovascular 
scores at one hour and baseline base excess, bicarbonate, chloride and haemoglobin in the no bolus group; in the 
bolus group, to account for changes in the blood parameters which were not measured at one hour, values were 
adjusted by the observed mean shifts at 24 hours in biochemical variables (base excess -1.41, bicarbonate -0.96, 
chloride +1.65) and at 8 hours for haemoglobin (-0.32). This represents a conservative estimate of the change in 
these variables in the bolus group at one hour. Data was standardized such that all covariates had mean zero and 
standard deviation of one before PCA. Only samples with complete measures for all seven covariates were used, 
n=1901. The principal component loadings are weights representing the contribution of each of the seven 




 V = XT U D-1/2 
where V are the PC loadings, X is the data matrix, U is the matrix of PCs and D is the diagonal matrix of 
eigenvalues. 
 
Evaluation of the effect of bolus-induced changes in blood parameters on survival 
 
Evaluation of changes in plasma chemistry and acid-base balance due to bolus 
Acid-base balance and plasma chemistry were only measured on admission (before bolus fluids were 
administered) and again 24 hours later. We therefore had no data on the actual values for plasma chemistry and 
acid-base status in the early hours of the trial when most of the deaths were occurring. Furthermore by 24 hours, 
when the second measurement of plasma biochemistry was undertaken, the majority of deaths in the study had 
already occurred. Therefore we used two approaches to estimate the likely biochemical and acid-base status 
immediately after bolus-administration. First we used the difference in these parameters between surviving bolus 
and no bolus recipients at 24 hours to calculate a conservative estimate of the change in these parameters 
immediately after bolus administration. Second we used a literature-based estimate of the likely magnitude of 
change due to albumin or saline bolus.  
Supporting the first approach, as shown in webextra Figure 10, baseline levels of bicarbonate, chloride and base 
excess were highly correlated with the levels at 24 hours in surviving patients. However, as shown in webextra 
Figure 11, patients with more severe derangement of base excess, bicarbonate and chloride at baseline had a 
greater change between 0 and 24 hours than those with less derangement. We concluded that the linear 
interpolation of the earlier time points from the 24 hour data was likely to significantly under estimate the change 
at the earlier time point.	Examination of the 24 hour blood sample results (Table 1 in the main manuscript) showed 
clear evidence of worse hyperchloraemic acidosis in bolus recipients, who had significantly lower plasma 
bicarbonate and increased base excess and chloride as compared to the no bolus controls. As increased base excess 
was a strong predictor of death and those patients who went on to die had lower base excess and bicarbonate at 
baseline than survivors, the 24 hour values available were likely to significantly underestimate the extent of bolus-
induced acidosis due to the higher death rate in bolus recipients by 24 hours. 
 
In order to estimate the bolus-induced changes at early time points we first used linear interpolation to estimate 
the one hour value for base excess, chloride and bicarbonate based on the levels observed at baseline and 24 hours 
in the bolus and no bolus arms and a linear change in the levels from 1 to 24 hours:  
 
Imputation of base excess (be) at 1 hour 
 
be(1hr) = be(baseline) + slope + I(bolus) x ( be(24hrs, bolus arm) - be(24hrs, no bolus arm) ) 
where: 
slope = ( be(24hrs, no bolus arm) - be(baseline, no bolus arm) ) / 24 
I(bolus) = 1 for bolus sample and 0 otherwise 
 
Chloride and bicarbonate were imputed similarly.		
Haemoglobin was imputed using the values at 8 hours rather than 24 hours, in subjects who had not received 
blood transfusion. 
 
Because the first approach is likely to underestimate the effects of albumin and saline on biochemical and acid-
base status we also sought evidence from published studies to establish what changes should be expected at one 
hour after bolus. There is an extensive literature dating from the 1990s reporting hyperchloraemic acidosis 
occurring in recipients of normal saline or other high chloride containing solutions or comparing these solutions 
with buffered salt solutions (web extra Table 8). These studies include administration of crystalloids to healthy 
volunteers; administration of crystalloid solutions to patients undergoing a range of surgical conditions including 
both adults and children and ranging from gynaecological procedures, general surgical procedures, renal surgery 
and cardiac surgery; and studies in experimental animals. These studies establish that administration of normal 
saline and other high chloride containing fluids is invariably followed by hypochloraemic acidosis with a rise in 
chloride, decline in plasma bicarbonate and decrease in base excess occurring concurrently with the infusion and 
maximal immediately after the infusion. While the extensive literature has used a range of different infusion rates 
and volumes, those studies which have had comparable fluid volumes and rates to the 20-40 ml/kg infused during 
FEAST have shown decrease in base excess of approximately 5 mmol/l, a decline in bicarbonate of approximately 
5 mmol/l and an increase in chloride of approximately 10 mmol/l in recipients of high chloride containing fluids. 
We therefore concluded there is strong evidence from the literature and our own data that the changes we have 
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detected in bolus recipients at the 24 hour time points are a minimum estimate of a predictable change induced by 
saline and albumin at earlier time points.   
In order to provide a more realistic estimate based on the factors discussed above, we also estimated the 1 hour 
values for base excess, bicarbonate and chloride based on the reported changes after saline infusion in the many 
studies reported and summarised in web extra Table 8. We used the changes reported in those studies most 
similar to FEAST in the volume and timing of infusion.  





Data estimate in 
bolus recipients 
Literature estimate in 
bolus recipients 
Base excess mEq/L +0·217 -1·025 -5 
Chloride mmol/L +0·011 +1·577 +10 
Bicarbonate mmol/L +0·194 -0·66 -5 
Haemoglobin g/L +0.03 -0.339 NA 
(-0.339*) 
 
*The change in haemoglobin was derived only from data, and not from literature values, because measurements 
were available at 8 hours. 
 
Cox proportional hazards regression modelling 
To explore whether the changes induced by bolus at one hour could explain the adverse effect of bolus we built 
Cox proportional hazards survival models with the outcome as time of death. The baseline model contained only 
bolus as a covariate, covariates were added iteratively, and at each iteration the covariate with the smallest p-
value for association with time of death in the multivariate survival model was added, until all covariates were 
added. In addition to a model using baseline variables, four sets of explanatory covariates representing the one 
hour time point were considered. 
 
Covariate set 1 
The first set of covariates contained the three scores at 1 hour and imputed levels for base excess, chloride, 
bicarbonate and haemoglobin based on the levels observed at baseline and 24 hours in the bolus and no bolus 
arms and a linear change in the levels from 1 to 24 hours.  
 
Covariate set 2 
In this set of covariates we used the scores and haemoglobin estimate as in covariate set 1 and imputed levels for 
base excess, chloride and bicarbonate in the bolus arm based on estimates of the effects of bolus on these blood 
parameters derived from published articles. 
 
Estimates in the no bolus arm were the same as those used in covariate set 1. 
 
Covariate set 3 
The third set of covariates contained the individual components of the score and the imputed blood levels used 
in covariate set 1. The individual components of the score were respiratory rate above the norm for age, systolic 
blood pressure above and below the norm for age and heart rate above and below the norm for age. 
 
Covariate set 4 
Individual components of the score as used in covariate set 3 and the literature based estimates of the effects of 
bolus on the blood markers as used in covariate set 2. 
 
The above models were refit including bolus as an additional explanatory covariate to calculate the hazard ratio 








Web extra Figure 1. Physiological scores associated with aetiology and severity of illness across cohorts 
and sequential changes over time in FEAST 
Respiratory (A), neurological (B) and cardiovascular (C) scores in FEAST and 4 other cohorts (Men, UK 
Meningococcal cohort; ML, Malawian cerebral malaria cohort; SA, South African sepsis cohort; SMH, St 
Mary’s Hospital emergency department cohort). D-F show sequential changes in the FEAST cohort in 
respiratory (D), neurological score (E) and cardiovascular (F) scores at time points from admission baseline to 
48 hours. Survivors are shown in red, cases dying in the next time period are shown in blue. Boxes show median 









Web extra Figure 2. Change in physiological scores from baseline to 4 hours.  
The proportion of individuals in FEAST with different magnitudes of change in physiological scores from baseline 
to four hours, compared between those randomized to no bolus (red bars) or bolus (blue bars). Negative values 
indicate decrease from the baseline, and positive values indicate increase from baseline. Values above bars show 






Web extra Figure 3. Distribution of physiological scores and blood parameters at first observation after 
randomization in FEAST.  
Comparison of the proportion of individuals in FEAST with indicated values of physiological scores and blood 
measurements at the next observation after initiation of fluid bolus (blue) or no fluid bolus (red). A-C show 
physiological scores at 1 hour. D-F show biochemical measures at 24 hours. G and H show haemoglobin 
concentration at 8 hours in non-transfused (G) and transfused (H) subjects. Values above bars show relative risk 







Web extra Figure 4. Distribution of physiological scores at 4 hours in FEAST. 
Comparison of physiological scores at 4 hours after initiation of fluid bolus (blue) or no fluid bolus (red). Values 






Web extra Figure 5. Distribution of physiological scores and blood parameters associated with volume of 
fluid bolus administered in FEAST. 
The proportion of individuals in FEAST with indicated values of physiological scores and blood measurements 
at the next observation after completion of bolus fluids in all groups, in those who received high volume bolus ( 
≥30ml/kg, green bars), low volume bolus (<30ml/kg, blue bars), or no bolus (red bars). A-C show physiological 
scores at 4 hours after bolus initiation. D-F show biochemical measures 24 hours after bolus initiation. G-H show 
haemoglobin concentration 8 hours after bolus initiation in non-transfused (G) and transfused (H) subjects. Values 
above bars show relative risks (95% CI) for comparison of proportions between low volume or high volume bolus 








Web extra Figure 6. Changes from baseline to next observation for physiological scores and blood measures 
according to volume of fluid bolus received in FEAST. 
Comparison of the proportion of individuals in FEAST with different magnitudes of change in physiological 
scores and blood measurements according to whether they received high volume bolus (≥30ml/kg, green bars), 
low volume bolus (<30ml/kg, blue bars) or no bolus (red bars). A-C show changes in physiological scores between 
0 and 4 hours. D-F show changes in biochemical measures from baseline to 24 hours. G and H show change in 
haemoglobin from baseline to 8 hours in non-transfused (G) and transfused (H) subjects. The change from baseline 
is shown for each segment of the distribution. Negative values indicate decrease from the baseline, and positive 
values indicate increase from baseline. Values above bars show relative risks (95% CI) for comparison of 






Web extra Figure 7. Hyperchloraemic acidosis in FEAST. 
A shows distribution of pH at baseline in FEAST subjects according to whether they were randomized to no 
fluid bolus (red bars) or fluid bolus (blue bars). B shows survival in FEAST by baseline pH (black line, pH 
≥7·35; red line pH <7·35; dotted lines 95% CI; Cox proportional hazards model with random effects for site; 
n=2082, 195 total events, p<0·0001). C shows proportion of individuals with indicated values of pH at 24 hours 
for no fluid bolus (red bars) or fluid bolus groups (blue bars). D shows correlation between chloride 
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concentration at 24 hours and pH at 24 hours shown by whether subjects were randomized to no fluid bolus (red 
dots and regression line, Pearson r=-0·28 (95% CI -0·38 to -0·17), p<0·0001) or fluid bolus (blue dots and 
regression line, Pearson r=-0·41 (95%CI -0·47 to -0·33), p<0.0001); p=0.05 for comparison of correlation 
coefficients using the z-test. E shows baseline respiratory rate and F the respiratory rate above mean for age. G-
H show the proportion of individuals with different magnitudes of change from baseline to one hour in oxygen 
saturation (G) and respiratory rate (H) according to whether they were randomized to no fluid bolus (red bars) or 
fluid bolus (blue bars). Values above bars show relative risks (95% CI) for comparison of proportions between 







Web extra Figure 8. Biochemical measurements in clusters within FEAST. 
Comparison of the distributions of baseline biochemical measurements by cluster within FEAST. Boxes show 





Web extra Figure 9. Principle component plot using physiological scores and blood parameters.		
Principal component (PC) analysis using the respiratory, neurological and cardiovascular scores at 1 hour after 
bolus, and conservative (data-derived) estimates of haemoglobin and biochemical values at 1 hour based on 
their values at 8 and 24 hours respectively (light red, no bolus, survivors; large dark red, no bolus, fatal cases; 
light blue, bolus, survivors; large dark blue, bolus, fatal cases). The principal component loadings (arrows) 
indicate the contributions of increasing values of each variable.	Analysis is based on 1898 subjects with 





Web extra Figure 10. Imputation of blood parameters based on relationships between baseline and 24 
hour values.	
Relationships between baseline values and those at next measurement for base excess, chloride and bicarbonate 
(all 24 hours) and haemoglobin (8 hours) (first column of panels). Distribution of blood parameter values in 
subjects who died and those who survived at baseline, imputed from data at 1 hour, and at next measurement 
(second column of panels; NB (red), no bolus; B (blue), bolus; boxes show median and IQR; whiskers extend up 
to 1·5-times IQR). Illustration of imputation of values in bolus group based on difference in values between 
baseline and next measurement in no bolus group, and difference between bolus and no bolus groups at the 





Web extra Figure 11. Relationship between baseline values and change at 24 hours for biochemical 
parameters.  
Relationships between values at baseline and change from baseline to 24 hours for blood base excess, 







Web extra Tables  
 
Web extra Table 1. Numbers (%) of surviving subjects at each time point in FEAST Stratum A	
with available data for each variable. 
	
 Baseline 1 hour 4 hours 8 hours 24 hours 48 hours 
Surviving 3141 3102 3025 2974 2882 2844 
Systolic blood 
pressure 
3100 (99) 3037 (98) 2975 (98) 2923 (98) 2830 (98) 2772 (97) 
Capillary refill 
time 
3137 (100) 3078 (99) 3004 (99) 2950 (99) 2854 (99) 2787 (98) 
Conscious 
level 
3123 (99) 3069 (99) 2998 (99) 2943 (99) 2847 (99) 2776 (98) 
Oxygen 
saturation 
3038 (97) 3030 (98) 2979 (98) 2930 (99) 2834 (98) 2772 (97) 
Heart rate 3141 (100) 3077 (99) 3002 (99) 2950 (99) 2853 (99) 2786 (98) 
Respiratory 
rate 
3124 (99) 3056 (99) 2997 (99) 2945 (99) 2845 (99) 2778 (98) 
Respiratory 
score 
3022 (96) 3008 (97) 2974 (98) 2925 (98) 2826 (98) 2763 (97) 
Cardiovascular 
score 
3096 (99) 3037 (98) 2975 (98) 2923 (98) 2829 (98) 2772 (97) 
Neurological 
score 
3082 (98) 3028 (98) 2969 (98) 2917 (98) 2822 (98) 2762 (97) 
Hemoglobin 3054 (97) 0 (0) 0 (0) 2785 (94) 2744 (95) 0 (0) 
Base excess 2070 (66) 0 (0) 0 (0) 0 (0) 914 (32) 0 (0) 
Bicarbonate 2080 (66) 0 (0) 0 (0) 0 (0) 912 (32) 0 (0) 



















Web extra Table 2. Associations between physiological scores and outcome* in FEAST and 4 
other cohorts.  
	
 
*Outcomes were defined as death in FEAST and the Meningococcal cohorts, death or neurological disability in the Malawian 
cohort, admission to intensive care in the South African cohort and admission to hospital or intensive care in the SMH 
emergency department cohorts. n, number of subjects with complete data available to calculate each score at baseline. 
  
Cohort n (% all 
subjects) 
Odds ratio for outcome per 10-unit 
increase in score 
95% CI P value 
Respiratory score 
FEAST 3037 (96) 1·09 (1·07, 1·11) <0·0001 
Malawi 357 (80) 1·04 (0·99, 1·1) 0·13 
South Africa 61 (100) 1·2 (0·97, 1·47) 0·089 
Meningococcal  363 (72) 1·32 (1·19, 1·45) <0·0001 
SMH 13934 (74) 1·6 (1·54, 1.66) <0·0001 
Neurology score 
FEAST 3096 (98) 1·26 (1·21, 1·31) <0·0001 
Malawi 411 (92) 1·24 (1·08, 1·43) 0·0030 
South Africa 61 (100) 1·6 (1·2, 2·14) 0·0010 
Meningococcal  399 (79) 1·04 (0·99, 1·09) 0·16 
SMH 2414 (13) 1·07 (0·97, 1·19) 0·16 
Cardiovascular score 
FEAST 3110 (98) 1·09 (1·05, 1·14) <0·0001 
Malawi 411 (92) 1·19 (1·1, 1·28) <0·0001 
South Africa 61 (100) 1·04 (0·88, 1·22) 0·66 
Meningococcal  333 (66) 1·08 (1·04, 1·12) <0·0001 




































































































































































































































































































































































































































































































































































































































































































































































































































































































Web extra Table 4. Association between changes in variables and risk of death in clusters within 
FEAST. 
	
Group n OR 95% CI p 
Respiratory score 
FEAST 3037 1·09 1·07,1·11 <0·0001 
Cluster 1 1967 1.00 0·90,1·11 0·98 
Cluster 2 717 1·07 1,1·14 0·040 
Cluster 3 353 1·03 1,1·06 0·020 
Neurology score 
FEAST 3096 1·26 1·21,1·31 <0·0001 
Cluster 1 1955 1·41 1·26,1·57 <0·0001 
Cluster 2 772 1·30 1·2,1·41 <0·0001 
Cluster 3 369 1·06 1·01,1·12 0·020 
Cardiovascular score 
FEAST 3110 1·09 1·05,1·14 <0·0001 
Cluster 1 1963 0·97 0·88,1·08 0·60 
Cluster 2 777 1·05 0·98,1·12 0·16 
Cluster 3 370 1·03 0·96,1·11 0·43 
Haemoglobin (g/dL) 
FEAST 3082 0·88 0·85,0·91 <0·0001 
Cluster 1 1929 1.00 0·91,1·1 0·97 
Cluster 2 780 1·11 1·01,1·22 0·030 
Cluster 3 373 0·91 0·85,0·98 0·008 
Lactate (mmol/L) 
FEAST 3009 1·23 1·2,1·26 <0·0001 
Cluster 1 1888 1·30 1·08,1·57 0·0060 
Cluster 2 768 1·15 1·08,1·22 <0·0001 
Cluster 3 353 1·15 1·09,1·22 <0·0001 
OR, odds ratio for death for each ten-unit increase in the physiological scores and each unit increase in 




Web extra Table 5. Changes in physiological scores and blood parameters associated with fluid 
bolus in FEAST Cluster 1. 
 
Time (Hours) n Effect size 95% CI  p 
Respiratory score 
1 1934 2·67 0·35, 4·99 0·020 
4 1935 1·54 -0·50, 3·57 0·14 
12  1916  0·87 -0·93, 2·67 0·34 
Neurology score 
1 1926 3·42 1·38, 5·46 0·0010 
4 1927 1·49 -0·47, 3·44 0· 13 
12 1906  -0·14 -1·92, 1·64 0·87 
Cardiovascular score 
1 1937 -1·72 -3·57, 0·14 0·070 
4 1933 0·55 -1·37, 2·47 0·57 
12 1915 0·66 1·24, 2·57 0·50 
Haemoglobin (g/dL) 
8 1837 -0·35 -0·49-0·20 <0·0001 
24 1818 -0·19 0·34, -0·035 0·020 
Lactate (mmol/L) 
8 1806 -0·16 -0·39, 0·064 0· 15 
24 1776 -0·070 -0·30, 0·16 0·50 
Base excess (mEql/L) 
24 590 -1·34 -2·03, -0·64 0·0002 
Bicarbonate (mmol/L) 
24 592 -0·90 -1·44, -0·36 0·0012 
Chloride (mmol/L) 
24 575 1·99 0·46, 3·52 0·0010 
 
*Effect size is the mean change in the variable attributable to bolus. Positive effect size indicates increase 





Web extra Table 6. Changes in physiological scores and blood parameters associated with fluid 
bolus in FEAST Cluster 2.  
 
Time (Hours) n Effect size 95% CI  p 
Respiratory score 
1 676 5·11 -0·37, 10·6 0·06 
4 655 3·8 0·038, 7·6 0·040 
12  634 1·1 -2·79, 5·02 0·50 
Neurology score 
1 730 4·32 0·41, 8·22 0·030 
4 698 1·19  -2·48, 4·86 0· 15 
12 676 0·57 -3·01, 4·16 0·70 
Cardiac score 
1 737 -1·75 -5·24, 1·75 0·32 
4 706 -0·65 -4·08, 2·78 0·71 
12 683 -0·33 -3·87, 3·21 0·85 
Haemoglobin (g/dL) 
8 646 -0·16 -0·45, 0·13 0·27 
24 628 -0·091 -0·38, 0·2 0·54 
Lactate (mmol/L) 
8 654 -0·041 -0·58, 0·50 0· 88 
24 616 0·030 -0·42, 0·48 0·90 
Base excess (mEql/L) 
24 182 -1·34 -3·46, -0·021 0·050 
Bicarbonate (mmol/L) 
24 180 -1·74 -2·62, 0·082 0·070 
Chloride (mmol/L) 
24 180 2·87 0·73, 5·02 0·0090 
 
*Effect size is the mean change in the variable attributable to bolus. Positive effect size indicates increase 
in parameter, negative effect size indicates decrease, as compared with no bolus control.  
27 
	
Web extra Table 7. Changes in physiological scores and blood parameters associated with fluid 
bolus in FEAST Cluster 3. 
	
Time (Hours) n Effect size 95% CI p 
Respiratory score 
1 315 3·44 -10·9, 17·8 0· 63 
4 294 3·69 -7·65, 15 0· 52 
12 288 7·13 -3·86, 18·1 0·20 
Neurology score 
1 336 -5·19 -12·9, 2·55 0·19 
4 308 -1·32 -8·46, 5·83 0· 71 
12 299 2·98 -3·79, 9·76 0·38 
Cardiac score 
1 336 -4·84 -10·2, 0·56 0·08 
4 309 -4·23 -10·1, 1·6 0·15 
12 299 -2·06 -7·8, 3·68 0·48 
Haemoglobin (g/dL) 
8 288 -0·52 -0·92, -0·12 0·010 
24 277 -0·59 -1·02, -0·16 0·008 
Lactate (mmol/L) 
8 277 0·0022 -0·75, 0·76 0· 99 
24 265 0·30 -0·40, 1.00 0·40 
Base excess (mEql/L) 
24 85 -1·09  -3·68, 1·5 0·41 
Bicarbonate (mmol/L) 
24 86 -0·69 -2·69, 1·32 0·50 
Chloride (mmol/L) 
24 85 -3·04 -5·94, -0·15 0·040 
*Effect size is the mean change in the variable attributable to bolus. Positive effect size indicates increase 
in parameter, negative effect size indicates decrease, as compared with no bolus control.  









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   






















































































































































































































































































































































































































































































































































































































































































































































































































































Web extra Table 9. Cox proportional hazard regression models for time of death.  
 
Covariate Coefficient p 
Model using values at baseline with composite physiological scores 
Bolus – literature derived estimates 0·50 0·011 
Neurological score 0·015 <0·0001 
Respiratory score 0·0019 0·075 
Base excess -0·024 0·34 
Bicarbonate -0·097 0·0065 
Chloride 0·019 0·095 
Haemoglobin -0·015 0·62 
Cardiovascular score 0·00093 0·77 
Model using values at 1 hour with composite physiological scores (covariate sets 1 & 2) 
Bolus – data derived estimates 0·17 0·42 
Bolus – literature derived estimates -0·37 0·15 
Neurological score 0·026 <0·0001 
Respiratory score 0·0082 <0·0001 
Base excess -0·029 0·25 
Bicarbonate -0·067 0·068 
Chloride 0·016 0·25 
Haemoglobin 0·020 0·50 
Cardiovascular score -0·00086 0·79 
Model using values at 1 hour with component physiological variables (covariate sets 3 & 4) 
Bolus – data derived estimates 0·22 0·30 
Bolus – literature derived estimates -0·33 0·20 
Heart rate - down 0·039 <0·0001 
Base excess -0·027 0·28 
AVPU 0·75 <0·0001 
O2 saturation -0·041 <0·0001 
SBP - up 0·021 <0·0001 
Bicarbonate -0·066 0·066 
SBP - down 0·026 0·092 
Chloride 0·018 0·18 
Respiratory rate - up 0·0066 0·25 
Haemoglobin 0·034 0·27 
Heart rate - up -0·0025 0·59 
Capillary refill time 0·019 0·88 
	
Cox-proportional hazards regression coefficients and p-values for association with time of death in a 
multivariate model with all listed covariates included. Coefficients and p-values for all covariates in 
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Background
The role of fluid resuscitation in the treatment of children with shock and life-
threatening infections who live in resource-limited settings is not established.
Methods
We randomly assigned children with severe febrile illness and impaired perfusion to 
receive boluses of 20 to 40 ml of 5% albumin solution (albumin-bolus group) or 0.9% 
saline solution (saline-bolus group) per kilogram of body weight or no bolus (control 
group) at the time of admission to a hospital in Uganda, Kenya, or Tanzania (stratum 
A); children with severe hypotension were randomly assigned to one of the bolus groups 
only (stratum B). All children received appropriate antimicrobial treatment, intravenous 
maintenance fluids, and supportive care, according to guidelines. Children with mal-
nutrition or gastroenteritis were excluded. The primary end point was 48-hour mor-
tality; secondary end points included pulmonary edema, increased intracranial 
pressure, and mortality or neurologic sequelae at 4 weeks.
Results
The data and safety monitoring committee recommended halting recruitment after 
3141 of the projected 3600 children in stratum A were enrolled. Malaria status (57% 
overall) and clinical severity were similar across groups. The 48-hour mortality was 
10.6% (111 of 1050 children), 10.5% (110 of 1047 children), and 7.3% (76 of 1044 
children) in the albumin-bolus, saline-bolus, and control groups, respectively (rela-
tive risk for saline bolus vs. control, 1.44; 95% confidence interval [CI], 1.09 to 1.90; 
P = 0.01; relative risk for albumin bolus vs. saline bolus, 1.01; 95% CI, 0.78 to 1.29; 
P = 0.96; and relative risk for any bolus vs. control, 1.45; 95% CI, 1.13 to 1.86; P = 0.003). 
The 4-week mortality was 12.2%, 12.0%, and 8.7% in the three groups, respectively 
(P = 0.004 for the comparison of bolus with control). Neurologic sequelae occurred 
in 2.2%, 1.9%, and 2.0% of the children in the respective groups (P = 0.92), and 
pulmonary edema or increased intracranial pressure occurred in 2.6%, 2.2%, and 1.7% 
(P = 0.17), respectively. In stratum B, 69% of the children (9 of 13) in the albumin-
bolus group and 56% (9 of 16) in the saline-bolus group died (P = 0.45). The results 
were consistent across centers and across subgroups according to the severity of 
shock and status with respect to malaria, coma, sepsis, acidosis, and severe anemia.
Conclusions
Fluid boluses significantly increased 48-hour mortality in critically ill children with 
impaired perfusion in these resource-limited settings in Africa. (Funded by the Med-
ical Research Council, United Kingdom; FEAST Current Controlled Trials number, 
ISRCTN69856593.)
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Rapid, early fluid resuscitation in patients with shock, a therapy that is aimed at the correction of hemodynamic abnor-
malities, is one component of goal-driven emer-
gency care guidelines. This approach is widely 
endorsed by pediatric life-support training pro-
grams, which recommend the administration of 
up to 60 ml of isotonic fluid per kilogram of body 
weight within 15 minutes after the diagnosis of 
shock.1 Children who do not have an adequate 
response to fluid resuscitation require intensive 
care for inotropic and ventilatory support.1 Sub-
stantial improvements in the outcomes of pediat-
ric septic shock have been attributed to this ap-
proach.2,3 Nevertheless, evidence regarding the 
criteria for intervention and the volume and type 
of fluid is lacking.4,5
In hospitals with poor resources in sub-Saharan 
Africa, in which intensive care facilities are rarely 
available, child-survival programs have largely 
ignored the role of triage and emergency care,6 
despite evidence of their cost-effectiveness.7,8 
Malaria, sepsis, and other infectious conditions 
cause major health burdens for children in sub-
Saharan Africa9,10 and are associated with high 
early mortality.11 Hypovolemic shock (a term in-
corporating all degrees of impaired perfusion) is 
common and increases mortality substantially.12-15 
However, World Health Organization guidelines16 
recommend reserving the practice of fluid resus-
citation for children with advanced shock (char-
acterized by a delayed capillary refill time of 
more than 3 seconds, weak and fast pulse, and 
cold extremities); consequently, it is not widely 
practiced. Most children in hospitals in sub-Saha-
ran Africa receive no specific fluid management 
apart from blood transfusion for severe anemia17 
or maintenance fluids.
The Fluid Expansion as Supportive Therapy 
(FEAST) study was designed to investigate the 
practice of early resuscitation with a saline bolus 
as compared with no bolus (control) and with an 
albumin bolus as compared with a saline bolus.
Me thods
Design and Treatment Protocol
We conducted this two-stratum, multicenter, 
open, randomized, controlled study in six clini-
cal centers in Kenya (one center), Tanzania (one 
center), and Uganda (four centers). In stratum A, 
we enrolled children without severe hypotension; 
children with severe hypotension (systolic blood 
pressure of <50 mm Hg in children younger than 
12 months of age, <60 mm Hg in children 1 to 
5 years of age, and <70 mm Hg in children older 
than 5 years of age) were enrolled in stratum B. 
In stratum A, eligible children were randomly as-
signed, in a 1:1:1 ratio, to rapid volume expan-
sion over the course of 1 hour with 20 ml of 
intravenous 0.9% saline solution per kilogram 
(saline-bolus group), 20 ml of 5% human-albu-
min solution per kilogram (albumin-bolus group), 
or no bolus (control group). Children in stratum B 
were randomly assigned to receive 40 ml of albu-
min bolus or saline bolus per kilogram. In both 
strata, the saline-bolus and albumin-bolus groups, 
but not the control group, received an additional 
20 ml of bolus solution per kilogram at 1 hour if 
impaired perfusion (see below) persisted. If se-
vere hypotension developed, the child was treated 
with 40-ml boluses of study fluid per kilogram 
(saline in the case of the control group); no cross-
over between bolus groups was permitted. Bolus 
volumes and rates were conservative relative to 
U.S. and European guidelines1 because we were 
concerned about the potential risk of pulmonary 
edema developing in children who were being 
treated in settings that lacked intensive care facili-
ties. The initial boluses were increased to 40 ml 
per kilogram (60 ml per kilogram in stratum B) 
after a protocol amendment in June 2010. The 
study protocol and a detailed description of study 
methods are available with the full text of this 
article at NEJM.org.
Study Oversight
The ethics committees at Imperial College, Lon-
don, Makerere University, Uganda, Medical Re-
search Institute, Kenya, and National Medical 
Research Institute, Tanzania, approved the pro-
tocol. In cases in which prior written consent 
from parents or guardians could not be obtained, 
provision was made for oral assent from a legal 
surrogate, followed by delayed written informed 
consent as soon as practicable.
An independent data and safety monitoring 
committee reviewed the interim analyses from 
the study twice a year. The Haybittle–Peto crite-
rion18 was the statistical guide that the commit-
tee used in considering a recommendation to stop 
or modify the trial. At the fifth interim review 
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of data on January 12, 2011, with data available 
from 2995 children, the independent data and 
safety monitoring committee recommended stop-
ping enrollment owing to safety concerns in the 
saline-bolus and albumin-bolus groups and be-
cause it was very unlikely that superiority of the 
bolus strategy over the control strategy would be 
shown.
Role of the Funding Sources
The study was funded by the Medical Research 
Council, United Kingdom; Baxter Healthcare do-
nated the 5% albumin and 0.9% saline solutions. 
Neither of those bodies, nor Imperial College, 
London, which held the legal responsibility for 
the trial, had any role in the design of the study, 
the collection, analysis, or interpretation of the 
data, or the writing of the manuscript. The cor-
responding author had full access to all trial data 
and assumes final responsibility for the decision 
to submit the manuscript for publication.
Study Population
Children were eligible for inclusion in the study 
if they were between 60 days and 12 years of age 
and presented with a severe febrile illness com-
plicated by impaired consciousness (prostration 
or coma), respiratory distress (increased work of 
breathing), or both, and with impaired perfusion, 
as evidenced by one or more of the following: 
a capillary refill time of 3 or more seconds, lower-
limb temperature gradient,19 weak radial-pulse 
volume, or severe tachycardia (>180 beats per 
minute in children younger than 12 months of 
age, >160 beats per minute in children 1 to 5 years 
of age, or >140 beats per minute in children older 
than 5 years of age) (Fig. 1). Exclusion criteria 
were severe malnutrition, gastroenteritis, non-
infectious causes of shock (e.g., trauma, surgery, 
or burns), and conditions for which volume ex-
pansion is contraindicated.
End Points
The primary end point was mortality at 48 hours 
after randomization. Secondary end points were 
mortality at 4 weeks, neurologic sequelae at 4 and 
24 weeks, episodes of hypotensive shock within 
48 hours after randomization, and adverse events 
potentially related to fluid resuscitation (pulmo-
nary edema, increased intracranial pressure, and 
severe allergic reaction). An end-point review 
committee, whose members were unaware of the 
treatment assignments, reviewed all deaths, neu-
rologic sequelae, and adverse events.
Randomization
Randomization was performed in permuted blocks 
of random sizes and was stratified according to 
clinical center. The trial statistician at the Medical 
Research Council Clinical Trials Unit, London, 
generated and kept all the randomization sched-
ules. The schedule for each center contained a 
list of trial numbers and the randomly assigned 
intervention. Trial numbers were kept inside 
opaque, sealed envelopes, which were numbered 
consecutively and opened in numerical order by a 
study clinician.
Study Procedures
Children were treated on general pediatric wards; 
assisted ventilation other than short-term bag-
and-mask support was unavailable. Training in 
triage and emergency pediatric life support was 
given to participating providers throughout the 
trial to optimize case recognition, supportive 
management, and adherence to the protocol. Ba-
sic infrastructural support was provided for emer-
gency care and for the monitoring of patients’ 
oxygen saturation and blood pressure, which was 
measured with the use of an automated blood-
pressure monitor. Children received intravenous 
maintenance fluids (2.5 to 4.0 ml per kilogram 
per hour); antibiotics; antimalarial, antipyretic, 
and anticonvulsant drugs; treatment for hypogly-
cemia (if the blood glucose was <2.5 mmol per 
liter [45 mg per deciliter]); and transfusion with 
20 ml of whole blood per kilogram over the course 
of 4 hours if the hemoglobin level was less than 
5 g per deciliter, according to national guidelines.
A structured clinical case-report form was 
completed at admission and at 1, 4, 8, 24, and 
48 hours. Hypovolemia, neurologic and cardio-
respiratory status, and adverse events — particu-
larly suspected pulmonary edema, increased in-
tracranial pressure, and allergic reaction — were 
recorded. Adverse events were reported to the 
Clinical Trials Facility in Kilifi, Kenya, within 
2 days and were verified against source docu-
ments by visiting monitors. At 4 weeks, assess-
ments of neurologic sequelae were performed, 
and these were reviewed by an independent cli-
nician, who was unaware of the treatment as-
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3170 Were enrolled
7838 Patients were assessed for eligibility
4668 Were excluded
2634 Did not meet inclusion criteria
1283 Met exclusion criteria
293 Declined to participate
458 Had other reasons
29 With severe hypotension were
randomly assigned within stratum B
13 Were assigned to the
albumin-bolus group
13 Received bolus
16 Were assigned to the
saline-bolus group
16 Received bolus





4 Died before inter-
vention
1044 Were assigned to  
the control (no
bolus) group 
1 Received bolus of
saline
3141 Were randomly assigned
within stratum A





4 Died before inter-
vention
1 Did not fulfill eligibility
criteria
7 Were lost to follow-up
by 48 hr
2 Withdrew
5 Were taken from
hospital (and 48-hr
status unknown)
27 Were lost to follow-up
by 28 days
6 Withdrew
5 Were taken from 
hospital




2 Did not fulfill eligibility
criteria
8 Were lost to follow-up
by 48 hr
3 Withdrew
5 Were taken from
hospital (and 48-hr
status unknown)
23 Were lost to follow-up
by 28 days
4 Withdrew
5 Were taken from 
hospital
14 Could not be 
located
2 Were lost to follow-up
by 48 hr
1 Withdrew
1 Was taken from
hospital (and 48-hr
status unknown)
20 Were lost to follow-up
by 28 days
4 Withdrew
3 Were taken from 
hospital






Figure 1. Screening, Randomization, and Follow-up.
Of the 4668 children excluded after initial assessment for eligibility, 2634 with severe illness did not meet the inclusion criteria because 
they did not have at least one of the following: impaired perfusion, impaired consciousness, fever, or respiratory distress. A total of 1283 
children met exclusion criteria because they had evidence of severe acute malnutrition, defined as visible severe wasting or kwashiorkor 
(254 children); gastroenteritis (792); chronic renal failure, pulmonary edema, or other conditions in which volume expansion is contrain-
dicated (90); or noninfectious causes of severe illness (68); or because they had already received isotonic volume resuscitation (79). In 
addition, 458 children were not enrolled in the trial because they were unable to return for follow-up assessments (111 children), were 
enrolled in a different study (65), had been previously enrolled in the FEAST trial (17), or died before enrollment (11); because no fluid or 
blood or trial packs were available (47); or because of other reasons (181). The reason for noneligibility was missing in the case of 26 chil-
dren. During the intervention period, among children in stratum A, 1 child in the albumin-bolus group did not fulfill the eligibility criteria 
because the child had no fever or history of fever, and 2 children in the saline-bolus group did not fulfill the eligibility criteria, one be-
cause the child had severe hypotension and the other because the child did not have impaired perfusion.
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signments. Children with neurologic sequelae at 
4 weeks were reassessed at 24 weeks.
Statistical Analysis
The protocol specified two primary comparisons 
(saline bolus vs. control, and albumin bolus vs. 
saline bolus) with respect to the risk of death 
from any cause by 48 hours. In stratum A, the 
initial sample size of 2800 assumed a risk of 
death of 15% in the control group12; however, 
through a protocol amendment in June 2010, the 
sample size was increased to 3600 because the 
risk of death in the combined groups was lower 
than anticipated. We estimated that with a sam-
ple size of 3600 children, the study would have 
80% power to detect a 33% relative reduction in 
mortality with a saline bolus as compared with 
the control group and a 40% reduction with an 
albumin bolus as compared with a saline bolus, 
assuming a risk of death of 11% in the control 
group, at a two-sided alpha level of 0.05, adjusted 
for two comparisons with the use of a nominal 
alpha of 0.025.
All the analyses were performed according to 
the intention-to-treat principle, and all the sta-
tistical tests were two-sided. The three treatment 
groups were compared with respect to the pri-
mary end point (48-hour mortality) with the use 
of the chi-square test, and the relative difference 
among the groups was estimated by a calculation 
of the relative risk (the ratio of the proportion of 
children who died by 48 hours), adjusted for 
stratification according to clinical center and 
randomization date (before or after the protocol 
amendment) with the use of a Mantel–Haenszel 
type of adjustment.20 Kaplan–Meier plots show 
the time to death according to treatment group 
during the first 48 hours. The few children whose 
vital status was unknown (because of withdrawal 
of consent or loss to follow-up) were assumed to 
be alive at the end of the study. The same meth-
ods were used for the prespecified secondary 
comparisons, including pairwise comparisons of 
the risk of death or neurologic sequelae by 4 weeks 
and comparisons of bolus therapy (combined albu-
min bolus and saline bolus) with control (no bo-
lus) with respect to the risk of death at 48 hours 
and the risk of neurologic sequelae or death by 
4 weeks. Comparisons among the three groups 
with respect to the primary end point were also 
summarized for predefined subgroups according 
to coma status, positive or negative status for ma-
laria, presence or absence of severe anemia (hemo-
globin level <5 g per deciliter vs. ≥5 g per decili-
ter), age, sex, base deficit (≥8 mmol per liter vs. 
<8 mmol per liter), lactate level (≥5 mmol per liter 
vs. <5 mmol per liter), and date of randomization 
(before or after the protocol amendment).
R esult s
Study Patients
In stratum A, 3141 children were randomly as-
signed from January 13, 2009, through January 
13, 2011 — 1050 to the albumin-bolus group, 
1047 to the saline-bolus group, and 1044 to the 
control group. Three children who did not meet 
the eligibility criteria were included in all the 
analyses (Fig. 1). The baseline characteristics of 
the children were similar across the groups (Ta-
ble 1). The median age was 24 months (inter-
quartile range, 13 to 38); 62% had prostration, 
15% were comatose, and 83% had respiratory dis-
tress. The majority of children (52%) had more 
than one feature of impaired perfusion, most 
commonly severe tachycardia and cold extremi-
ties. Moderate-to-severe acidosis was present in 
51% of the children (1070 of 2079) and severe 
lactic acidosis (lactate ≥5 mmol per liter) in 39% 
(1159 of 2981). The mean (±SD) hemoglobin level 
was 7.1±3.2 g per deciliter, and the glucose was 
6.9±3.9 mmol per liter (124±70 mg per deciliter). 
Malaria was confirmed in 57% of the children 
(1793 of 3123), and 4% (106 of 2483) were posi-
tive for human immunodeficiency virus infection. 
Only 17 children (0.5%) were lost to follow-up for 
the primary end point — 7 in the albumin-bolus 
group, 8 in the saline-bolus group, and 2 in the 
control group. Vital status at 4 weeks was ascer-
tained in 97% (1023 of 1050), 98% (1024 of 1047), 
and 98% (1024 of 1044) of the children in the 
three groups, respectively. A total of 29 children 
were enrolled in stratum B. The median systolic 
blood pressure was 57 mm Hg (interquartile range, 
51 to 59) (Table 1 in the Supplementary Appendix, 
available at NEJM.org); no children in stratum B 
were lost to follow-up. In both strata, working di-
agnoses were reported by a clinician at 48 hours 
(Table 2 in the Supplementary Appendix).
Administered Fluids
A total of 99.5% of the children in the albumin-
bolus group (1045 of 1050 children) and 99.4% of 
the children in the saline-bolus group (1041 of 
1047) received the treatment to which they had 
been randomly assigned (Fig. 1). One child in the 
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control group received a saline bolus in the first 
hour (owing to hypotension). The median vol-
umes of all fluids (including blood) received dur-
ing the first and second hours were 20.0 ml per 
kilogram (interquartile range, 20.0 to 20.0) and 
4.5 ml per kilogram (interquartile range, 1.7 to 
16.2), respectively, in the albumin-bolus group; 
20.0 ml per kilogram (interquartile range, 20.0 
to 20.0) and 5.0 ml per kilogram (interquartile 
range, 1.7 to 16.0), respectively, in the saline-
bolus group; and 1.2 ml per kilogram (interquar-
tile range, 0 to 2.5) and 2.9 ml per kilogram (in-
terquartile range, 0.2 to 4.2), respectively, in the 
control group. Over the course of 8 hours, the 
median cumulative volume of fluid received was 
40.0 ml per kilogram (interquartile range, 30.0 
to 50.0) in the albumin-bolus group, 40.0 ml per 
kilogram (interquartile range, 30.4 to 50.0) in the 
saline-bolus group, and 10.1 ml per kilogram 
(interquartile range, 10.0 to 25.9) in the control 
group. A total of 1408 children received blood 
transfusions — 472 (45%) in the albumin-bolus 










Demographic and anthropometric characteristics
Age — mo
Median 23 23 25 24
Interquartile range 14–37 13–37 14–40 13–38
Female sex — no. (%) 474 (45) 480 (46) 498 (48) 1452 (46)
Mid-upper-arm circumference ≤11.5 cm —  
no./total no. (%)
21/982 (2) 24/974 (2) 25/1003 (2) 70/2959 (2)
Findings at presentation
Axillary temperature >39°C — no. (%) 243 (23) 236 (23) 264 (25) 743 (24)
Hypothermia (temperature <36°C) — no. (%) 59 (6) 64 (6) 66 (6) 189 (6)
Respiratory distress — no./total no. (%) 874/1048 (83) 854/1045 (82) 857/1037 (83) 2585/3130 (83)
Respiratory rate — breaths/min 58±15 58±15 57±15 58±15
Oxygen saturation <90% — no. (%)† 249/1015 (25) 253/1008 (25) 257/1015 (25) 759/3038 (25)
Bradycardia (<80 beats/min) — no. (%) 13 (1) 7 (1) 10 (1) 30 (1)
Severe tachycardia — no. (%) 736 (70) 721 (69) 738 (71) 2195 (70)
Weak radial pulse — no. (%) 210 (20) 238 (23) 206 (20) 654 (21)
Capillary refill time — no. (%)
≥2 sec 712 (68) 720 (69) 673 (64) 2105 (67)
≥3 sec 263 (25) 299 (29) 257 (25) 819 (26)
Positive temperature gradient — no. (%)‡ 620 (59) 629 (60) 610 (58) 1859 (59)
Systolic blood pressure — mm Hg
Median 92 93 92 93
Interquartile range 85–101 85–101 86–101 85–101
Moderate hypotension — no./total no. (%)§ 66/1030 (6) 69/1036 (7) 57/1034 (6) 192/3100 (6)
Dehydration — no. (%)¶ 78 (7) 95 (9) 58 (6) 231 (7)
Severe pallor manifested in lips, gums, or inner eyelids 
— no. (%)
523 (50) 546 (52) 520 (50) 1589 (51)
Prostration — no./total no. (%)∥ 655/1048 (62) 667/1046 (64) 619/1044 (59) 1941/3138 (62)
Coma — no. (%)** 156 (15) 161 (15) 140 (13) 457 (15)
Convulsions during this illness — no./total no. (%) 414/1047 (40) 387/1045 (37) 371/1039 (36) 1172/3131 (37)
Hemoglobinuria (dark urine) — no. (%) 122 (12) 123 (12) 144 (14) 389 (12)
Jaundice visible to clinician — no. (%) 336 (32) 336 (32) 330 (32) 1002 (32)
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group, 487 (47%) in the saline-bolus group, and 
449 (43%) in the control group. Transfusion was 
initiated marginally earlier in the control group, 
but by 2 hours the proportion of children who 
received transfusions and the volumes of blood 
received were similar across all groups (Fig. 1 and 
Table 3 in the Supplementary Appendix).
End Points
By 48 hours, 111 of the children in the albumin-
bolus group (10.6%), 110 children in the saline-
bolus group (10.5%), and 76 children in the control 
group (7.3%) had died. The relative risk of death 
with a saline bolus versus no bolus was 1.44 (95% 
confidence interval [CI], 1.09 to 1.90; P = 0.01); 
the relative risk of death with an albumin bolus 
versus a saline bolus was 1.00 (95% CI, 0.78 to 
1.29; P = 0.96); and the relative risk of death with 
bolus therapy (combined albumin bolus and sa-
line bolus) versus no bolus was 1.45 (95% CI, 
1.13 to 1.86; P = 0.003) (Table 2); the absolute dif-
ference in risk was 3.3 percentage points (95% CI, 
1.2 to 5.3). There was no evidence of heterogeneity 
according to center (Fig. 2 in the Supplementary 
Appendix) or date of randomization before or after 
the protocol amendment (Fig. 2). In stratum B, 
9 of 13 children in the albumin-bolus group (69%) 
and 9 of 16 in the saline-bolus group (56%) died 
(relative risk with albumin bolus, 1.23; 95% CI, 












Positive for malaria parasitemia — no./total no. (%)‡‡ 590/1044 (57) 612/1042 (59) 591/1037 (57) 1793/3123 (57)
Hemoglobin — no./total no. (%)
<5 g/dl 323/1024 (32) 332/1015 (33) 332/1015 (33) 987/3054 (32)
>10 g/dl 231/1024 (23) 230/1015 (23) 244/1015 (24) 705/3054 (23)
Glucose — no./total no. (%)
<2.5 mmol/liter (45 mg/dl) 43/990 (4) 46/991 (5) 42/989 (4) 131/2970 (4)
<3.0 mmol/liter (54 mg/dl) 67/990 (7) 61/991 (6) 59/989 (6) 187/2970 (6)
Lactate ≥5 mmol/liter — no./total no. (%) 357/1000 (36) 407/989 (41) 395/992 (40) 1159/2981(39)
Base deficit ≥8 mmol/liter — no./total no. (%) 380/710 (54) 360/689 (52) 330/680 (49) 1070/2079 (51)
Severe acidemia (pH <7.2) — no./total no. (%) 71/712 (10) 73/694 (11) 65/685 (9) 209/2091 (10)
Hyperkalemia (potassium >6.5 mmol/liter) — no./ 
total no. (%)
67/686 (10) 68/687 (10) 65/670 (10) 200/2043 (10)
Positive for HIV antibody — no./total no. (%) 37/817 (5) 28/827 (3) 41/839 (5) 106/2483 (4)
Positive blood culture — no. of positive cultures/ 
total no. of cultures (%)
38/347 (11) 52/360 (14) 36/363 (10) 126/1070 (12)
Positive cerebrospinal fluid culture — no. of positive 
cultures/total no. of cultures (%)
2/94 (2) 4/102 (4) 4/96 (4) 10/292 (3)
* Plus–minus values are mean ±SD. HIV denotes human immunodeficiency virus.
† Oxygen saturation and pulse rate were recorded by a pulse oximeter.
‡ The temperature gradient was assessed by running the back of hand from the toe to the knee; a positive temperature gradient was defined 
as a notable temperature change from cold (dorsum of foot) to warm (knee).
§ Moderate hypotension was defined as a systolic blood pressure of 50 to 75 mm Hg in children younger than 12 months of age, 60 to 75 
mm Hg in children 12 months to 5 years of age, and 70 to 85 mm Hg in children older than 5 years of age, as measured with the use of 
an automated blood-pressure monitor.
¶ Dehydration was identified by the presence of sunken eyes or decreased skin turgor.
∥ Prostration was defined as the inability of a child older than 8 months of age to sit upright or the inability of a child 8 months of age or 
younger to breast-feed.
** Coma was defined as the inability to localize a painful stimulus.
†† Venous blood samples were obtained at admission for immediate analyses of pH level and potassium level with the use of a handheld 
blood analyzer (i-STAT, Abbott Laboratories); measurement of hemoglobin (HemoCue), blood glucose, and lactate levels; and HIV anti-
body testing. Denominators vary because data for some children were not available. Blood smears to test for malaria parasites were pre-
pared for immediate reading and subsequent quality control. Blood cultures at admission were obtained at certain centers only.
‡‡ The parasite that was identified was Plasmodium falciparum in every case except four: three in which P. vivax was identified and one in 
which P. ovale was identified.
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The risk of death 1 hour after randomization 
was similar in the three groups (1.2% in the al-
bumin-bolus group, 1.1% in the saline-bolus 
group, and 1.3% in the control group). Beyond 
1 hour, there was a persistent trend to higher 
mortality in the bolus groups as compared with 
the control group (Fig. 2A). Most deaths oc-
curred before 24 hours (259 deaths, 87%). Only a 
small number of deaths occurred after 48 hours, 
and there was no evidence that children in the 
control group had excess delayed mortality (Fig. 
2B). The excess mortality associated with the 
bolus groups as compared with the control group 
was consistent across all prespecified subgroups 
(Fig. 3), and there was no evidence supporting a 
benefit from bolus fluid infusion in any sub-
group. At 4 weeks, neurologic sequelae were 
noted in 22 children (2.2%) in the albumin-bolus 
group, 19 (1.9%) in the saline-bolus group, and 
20 (2.0%) in the control group (P = 0.92 for bolus 
vs. control) (Table 2). The 24-week follow-up as-
sessment is ongoing.
Suspected pulmonary edema occurred in 26 
children (14 in the albumin-bolus group, 6 in the 
saline-bolus group, and 6 in the control group) 
and increased intracranial pressure in 45 children 
(16 in the albumin-bolus group, 18 in the saline-
bolus group, and 11 in the control group) (P = 0.17 
for the comparison of bolus with control with 
respect to combined pulmonary edema and in-
creased intracranial pressure) (Table 2). Details 
of the review of deaths and targeted adverse 
events by the end-point review committee are 
provided in Tables 4A and 4B in the Supplemen-
tary Appendix.
Discussion
We evaluated the effect of resuscitation with bo-
lus fluids in children who presented to the hos-
pital with severe febrile illness and impaired per-
fusion, in order to generate practical data for 
resource-poor settings in sub-Saharan Africa in 
which malaria is endemic. Bolus-fluid resuscita-
tion with either albumin or saline, as compared 
with control, increased the absolute risk of death 
at 48 hours by 3.3 percentage points and the risk 
of death, neurologic sequelae, or both at 4 weeks 
by nearly 4 percentage points. There was no evi-
dence of a difference in either primary or second-
ary end points between the albumin-bolus and 
saline-bolus groups. Most deaths (87%) occurred 
before 24 hours; however, the predicted severe 
adverse effects of fluid overload (pulmonary ede-
ma or increased intracranial pressure) developed 
in few children. Our findings appear to be robust 
owing to the large number of children enrolled, 
the multinational nature of the sample, the small 
loss to follow-up, the concealment of treatment 
assignments, and the high rate of adherence to 
the assigned treatment. The results do not sup-
port the routine use of bolus resuscitation in se-
verely ill febrile children with impaired perfusion 
in African hospitals and also raise questions about 
its use in other settings.
Our large, controlled trial of fluid resuscita-
tion applied an international standard of prac-
tice (bolus-fluid resuscitation) and compared it 
with the local standard of care (no bolus-fluid 
resuscitation). It was conducted in typical African 
hospitals, which have no intensive care facilities. 
The inclusion criteria were broad, but children 
with gastroenteritis, severe malnutrition, or non-
infectious causes of shock were excluded, so re-
sults cannot be extrapolated to those groups. 
Few children were recruited to stratum B, which 
was reserved for children with severe hypoten-
sion, in whom randomization to a control group 
was considered to be unethical, and mortality 
was high in both bolus groups in that stratum.
Clinical differentiation of major causes of se-
vere illness in sub-Saharan Africa — in particular, 
severe malaria, sepsis, pneumonia, and menin-
gitis — is not possible at the time of admission 
to the hospital.21,22 However, recommendations 
regarding fluid resuscitation differ substantially 
among these conditions,16 and the practice of 
fluid resuscitation remains highly controversial 
in children with severe malaria.23-25 By including 
in our study children with these critical illnesses, 
our trial offered an efficient means of providing 
practical information for hospitals that have few 
diagnostic facilities. Mortality was lower than 
expected and than previously reported.12,14,22 
Consistent with other studies,22,26 mortality was 
lower in children with severe malaria than in the 
subgroup without malaria, but there was no evi-
dence that the increase in 48-hour mortality as-
sociated with boluses differed between the two 
subgroups. Although fluid boluses adversely af-
fected the outcome, important survival gains, 
across all the groups, may have resulted from 
training and implementation of triage, basic life-
support measures, and regular observation.
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We could not identify any subgroup in which 
fluid resuscitation was beneficial; this is remark-
able given that many of the baseline characteris-
tics of the children in this study are considered 
to be important criteria for bolus-fluid therapy, 
including moderate hypotension and severe met-
abolic acidosis.27 All the children received main-
tenance fluids and the standard of care recom-
mended by national guidelines. The receipt, and 
the timing of the receipt, of blood, quinine, and 
antibiotics were similar across groups; only bolus-
fluid resuscitation differed between the interven-
tion and control groups. The apparent lack of 
effect on early mortality (<1 hour), followed by 
an increasing negative effect over time, without 
amelioration of neurologic events, suggests a 
consistent adverse effect of bolus resuscitation 
with both saline and albumin. It has been 
thought that albumin has physiological benefits 
over saline, a hypothesis that was supported by 
the results of small trials involving children with 
severe malaria28-30 and a recent analysis of the 
sepsis subgroup31,32 of the adult Saline versus 
Albumin Fluid Evaluation trial (SAFE; Current 
Controlled Trials number, ISRCTN76588266). 
However, we observed no detectable differences 
between the bolus groups, providing evidence 
against a beneficial effect of albumin over saline. 
The excess mortality with fluid resuscitation was 
consistent across all subgroups, irrespective of 
physiological derangement or underlying micro-
bial pathogen, also raising fundamental ques-
tions about our understanding of the patho-
physiology of critical illness.
We had predicted that complications of fluid 
Figure 2. Kaplan–Meier Curves for Mortality.
Kaplan–Meier curves show the rate of death in the three 
study groups over the course of 48 hours from random-
ization (Panel A) and over the course of 4 weeks from 
randomization (Panel B).
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Figure 3. Mortality at 48 hours in Prespecified Subgroups.
The sizes of the boxes are proportional to the Mantel–Haenszel weights. The I2 statistic indicates the percentage of 
total variation that was due to heterogeneity.
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overload would develop in some children and 
incorporated mandatory clinical reviews to moni-
tor for pulmonary edema and increased intracra-
nial pressure. All reported adverse events were re-
viewed by the end-point review committee, whose 
members were unaware of the treatment assign-
ments; in addition the committee reviewed the 
records of all deaths for evidence of the presence 
of pulmonary edema or increased intracranial 
pressure. Few events were identified by this pro-
cess, and there was no evidence of differences 
among the groups; most deaths appeared to be 
attributable to the severity of the underlying con-
dition. The question therefore arises as to the 
reasons for the excess mortality among children 
receiving boluses. Our a priori hypothesis was 
that the benefit of bolus interventions would be 
greatest for the group that was at the highest 
risk, which included the children with the most 
severe hemodynamic and metabolic derange-
ment. However, although the degree of shock 
has been shown to be prognostic for an adverse 
outcome,12,14 our results suggest that it may not 
be a surrogate on the causal pathway for the ef-
fect of bolus resuscitation on survival. One could 
speculate that the vasoconstrictor response in 
shock confers protection by reducing perfusion to 
nonvital tissues and that rapid reversal with 
fluid resuscitation is deleterious. Alternatively, 
the adverse consequences of fluid boluses (even 
at low volumes) might act through other mecha-
nisms such as reperfusion injury, subclinical ef-
fects on pulmonary compliance, myocardial func-
tion, or intracranial pressure.33
In conclusion, the results of this study chal-
lenge the importance of bolus resuscitation as 
a lifesaving intervention in resource-limited 
settings for children with shock who do not 
have hypotension and raise questions regarding 
fluid-resuscitation guidelines in other settings 
as well.
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